liraglutide	SIMPLE	Good	1	0.9613	0.9613
trabectedin	SIMPLE	Good	1	0.9589	0.9589
carnitine-deficient formulas	Normal_NP	Good	1	0.9564	0.9564
golimumab	SIMPLE	Good	1	0.9548	0.9548
cardiometabolic disease	Normal_NP	Good	1	0.954	0.954
mu abobotulinumtoxina	Normal_NP	Good	1	0.9532	0.9532
eltrombopag	SIMPLE	Good	1	0.9524	0.9524
intraoral photographs	Normal_NP	Good	1	0.9516	0.9516
adult platelets	Normal_NP	Good	1	0.95	0.95
pldh	ABBREVIATION	Good	1	0.9491	0.9491
non-splenectomised patient	Normal_NP	Good	1	0.9483	0.9483
irlen syndrome	Normal_NP	Good	1	0.9475	0.9475
cultural competency curriculum	Normal_NP	Good	1	0.9451	0.9451
long-stay chronic care hospital	Normal_NP	Good	1	0.9443	0.9443
surgical site infection	Normal_NP	Good	1	0.9435	0.9435
incobotulinumtoxina	SIMPLE	Good	1	0.9419	0.9419
intradermal botulinum toxin	Normal_NP	Good	1	0.9411	0.9411
hibch gene mutation	Normal_NP	Good	1	0.9403	0.9403
microalbuminuria	SIMPLE	Good	1	0.9395	0.9395
oral antipsychotic	Normal_NP	Good	1	0.9387	0.9387
prucalopride	SIMPLE	Good	1	0.9378	0.9378
medium-long stay hospital	Normal_NP	Good	1	0.9354	0.9354
ofatumumab	SIMPLE	Good	1	0.9346	0.9346
particulate matter	Normal_NP	Good	1	0.9338	0.9338
schizophrenic spectrum	Normal_NP	Good	1	0.933	0.933
chronic lumbosacral radiculopathy	Normal_NP	Good	1	0.9314	0.9314
mu onabotulinumtoxina	Normal_NP	Good	1	0.9306	0.9306
long-stay chronic care	Normal_NP	Good	1	0.9306	0.9306
calmodulin antagonist	Normal_NP	Good	1	0.9306	0.9306
anaerobic gram-negative bacteria	Normal_NP	Good	1	0.9282	0.9282
nccn colorectal cancer guidelines	Normal_NP	Good	1	0.9274	0.9274
hibch gene	Normal_NP	Good	1	0.9266	0.9266
gene expression analysis tools	Normal_NP	Good	1	0.9242	0.9242
leigh-like syndrome	Normal_NP	Good	1	0.9226	0.9226
static pressure-volume loop	Normal_NP	Good	1	0.9218	0.9218
synaptogenesis	SIMPLE	Good	1	0.921	0.921
hbsag quantification	Normal_NP	Good	1	0.921	0.921
haemophilia b	Normal_NP	Good	1	0.921	0.921
l-carnitine	HYPHENATION	Good	1.0	0.9202	0.9202
colorectal cancer guidelines	Normal_NP	Good	1	0.9194	0.9194
autistic spectrum	Normal_NP	Good	1	0.917	0.917
lumbosacral radiculopathy	Normal_NP	Good	1	0.9155	0.9155
cultural competency training	Normal_NP	Good	1	0.9155	0.9155
nitrous oxide	Normal_NP	Good	1	0.9139	0.9139
kvik pathways	Normal_NP	Good	1	0.9139	0.9139
gram-negative bacteria	Normal_NP	Good	1	0.9131	0.9131
colorectal carcinogenesis	Normal_NP	Good	1	0.9123	0.9123
hibch	ABBREVIATION	Good	1	0.9115	0.9115
pediatric asthma	Normal_NP	Good	1	0.9107	0.9107
neisseria vaccines	Normal_NP	Good	1	0.9107	0.9107
minirin parenteral	Normal_NP	Good	1	0.9107	0.9107
medium-long stay	Normal_NP	Good	1	0.9107	0.9107
hypertonic saline	Normal_NP	Good	1	0.9107	0.9107
carbonyl cyanide m-chlorophenyl hydrazone	Normal_NP	Good	1	0.9099	0.9099
electrochemical potential	Normal_NP	Good	1	0.9091	0.9091
attention-deficit hyperactivity disorder	Normal_NP	Good	1	0.9067	0.9067
tmd symptoms	Normal_NP	Good	1	0.9044	0.9044
person-years	HYPHENATION	Good	1	0.9044	0.9044
enteroviruses	SIMPLE	Good	1	0.9044	0.9044
fga-lai	HYPHENATION	Good	1.0	0.9012	0.9012
competency curriculum	Normal_NP	Good	1	0.9004	0.9004
orthopaedic trauma fellowship match	Normal_NP	Good	1	0.8996	0.8996
enteral carnitine-deficient formulas	Normal_NP	Good	1	0.8996	0.8996
idiopathic rbd	Normal_NP	Good	1	0.8988	0.8988
low-cost science communication activity	Normal_NP	Good	1	0.898	0.898
legume-rhizobium symbiosis proteomics	Normal_NP	Good	1	0.898	0.898
ground air quality observation sites	Normal_NP	Good	1	0.898	0.898
renal osteodystrophy	Normal_NP	Good	1	0.8973	0.8973
pressure-volume loop	Normal_NP	Good	1	0.8973	0.8973
bluecross blueshield	Normal_NP	Good	1	0.8973	0.8973
non-native hawaiians	Normal_NP	Good	1	0.8941	0.8941
nccn lymphoma panels	Normal_NP	Good	1	0.8941	0.8941
haemorrhagic disorder	Normal_NP	Good	1	0.8941	0.8941
post-dormitum	HYPHENATION	Good	1.0	0.8925	0.8925
platinum-sensitive ovarian cancer	Normal_NP	Good	1	0.8918	0.8918
multiagent chemotherapy regimen	Normal_NP	Good	1	0.8918	0.8918
cyanide m-chlorophenyl hydrazone	Normal_NP	Good	1	0.8918	0.8918
atherosclerotic vascular disease	Normal_NP	Good	1	0.8918	0.8918
image-reconstruction algorithm	Normal_NP	Good	1	0.891	0.891
end-expiratory pressure adjustment	Normal_NP	Good	1	0.891	0.891
electroencephalographic abnormalities	Normal_NP	Good	1	0.891	0.891
cftr-related metabolic syndrome	Normal_NP	Good	1	0.891	0.891
carnitine-supplemented formula	Normal_NP	Good	1	0.891	0.891
aerobic gram-positive bacteria	Normal_NP	Good	1	0.891	0.891
aerobic gram-negative bacteria	Normal_NP	Good	1	0.891	0.891
intra-observer agreement	Normal_NP	Good	1	0.8902	0.8902
haemophilia b patients	Normal_NP	Good	1	0.8902	0.8902
diabetes self-management education	Normal_NP	Good	1	0.8878	0.8878
cognitive-behavioral strategies	Normal_NP	Good	1	0.8878	0.8878
surgical luxation	Normal_NP	Good	1	0.8871	0.8871
bullous rash	Normal_NP	Good	1	0.8871	0.8871
cardiotoxicity	SIMPLE	Good	1	0.8863	0.8863
airtum	SIMPLE	Good	1	0.8855	0.8855
subtalar joint endoprosthesis	Normal_NP	Good	1	0.8847	0.8847
fand-graev inversion formula	Normal_NP	Good	1	0.8847	0.8847
hx-cd20-406 study	Normal_NP	Good	1	0.8839	0.8839
airway epithelium	Normal_NP	Good	1	0.8839	0.8839
mbar	SIMPLE	Good	1	0.8831	0.8831
syr-darya valley fever virus	Normal_NP	Good	1	0.8824	0.8824
rural primary care workforce	Normal_NP	Good	1	0.8824	0.8824
polyreactive immunoglobulins	Normal_NP	Good	1	0.8824	0.8824
mucocutaneous bullous reactions	Normal_NP	Good	1	0.8824	0.8824
proteinuria	SIMPLE	Good	1	0.8816	0.8816
samoa health care	Normal_NP	Good	1	0.8808	0.8808
pldh monotherapy	Normal_NP	Good	1	0.8808	0.8808
haemophilic patients	Normal_NP	Good	1	0.8808	0.8808
fibrous encapsulation	Normal_NP	Good	1	0.8808	0.8808
competency training	Normal_NP	Good	1	0.8808	0.8808
aluminum chloride	Normal_NP	Good	1	0.8808	0.8808
georgetown diabetes coalition	Normal_NP	Good	1	0.88	0.88
pipaq-short	HYPHENATION	Good	1.0	0.8792	0.8792
btxa injection	Normal_NP	Good	1	0.8792	0.8792
post-participation surveys	Normal_NP	Good	1	0.8785	0.8785
pediatric cardiac surgery	Normal_NP	Good	1	0.8785	0.8785
legume-rhizobium symbiosis	Normal_NP	Good	1	0.8785	0.8785
ground air quality observation	Normal_NP	Good	1	0.8785	0.8785
cultural identity subscale	Normal_NP	Good	1	0.8785	0.8785
adiponectin-deficient mice	Normal_NP	Good	1	0.8785	0.8785
mitochondria	SIMPLE	Good	1	0.8777	0.8777
site infection	Normal_NP	Good	1	0.8769	0.8769
vasogenic edema	Normal_NP	Good	1	0.8746	0.8746
eb virus infection	Normal_NP	Good	1	0.8746	0.8746
contrast detectability	Normal_NP	Good	1	0.8746	0.8746
cadaveric wrist	Normal_NP	Good	1	0.8746	0.8746
aortic pathology	Normal_NP	Good	1	0.8746	0.8746
anti-reflux medication	Normal_NP	Good	1	0.8746	0.8746
secondary organic carbon	Normal_NP	Good	1	0.8738	0.8738
samoa health care providers	Normal_NP	Good	1	0.8738	0.8738
pediatric surgical capacity	Normal_NP	Good	1	0.8738	0.8738
gastro-oesophageal junction	Normal_NP	Good	1	0.8738	0.8738
epidemiological investigation	Normal_NP	Good	1	0.8738	0.8738
st jude medical portico valve transcatheter aortic	Normal_NP	Good	1	0.8722	0.8722
ebv-associated hemophagocytic lymphohistiocytosis	Normal_NP	Good	1	0.8722	0.8722
systematic review second-generation antipsychotics	Normal_NP	Good	1	0.8715	0.8715
edwards centera valve transcatheter aortic valve	Normal_NP	Good	1	0.8715	0.8715
disorder attention deficit hyperactivity disorder	Normal_NP	Good	1	0.8715	0.8715
cultural competency curriculum development team	Normal_NP	Good	1	0.8715	0.8715
attention deficit hyperactivity disorder cognitive	Normal_NP	Good	1	0.8715	0.8715
hepatobiliary cancer	Normal_NP	Good	1	0.8707	0.8707
n-terminal pro-brain b-type natriuretic peptide	Normal_NP	Good	1	0.8691	0.8691
hermansky-pudlak syndrome oculocutaneous albinism	Normal_NP	Good	1	0.8691	0.8691
chrysotile asbestos ore concentration workshop	Normal_NP	Good	1	0.8691	0.8691
staphylococcal endocarditis	Normal_NP	Good	1	0.8684	0.8684
st jude medical portico	Normal_NP	Good	1	0.8684	0.8684
primary molar hypomineralization	Normal_NP	Good	1	0.8684	0.8684
musculoskeletal parameters	Normal_NP	Good	1	0.8684	0.8684
m-chlorophenyl hydrazone	Normal_NP	Good	1	0.8684	0.8684
ischemic cardiomyopathy	Normal_NP	Good	1	0.8684	0.8684
site infection aerobic gram-positive bacteria	Normal_NP	Good	1	0.8668	0.8668
diverse clinic population group medical visits	Normal_NP	Good	1	0.8668	0.8668
pipaq-long	HYPHENATION	Good	1.0	0.8661	0.8661
perfectionism	SIMPLE	Good	1	0.8661	0.8661
bangladesh	SIMPLE	Good	1	0.8661	0.8661
eeep	ABBREVIATION	Good	1	0.8653	0.8653
osteodystrophy	SIMPLE	Good	1	0.8645	0.8645
second-generation oral antipsychotics confidence	Normal_NP	Good	1	0.8637	0.8637
primary prevention current practice guidelines	Normal_NP	Good	1	0.8637	0.8637
intradermal facial onabotulinumtoxina injection	Normal_NP	Good	1	0.8637	0.8637
gw nonsynonymous single-nucleotide polymorphism	Normal_NP	Good	1	0.8637	0.8637
cystic fibrosis foundation practice guidelines	Normal_NP	Good	1	0.8637	0.8637
von willebrand syndrome	Normal_NP	Good	1	0.863	0.863
ventricular hypoplasia	Normal_NP	Good	1	0.863	0.863
sarcoplasmic reticulum	Normal_NP	Good	1	0.863	0.863
propriospinal myoclonus	Normal_NP	Good	1	0.863	0.863
intracellular bacteria	Normal_NP	Good	1	0.863	0.863
immunoglobulin molecules	Normal_NP	Good	1	0.863	0.863
encephalomyelitis virus	Normal_NP	Good	1	0.863	0.863
baseline iga-lcl severity	Normal_NP	Good	1	0.863	0.863
adult haemophilic patients	Normal_NP	Good	1	0.863	0.863
omalizumab	SIMPLE	Good	1	0.8622	0.8622
unambiguous patient identification strategy	Normal_NP	Good	1	0.8614	0.8614
medical management primary hyperparathyroidism	Normal_NP	Good	1	0.8614	0.8614
first-cancer-site-and-gender-specific sheets	Normal_NP	Good	1	0.8614	0.8614
beta-hydroxyisobutyryl coa deacylase deficiency	Normal_NP	Good	1	0.8614	0.8614
carboxyl-terminal parathyroid hormone fragments	Normal_NP	Good	1	0.8606	0.8606
ampicillin-ceftriaxone combination therapy	Normal_NP	Good	1	0.8606	0.8606
sdvfv	ABBREVIATION	Good	1	0.8599	0.8599
pediatric neurologists	Normal_NP	Good	1	0.8591	0.8591
hawaiian medical students	Normal_NP	Good	1	0.8591	0.8591
durable medical equipment	Normal_NP	Good	1	0.8591	0.8591
ulcerative colitis disease activity index	Normal_NP	Good	1	0.8583	0.8583
st jude medical portico valve transcatheter	Normal_NP	Good	1	0.8583	0.8583
oral second-generation antipsychotic drugs	Normal_NP	Good	1	0.8583	0.8583
nonsynonymous single-nucleotide polymorphism	Normal_NP	Good	1	0.8583	0.8583
heparin-induced thrombocytopenia diagnosis	Normal_NP	Good	1	0.8583	0.8583
radiculopathy	SIMPLE	Good	1	0.8576	0.8576
madrid health	Normal_NP	Good	1	0.8576	0.8576
bullous reactions	Normal_NP	Good	1	0.8576	0.8576
sleep-to-wake transition movement disorders	Normal_NP	Good	1	0.8568	0.8568
productive government-sector partnership	Normal_NP	Good	1	0.8568	0.8568
post-natal biventricular repair strategies	Normal_NP	Good	1	0.8568	0.8568
pediatric ulcerative colitis disease activity	Normal_NP	Good	1	0.8568	0.8568
parathyroid-related hypocalcemic syndromes	Normal_NP	Good	1	0.8568	0.8568
iterative image-reconstruction algorithm	Normal_NP	Good	1	0.8568	0.8568
infection aerobic gram-positive bacteria	Normal_NP	Good	1	0.8568	0.8568
hereditary hyperparathyroidism-jaw tumor	Normal_NP	Good	1	0.8568	0.8568
health care administration physician roles	Normal_NP	Good	1	0.8568	0.8568
edwards centera valve transcatheter aortic	Normal_NP	Good	1	0.8568	0.8568
cross-sectional epidemiological investigation	Normal_NP	Good	1	0.8568	0.8568
cf foundation clinical practice guidelines	Normal_NP	Good	1	0.8568	0.8568
wanfang data knowledge service platform	Normal_NP	Good	1	0.856	0.856
safety attitude questionnaire-icu model	Normal_NP	Good	1	0.856	0.856
attention deficit hyper-activity disorder	Normal_NP	Good	1	0.856	0.856
airtum population-based cancer registries	Normal_NP	Good	1	0.856	0.856
aggressive preventive treatment programs	Normal_NP	Good	1	0.856	0.856
cone-beam	HYPHENATION	Good	1.0	0.8553	0.8553
septal defect closure	Normal_NP	Good	1	0.8545	0.8545
post-doctoral fellow	Normal_NP	Good	1	0.8545	0.8545
phosphate homeostasis	Normal_NP	Good	1	0.8545	0.8545
nosocomial pneumonia	Normal_NP	Good	1	0.8545	0.8545
nonconventional risk	Normal_NP	Good	1	0.8545	0.8545
neuromuscular disorders	Normal_NP	Good	1	0.8545	0.8545
nccn colorectal cancer	Normal_NP	Good	1	0.8545	0.8545
mitochondrial matrix	Normal_NP	Good	1	0.8545	0.8545
hypertrypsinogenemia	SIMPLE	Good	1	0.8545	0.8545
hematological malignancies	Normal_NP	Good	1	0.8545	0.8545
experiential program	Normal_NP	Good	1	0.8545	0.8545
chlorpyrifos exposure	Normal_NP	Good	1	0.8545	0.8545
qingdao	SIMPLE	Good	1	0.8537	0.8537
ovarian tissue	Normal_NP	Good	1	0.853	0.853
neisseria	SIMPLE	Good	1	0.8522	0.8522
hypomineralization	SIMPLE	Good	1	0.8522	0.8522
total-variation minimization algorithm	Normal_NP	Good	1	0.8514	0.8514
short-course preoperative radiotherapy	Normal_NP	Good	1	0.8514	0.8514
rehab experience holland bloorview kids	Normal_NP	Good	1	0.8514	0.8514
potential-sensitive carbocyanine-derived	Normal_NP	Good	1	0.8514	0.8514
methicillin-susceptible staphylococcci	Normal_NP	Good	1	0.8514	0.8514
culturally-specific measurement instrument	Normal_NP	Good	1	0.8514	0.8514
cultural competency curriculum development	Normal_NP	Good	1	0.8514	0.8514
competency curriculum development team	Normal_NP	Good	1	0.8514	0.8514
carbapenemase-producing enterobacteria	Normal_NP	Good	1	0.8514	0.8514
state-of-the art health care delivery	Normal_NP	Good	1	0.8507	0.8507
sensitive sodium-chloride cotransporter	Normal_NP	Good	1	0.8507	0.8507
quality diabetes self-management education	Normal_NP	Good	1	0.8507	0.8507
psoriatic arthritis response criteria	Normal_NP	Good	1	0.8507	0.8507
non-epileptic nocturnal paroxysmal events	Normal_NP	Good	1	0.8507	0.8507
mitochondrial electrochemical potential	Normal_NP	Good	1	0.8507	0.8507
infectious disease prevention programs	Normal_NP	Good	1	0.8507	0.8507
hyperparathyroidism-jaw tumor syndrome	Normal_NP	Good	1	0.8507	0.8507
foundation clinical practice guidelines	Normal_NP	Good	1	0.8507	0.8507
fibrosis foundation practice guidelines	Normal_NP	Good	1	0.8507	0.8507
facial rejuvenation combination treatment	Normal_NP	Good	1	0.8507	0.8507
dental hygiene research dental hygiene	Normal_NP	Good	1	0.8507	0.8507
clinic population group medical visits	Normal_NP	Good	1	0.8507	0.8507
asymptomatic primary hyperparathyroidism	Normal_NP	Good	1	0.8507	0.8507
aggressive intravenous fluid resuscitation	Normal_NP	Good	1	0.8507	0.8507
phosphate reabsorption	Normal_NP	Good	1	0.8499	0.8499
pediatric rehabilitation	Normal_NP	Good	1	0.8499	0.8499
parathyroid adenoma	Normal_NP	Good	1	0.8499	0.8499
otolaryngology-head	HYPHENATION	Good	1.0	0.8499	0.8499
metacognitive regulation	Normal_NP	Good	1	0.8499	0.8499
janeiro-born doctor	Normal_NP	Good	1	0.8499	0.8499
inpatient satisfaction	Normal_NP	Good	1	0.8499	0.8499
immunologic parameters	Normal_NP	Good	1	0.8499	0.8499
hepatocellular cancer	Normal_NP	Good	1	0.8499	0.8499
elective laparotomy	Normal_NP	Good	1	0.8499	0.8499
bidirectional influence	Normal_NP	Good	1	0.8499	0.8499
antidiuretic hormone	Normal_NP	Good	1	0.8499	0.8499
listeria monocytogenes	Normal_NP	Good	1	0.8491	0.8491
samoa health	Normal_NP	Good	1	0.8484	0.8484
pre-dormitum	HYPHENATION	Good	1.0	0.8484	0.8484
pipaq instruments	Normal_NP	Good	1	0.8484	0.8484
ctn concentration	Normal_NP	Good	1	0.8484	0.8484
second-line treatment post rituximab	Normal_NP	Good	1	0.8476	0.8476
second-generation antipsychotic drugs	Normal_NP	Good	1	0.8476	0.8476
review second-generation antipsychotics	Normal_NP	Good	1	0.8476	0.8476
quaternary-level academic health sciences	Normal_NP	Good	1	0.8476	0.8476
prevention current practice guidelines	Normal_NP	Good	1	0.8476	0.8476
patient lacrimo-auriculo-dento-digital	Normal_NP	Good	1	0.8476	0.8476
non-proliferatious fibroadenoma masses	Normal_NP	Good	1	0.8476	0.8476
heterogeneous neurobiological disorder	Normal_NP	Good	1	0.8476	0.8476
her2-negative metastatic breast cancer	Normal_NP	Good	1	0.8476	0.8476
health information technology vendors	Normal_NP	Good	1	0.8476	0.8476
health care administration physician	Normal_NP	Good	1	0.8476	0.8476
gestational antiblastic chemotherapy	Normal_NP	Good	1	0.8476	0.8476
georgetown diabetes coalition diabetes	Normal_NP	Good	1	0.8476	0.8476
differential centrifugation sedimentation	Normal_NP	Good	1	0.8476	0.8476
carboxyl-terminal parathyroid hormone	Normal_NP	Good	1	0.8476	0.8476
autosomal-dominant congenital disorder	Normal_NP	Good	1	0.8476	0.8476
nhpi	SIMPLE	Good	1	0.8468	0.8468
btxa	ABBREVIATION	Good	1	0.8468	0.8468
watch-and-rescue treatment scenario	Normal_NP	Good	1	0.8461	0.8461
self-expandable edwards centera thv	Normal_NP	Good	1	0.8461	0.8461
prototypic transcatheter heart valves	Normal_NP	Good	1	0.8461	0.8461
pro-brain b-type natriuretic peptide	Normal_NP	Good	1	0.8461	0.8461
primary hyperparathyroidism vitamin	Normal_NP	Good	1	0.8461	0.8461
pediatric ulcerative colitis disease	Normal_NP	Good	1	0.8461	0.8461
onabotulinumtoxina-treated participants	Normal_NP	Good	1	0.8461	0.8461
methicillin-resistant staphylococci	Normal_NP	Good	1	0.8461	0.8461
measles vaccine vaccination history	Normal_NP	Good	1	0.8461	0.8461
management primary hyperparathyroidism	Normal_NP	Good	1	0.8461	0.8461
literature review infectious diseases	Normal_NP	Good	1	0.8461	0.8461
laxative-refractory chronic constipation	Normal_NP	Good	1	0.8461	0.8461
beta-hydroxyisobutyryl coa deacylase	Normal_NP	Good	1	0.8461	0.8461
asbestos ore concentration workshop	Normal_NP	Good	1	0.8461	0.8461
virus infection	Normal_NP	Good	1	0.8453	0.8453
cone-beam ct	Normal_NP	Good	1	0.8453	0.8453
willebrand syndrome	Normal_NP	Good	1	0.8445	0.8445
subjective symptoms	Normal_NP	Good	1	0.8445	0.8445
prenosologic evaluation	Normal_NP	Good	1	0.8445	0.8445
non-randomised trial	Normal_NP	Good	1	0.8445	0.8445
mirror-image studies	Normal_NP	Good	1	0.8445	0.8445
low-income countries	Normal_NP	Good	1	0.8445	0.8445
legislative agenda	Normal_NP	Good	1	0.8445	0.8445
interfacial strains	Normal_NP	Good	1	0.8445	0.8445
executive dysfunction	Normal_NP	Good	1	0.8445	0.8445
chromosomal abnormalities	Normal_NP	Good	1	0.8445	0.8445
video-polysomnographic pilot study	Normal_NP	Good	1	0.8438	0.8438
valve academic research consortium	Normal_NP	Good	1	0.8438	0.8438
ultra-high molecular weight multimers	Normal_NP	Good	1	0.8438	0.8438
treatment-refractory schizophrenia	Normal_NP	Good	1	0.8438	0.8438
transcatheter mitral valve therapy	Normal_NP	Good	1	0.8438	0.8438
symptomatic talonavicular arthrosis	Normal_NP	Good	1	0.8438	0.8438
stepwise logistic regression models	Normal_NP	Good	1	0.8438	0.8438
stem cell research onjornal nacional	Normal_NP	Good	1	0.8438	0.8438
second-generation oral antipsychotics	Normal_NP	Good	1	0.8438	0.8438
rural primary care workforce crisis	Normal_NP	Good	1	0.8438	0.8438
rehab experience holland bloorview	Normal_NP	Good	1	0.8438	0.8438
proline-rich transmembrane protein	Normal_NP	Good	1	0.8438	0.8438
primary prevention current practice	Normal_NP	Good	1	0.8438	0.8438
oral second-generation antipsychotic	Normal_NP	Good	1	0.8438	0.8438
multiple organ dysfunction syndrome	Normal_NP	Good	1	0.8438	0.8438
multidrug anti-cancer chemotherapy	Normal_NP	Good	1	0.8438	0.8438
intradermal botulinum toxin injections	Normal_NP	Good	1	0.8438	0.8438
hbeag negative chronic hepatitis b	Normal_NP	Good	1	0.8438	0.8438
hawaiian cultural identity subscale	Normal_NP	Good	1	0.8438	0.8438
first-generation antipsychotic lais	Normal_NP	Good	1	0.8438	0.8438
family medicine resident physician	Normal_NP	Good	1	0.8438	0.8438
facultative intracellular bacteria	Normal_NP	Good	1	0.8438	0.8438
epidermal growth factor receptor-2	Normal_NP	Good	1	0.8438	0.8438
endocrinopathy-induced osteoporosis	Normal_NP	Good	1	0.8438	0.8438
cystic fibrosis foundation practice	Normal_NP	Good	1	0.8438	0.8438
cf transmembrane conductance regulator	Normal_NP	Good	1	0.8438	0.8438
cardiovascular disease osteoporosis	Normal_NP	Good	1	0.8438	0.8438
biventricular therapeutic strategies	Normal_NP	Good	1	0.8438	0.8438
chrysotile asbestos	Normal_NP	Good	1	0.843	0.843
transfusion-requiring menorrhagia	Normal_NP	Good	1	0.8422	0.8422
rigorous quality-control standards	Normal_NP	Good	1	0.8422	0.8422
retrospective cohort study surveys	Normal_NP	Good	1	0.8422	0.8422
pediatric asthma pediatric asthma	Normal_NP	Good	1	0.8422	0.8422
paroxysmal kinesigenic dyskinesia	Normal_NP	Good	1	0.8422	0.8422
orthopedic trauma research involvement	Normal_NP	Good	1	0.8422	0.8422
oleksandr volodymyrovych palladin	Normal_NP	Good	1	0.8422	0.8422
novel botulinum toxin topical gel	Normal_NP	Good	1	0.8422	0.8422
non-cystic fibrosis bronchiectasis	Normal_NP	Good	1	0.8422	0.8422
neisseria species vaccine development	Normal_NP	Good	1	0.8422	0.8422
molecular tumor genetics platforms	Normal_NP	Good	1	0.8422	0.8422
microbiological aerosol distribution	Normal_NP	Good	1	0.8422	0.8422
institutional review board approval	Normal_NP	Good	1	0.8422	0.8422
immunotherapeutic agent rituximab	Normal_NP	Good	1	0.8422	0.8422
high sensitive c-reactive protein	Normal_NP	Good	1	0.8422	0.8422
gw nonsynonymous single-nucleotide	Normal_NP	Good	1	0.8422	0.8422
g-protein-coupled receptor family	Normal_NP	Good	1	0.8422	0.8422
fibroblast growth factor receptors	Normal_NP	Good	1	0.8422	0.8422
familial hyperparathyroid syndrome	Normal_NP	Good	1	0.8422	0.8422
edwards centera valve transcatheter	Normal_NP	Good	1	0.8422	0.8422
diabetes quality improvement alliance	Normal_NP	Good	1	0.8422	0.8422
chlorpyrifos exposure chlorpyrifos	Normal_NP	Good	1	0.8422	0.8422
associative perisylvian subsystem	Normal_NP	Good	1	0.8422	0.8422
zoledronate	SIMPLE	Good	1	0.8415	0.8415
taurellus	SIMPLE	Good	1	0.8415	0.8415
parenteral	SIMPLE	Good	1	0.8415	0.8415
aral sea	Normal_NP	Good	1	0.8415	0.8415
agrypnia	SIMPLE	Good	1	0.8415	0.8415
rbd patients	Normal_NP	Good	1	0.8407	0.8407
plasma ptx3	Normal_NP	Good	1	0.8407	0.8407
mitral leaks	Normal_NP	Good	1	0.8407	0.8407
inr monitors	Normal_NP	Good	1	0.8407	0.8407
chlorpyrifos	SIMPLE	Good	1	0.8407	0.8407
bunyaviridae	SIMPLE	Good	1	0.8407	0.8407
anti-tumour	HYPHENATION	Good	1.0	0.8407	0.8407
angiostatin	SIMPLE	Good	1	0.8407	0.8407
vancomycin-resistant	HYPHENATION	Good	1.0	0.84	0.84
syndromic surveillance	Normal_NP	Good	1	0.84	0.84
symbiosis proteomics	Normal_NP	Good	1	0.84	0.84
second-line treatment	Normal_NP	Good	1	0.84	0.84
prosthetic infection	Normal_NP	Good	1	0.84	0.84
phenotypic diversity	Normal_NP	Good	1	0.84	0.84
perinatal networks	Normal_NP	Good	1	0.84	0.84
parathyroid glands	Normal_NP	Good	1	0.84	0.84
oxygenation index	Normal_NP	Good	1	0.84	0.84
nicolaus taurellus	Normal_NP	Good	1	0.84	0.84
neuropediatrician	SIMPLE	Good	1	0.84	0.84
neonatal platelets	Normal_NP	Good	1	0.84	0.84
janeiro polytechnic	Normal_NP	Good	1	0.84	0.84
holland bloorview	Normal_NP	Good	1	0.84	0.84
grantmaking model	Normal_NP	Good	1	0.84	0.84
georgetown diabetes	Normal_NP	Good	1	0.84	0.84
chromosomal aberrations	Normal_NP	Good	1	0.84	0.84
ventricular septal defect closure	Normal_NP	Good	1	0.8392	0.8392
vancomycin-resistant enterococcus	Normal_NP	Good	1	0.8392	0.8392
vancomycin-resistant enterococci	Normal_NP	Good	1	0.8392	0.8392
three-tier data exploration tools	Normal_NP	Good	1	0.8392	0.8392
surgical wait time access target	Normal_NP	Good	1	0.8392	0.8392
remission-induction chemotherapy	Normal_NP	Good	1	0.8392	0.8392
quaternary-level academic health	Normal_NP	Good	1	0.8392	0.8392
quality control electromyography	Normal_NP	Good	1	0.8392	0.8392
prosthesis-size-annulus mismatch	Normal_NP	Good	1	0.8392	0.8392
osteoporosis therapy osteoporosis	Normal_NP	Good	1	0.8392	0.8392
non-inhibitor haemophilia b patients	Normal_NP	Good	1	0.8392	0.8392
non-faculty pharmacist preceptors	Normal_NP	Good	1	0.8392	0.8392
moderate childhood atopic dermatitis	Normal_NP	Good	1	0.8392	0.8392
mena-nccn breast cancer guidelines	Normal_NP	Good	1	0.8392	0.8392
interictal epileptiform discharges	Normal_NP	Good	1	0.8392	0.8392
hypertension--preliminary observations	Normal_NP	Good	1	0.8392	0.8392
facial onabotulinumtoxina injection	Normal_NP	Good	1	0.8392	0.8392
embryonic neural stem cell regulation	Normal_NP	Good	1	0.8392	0.8392
doctoral education doctoral education	Normal_NP	Good	1	0.8392	0.8392
diagnostisch interview voor adhd	Normal_NP	Good	1	0.8392	0.8392
culturally-specific physical activity	Normal_NP	Good	1	0.8392	0.8392
cultural competency training modalities	Normal_NP	Good	1	0.8392	0.8392
collagen-induced platelet aggregation	Normal_NP	Good	1	0.8392	0.8392
coagulase-negative staphylococci	Normal_NP	Good	1	0.8392	0.8392
chrysotile asbestos ore concentration	Normal_NP	Good	1	0.8392	0.8392
cancer patient navigator program	Normal_NP	Good	1	0.8392	0.8392
attitude questionnaire-icu model	Normal_NP	Good	1	0.8392	0.8392
anaerobic gram-positive bacteria	Normal_NP	Good	1	0.8392	0.8392
age-specific gastric cancer risk	Normal_NP	Good	1	0.8392	0.8392
rt001	SIMPLE	Good	1	0.8384	0.8384
watch-and-rescue economic model	Normal_NP	Good	1	0.8377	0.8377
tumor necrosis factor inhibitors	Normal_NP	Good	1	0.8377	0.8377
transmembrane conductance regulator	Normal_NP	Good	1	0.8377	0.8377
transfemoral jenavalve delivery	Normal_NP	Good	1	0.8377	0.8377
thermodynamic equilibrium model	Normal_NP	Good	1	0.8377	0.8377
symptomatic aortic valve disease	Normal_NP	Good	1	0.8377	0.8377
serum calcium homeostasis regulation	Normal_NP	Good	1	0.8377	0.8377
self-expandable nitinol stent housing	Normal_NP	Good	1	0.8377	0.8377
self-expandable edwards centera	Normal_NP	Good	1	0.8377	0.8377
reprise clinical trial programme	Normal_NP	Good	1	0.8377	0.8377
rem-related motoneuron paralysis	Normal_NP	Good	1	0.8377	0.8377
prospective observational studies	Normal_NP	Good	1	0.8377	0.8377
post-natal biventricular repair	Normal_NP	Good	1	0.8377	0.8377
pediatric critical illness score	Normal_NP	Good	1	0.8377	0.8377
pediatric clinical illness score	Normal_NP	Good	1	0.8377	0.8377
novel compound heterozygous mutation	Normal_NP	Good	1	0.8377	0.8377
medtronic corevalve evolut valve	Normal_NP	Good	1	0.8377	0.8377
ligation-dependent probe amplification	Normal_NP	Good	1	0.8377	0.8377
glial fibrillary acidic protein	Normal_NP	Good	1	0.8377	0.8377
genentech oncology trend report	Normal_NP	Good	1	0.8377	0.8377
extrahepatic cholangiocarcinoma	Normal_NP	Good	1	0.8377	0.8377
discussion mantle cell lymphoma	Normal_NP	Good	1	0.8377	0.8377
congenital defect heart surgery	Normal_NP	Good	1	0.8377	0.8377
commercialising innovative ideas	Normal_NP	Good	1	0.8377	0.8377
chronic heart failure follow-up	Normal_NP	Good	1	0.8377	0.8377
centro brasileiro de estudos da	Normal_NP	Good	1	0.8377	0.8377
blood culture-negative endocarditis	Normal_NP	Good	1	0.8377	0.8377
azoxymethane-induced colon cancer	Normal_NP	Good	1	0.8377	0.8377
airtum data management protocol	Normal_NP	Good	1	0.8377	0.8377
plasminogen	SIMPLE	Good	1	0.8362	0.8362
lowlife	SIMPLE	Good	1	0.8354	0.8354
wakefulness--the post-dormitum	Normal_NP	Good	1	0.8346	0.8346
vegetative dysfunction syndrome	Normal_NP	Good	1	0.8346	0.8346
toxic organophosphate compound	Normal_NP	Good	1	0.8346	0.8346
thalamo-limbic system dysfunction	Normal_NP	Good	1	0.8346	0.8346
sporadic parathyroid carcinoma	Normal_NP	Good	1	0.8346	0.8346
risperidone long-acting injection	Normal_NP	Good	1	0.8346	0.8346
rankl-mediated vascular disease	Normal_NP	Good	1	0.8346	0.8346
prototypic transcatheter heart	Normal_NP	Good	1	0.8346	0.8346
prospective non-randomised trial	Normal_NP	Good	1	0.8346	0.8346
population group medical visits	Normal_NP	Good	1	0.8346	0.8346
pediatric rehabilitation centre	Normal_NP	Good	1	0.8346	0.8346
otorhinosinusal system account	Normal_NP	Good	1	0.8346	0.8346
negative post-operative outcomes	Normal_NP	Good	1	0.8346	0.8346
nature influence media coverage	Normal_NP	Good	1	0.8346	0.8346
multiresistant corynebacterium	Normal_NP	Good	1	0.8346	0.8346
multicentre non-randomised trial	Normal_NP	Good	1	0.8346	0.8346
monoclonal parathyroid adenoma	Normal_NP	Good	1	0.8346	0.8346
minimise paravalvular regurgitation	Normal_NP	Good	1	0.8346	0.8346
homogeneous multimer distribution	Normal_NP	Good	1	0.8346	0.8346
first-in-human clinical experience	Normal_NP	Good	1	0.8346	0.8346
extracorporeal membrane oxygenation	Normal_NP	Good	1	0.8346	0.8346
extracellular calcium concentrations	Normal_NP	Good	1	0.8346	0.8346
endocrinology clinical practice	Normal_NP	Good	1	0.8346	0.8346
coordination skill gait rhythm	Normal_NP	Good	1	0.8346	0.8346
conventional radiographic findings	Normal_NP	Good	1	0.8346	0.8346
collaborative research project	Normal_NP	Good	1	0.8346	0.8346
collaborative health care teams	Normal_NP	Good	1	0.8346	0.8346
clinical trial pityriasis alba	Normal_NP	Good	1	0.8346	0.8346
cf foundation clinical practice	Normal_NP	Good	1	0.8346	0.8346
carefirst bluecross blueshield	Normal_NP	Good	1	0.8346	0.8346
cardiometabolic disease disparity	Normal_NP	Good	1	0.8346	0.8346
atherosclerosis-related diseases	Normal_NP	Good	1	0.8346	0.8346
acinetobacter baumannii infections	Normal_NP	Good	1	0.8346	0.8346
tourette syndrome	Normal_NP	Good	1	0.8339	0.8339
thrombocytopathy	SIMPLE	Good	1	0.8339	0.8339
synthetic peptides	Normal_NP	Good	1	0.8339	0.8339
serum pepsinogen	Normal_NP	Good	1	0.8339	0.8339
myocardial enzyme	Normal_NP	Good	1	0.8339	0.8339
intraoral camera	Normal_NP	Good	1	0.8339	0.8339
identity subscale	Normal_NP	Good	1	0.8339	0.8339
cortical-networks	HYPHENATION	Good	1	0.8339	0.8339
clinical vertebral	Normal_NP	Good	1	0.8339	0.8339
chronic idiopathic	Normal_NP	Good	1	0.8339	0.8339
wanfang data knowledge service	Normal_NP	Good	1	0.8324	0.8324
vegetative dysfunction intensity	Normal_NP	Good	1	0.8324	0.8324
thrombocytopathy desmopressin	Normal_NP	Good	1	0.8324	0.8324
syndrome oculocutaneous albinism	Normal_NP	Good	1	0.8324	0.8324
symmetrical basal ganglia lesions	Normal_NP	Good	1	0.8324	0.8324
substantia nigra hyperechogenicity	Normal_NP	Good	1	0.8324	0.8324
scapholunate interosseus ligament	Normal_NP	Good	1	0.8324	0.8324
preventive oral health services	Normal_NP	Good	1	0.8324	0.8324
potential bidirectional influences	Normal_NP	Good	1	0.8324	0.8324
peroxisome proliferator activator	Normal_NP	Good	1	0.8324	0.8324
pediatric neurological disorders	Normal_NP	Good	1	0.8324	0.8324
outreach cancer health disparities	Normal_NP	Good	1	0.8324	0.8324
non-cancerous breast pathologies	Normal_NP	Good	1	0.8324	0.8324
nocturnal paroxysmal dystonia	Normal_NP	Good	1	0.8324	0.8324
nocturnal frontal lobe seizures	Normal_NP	Good	1	0.8324	0.8324
murine encephalomyelitis virus	Normal_NP	Good	1	0.8324	0.8324
multi-linear regression model	Normal_NP	Good	1	0.8324	0.8324
microbiological aerosol sampler	Normal_NP	Good	1	0.8324	0.8324
mental health treatment centre	Normal_NP	Good	1	0.8324	0.8324
mainstream health care providers	Normal_NP	Good	1	0.8324	0.8324
intestinal virus-nucleic acid	Normal_NP	Good	1	0.8324	0.8324
interdisciplinary outreach initiative	Normal_NP	Good	1	0.8324	0.8324
integrin-mediated niche adhesion	Normal_NP	Good	1	0.8324	0.8324
government-sector partnership	Normal_NP	Good	1	0.8324	0.8324
free-radical oxidative stress	Normal_NP	Good	1	0.8324	0.8324
epirubicin-containing triplets	Normal_NP	Good	1	0.8324	0.8324
electroencephalographic studies	Normal_NP	Good	1	0.8324	0.8324
deficit hyper-activity disorder	Normal_NP	Good	1	0.8324	0.8324
compressive forearm haematoma	Normal_NP	Good	1	0.8324	0.8324
chronic lymphocytic leukaemia	Normal_NP	Good	1	0.8324	0.8324
cell research onjornal nacional	Normal_NP	Good	1	0.8324	0.8324
biventricular repair strategies	Normal_NP	Good	1	0.8324	0.8324
average interinjection intervals	Normal_NP	Good	1	0.8324	0.8324
anti-tnf therapy-induced imid	Normal_NP	Good	1	0.8324	0.8324
africa region colorectal cancer	Normal_NP	Good	1	0.8324	0.8324
nc patients	Normal_NP	Good	1	0.8316	0.8316
videopolysomnographic recording	Normal_NP	Good	1	0.8308	0.8308
video-polysomnographic pilot	Normal_NP	Good	1	0.8308	0.8308
surgical aortic valve replacement	Normal_NP	Good	1	0.8308	0.8308
subendothelial lipid accumulation	Normal_NP	Good	1	0.8308	0.8308
st jude medical portico valve	Normal_NP	Good	1	0.8308	0.8308
sporadic parathyroid adenomas	Normal_NP	Good	1	0.8308	0.8308
sensitive c-reactive protein	Normal_NP	Good	1	0.8308	0.8308
samoa health care professionals	Normal_NP	Good	1	0.8308	0.8308
regular porcine bioprosthesis	Normal_NP	Good	1	0.8308	0.8308
pth-related protein receptor	Normal_NP	Good	1	0.8308	0.8308
prioritizing dose constraints	Normal_NP	Good	1	0.8308	0.8308
preemptive kidney transplantation	Normal_NP	Good	1	0.8308	0.8308
pre-approval multicentre trials	Normal_NP	Good	1	0.8308	0.8308
posttraumatic epileptogenesis	Normal_NP	Good	1	0.8308	0.8308
pivotal pathophysiologic sites	Normal_NP	Good	1	0.8308	0.8308
pathophysiological interpretations	Normal_NP	Good	1	0.8308	0.8308
participatory research study	Normal_NP	Good	1	0.8308	0.8308
paravalvular aortic regurgitation	Normal_NP	Good	1	0.8308	0.8308
optimize functional recovery	Normal_NP	Good	1	0.8308	0.8308
negative chronic hepatitis b	Normal_NP	Good	1	0.8308	0.8308
nccn specialty pharmacy task	Normal_NP	Good	1	0.8308	0.8308
multiple endocrine neoplasia	Normal_NP	Good	1	0.8308	0.8308
mitochondrial membrane polarization	Normal_NP	Good	1	0.8308	0.8308
macrophage phenotypic switch	Normal_NP	Good	1	0.8308	0.8308
lacrimo-auriculo-dento-digital	HYPHENATION	Good	1.0	0.8308	0.8308
intra-examiner reliability k	Normal_NP	Good	1	0.8308	0.8308
hbeag negative chronic hepatitis	Normal_NP	Good	1	0.8308	0.8308
first-generation antipsychotic	Normal_NP	Good	1	0.8308	0.8308
evidence review group report	Normal_NP	Good	1	0.8308	0.8308
doctoral dental hygiene education	Normal_NP	Good	1	0.8308	0.8308
cooperative health care clinic	Normal_NP	Good	1	0.8308	0.8308
chrysotile asbestos industry	Normal_NP	Good	1	0.8308	0.8308
chronic tension-type headache	Normal_NP	Good	1	0.8308	0.8308
camp-dependent protein kinase	Normal_NP	Good	1	0.8308	0.8308
blepharoptosis blepharoptosis	Normal_NP	Good	1	0.8308	0.8308
autologous stem cell transplant	Normal_NP	Good	1	0.8308	0.8308
atherosclerotic heart disease	Normal_NP	Good	1	0.8308	0.8308
airtum population-based cancer	Normal_NP	Good	1	0.8308	0.8308
africa region palliative care	Normal_NP	Good	1	0.8308	0.8308
adductor spasmodic dysphonia	Normal_NP	Good	1	0.8308	0.8308
denosumab	SIMPLE	Good	1	0.8301	0.8301
kvik	SIMPLE	Good	1	0.8293	0.8293
cofa	SIMPLE	Good	1	0.8293	0.8293
wad medani virus	Normal_NP	Good	1	0.8286	0.8286
synaptic growth	Normal_NP	Good	1	0.8286	0.8286
primary symptoms	Normal_NP	Good	1	0.8286	0.8286
platelet aggregation	Normal_NP	Good	1	0.8286	0.8286
pityriasis alba	Normal_NP	Good	1	0.8286	0.8286
parathyroid cell	Normal_NP	Good	1	0.8286	0.8286
non-lung injury	Normal_NP	Good	1	0.8286	0.8286
nairovirus genus	Normal_NP	Good	1	0.8286	0.8286
molar hypomineralization	Normal_NP	Good	1	0.8286	0.8286
medial diastema	Normal_NP	Good	1	0.8286	0.8286
hawaiian health	Normal_NP	Good	1	0.8286	0.8286
fistulous tract	Normal_NP	Good	1	0.8286	0.8286
catphan phantom	Normal_NP	Good	1	0.8286	0.8286
adult haemophilic	Normal_NP	Good	1	0.8286	0.8286
twice-annual school inspections	Normal_NP	Good	1	0.8278	0.8278
state-of-the art health care	Normal_NP	Good	1	0.8278	0.8278
speech-language pathologist	Normal_NP	Good	1	0.8278	0.8278
sodium-chloride cotransporter	Normal_NP	Good	1	0.8278	0.8278
serum free-carnitine deficiency	Normal_NP	Good	1	0.8278	0.8278
rna-dependent rna-polymerase	Normal_NP	Good	1	0.8278	0.8278
radioisotopic synoviorthesis	Normal_NP	Good	1	0.8278	0.8278
post-translational carboxylation	Normal_NP	Good	1	0.8278	0.8278
platinum-sensitive subgroup	Normal_NP	Good	1	0.8278	0.8278
ovarian cancer tissue indices	Normal_NP	Good	1	0.8278	0.8278
non-inhibitor haemophilia b	Normal_NP	Good	1	0.8278	0.8278
non-clinical hospital staff	Normal_NP	Good	1	0.8278	0.8278
non-cancerous breast diseases	Normal_NP	Good	1	0.8278	0.8278
mn-superoxide dismutase activity	Normal_NP	Good	1	0.8278	0.8278
medical malpractice--a patient	Normal_NP	Good	1	0.8278	0.8278
intrinsic myocardial growth	Normal_NP	Good	1	0.8278	0.8278
intrinsic microbial complexity	Normal_NP	Good	1	0.8278	0.8278
inter-professional strategy	Normal_NP	Good	1	0.8278	0.8278
hepatocellular cancer incidence	Normal_NP	Good	1	0.8278	0.8278
heart failure disease management	Normal_NP	Good	1	0.8278	0.8278
hawaiian cardiac care queen	Normal_NP	Good	1	0.8278	0.8278
flood risk management actors	Normal_NP	Good	1	0.8278	0.8278
expert oculoplastic surgeon	Normal_NP	Good	1	0.8278	0.8278
endogenous thrombin potential	Normal_NP	Good	1	0.8278	0.8278
empire bluecross blueshield	Normal_NP	Good	1	0.8278	0.8278
empathic clinical interview	Normal_NP	Good	1	0.8278	0.8278
diagnostisch interview voor	Normal_NP	Good	1	0.8278	0.8278
critical phase bullous rash	Normal_NP	Good	1	0.8278	0.8278
cognitive-behavioural treatment	Normal_NP	Good	1	0.8278	0.8278
centro brasileiro de estudos	Normal_NP	Good	1	0.8278	0.8278
cardiac contractility modulation	Normal_NP	Good	1	0.8278	0.8278
botulinum toxin topical gel	Normal_NP	Good	1	0.8278	0.8278
balloon-expandable prostheses	Normal_NP	Good	1	0.8278	0.8278
atrial septal defect closure	Normal_NP	Good	1	0.8278	0.8278
articular prosthetic replacements	Normal_NP	Good	1	0.8278	0.8278
arthrotic upper ankle joint	Normal_NP	Good	1	0.8278	0.8278
antiretroviral drug development	Normal_NP	Good	1	0.8278	0.8278
antidiuretic hormone secretion	Normal_NP	Good	1	0.8278	0.8278
anatomo-pathological observations	Normal_NP	Good	1	0.8278	0.8278
address hepatocellular cancer	Normal_NP	Good	1	0.8278	0.8278
reagibility	SIMPLE	Good	1	0.8271	0.8271
onabota	SIMPLE	Good	1	0.8271	0.8271
mp risk	Normal_NP	Good	1	0.8271	0.8271
minirin	SIMPLE	Good	1	0.8271	0.8271
glargine	SIMPLE	Good	1	0.8271	0.8271
eb virus	Normal_NP	Good	1	0.8271	0.8271
ar-gg27	HYPHENATION	Good	1.0	0.8271	0.8271
tourette syndrome research	Normal_NP	Good	1	0.8263	0.8263
thecorreio da manh newspaper	Normal_NP	Good	1	0.8263	0.8263
surgical testicular detorsion	Normal_NP	Good	1	0.8263	0.8263
subjective five-point scale	Normal_NP	Good	1	0.8263	0.8263
second-line treatment post	Normal_NP	Good	1	0.8263	0.8263
rio de janeiro-born doctor	Normal_NP	Good	1	0.8263	0.8263
retrospective study focussing	Normal_NP	Good	1	0.8263	0.8263
rem sleep behaviour disorder	Normal_NP	Good	1	0.8263	0.8263
physiological mesial drift	Normal_NP	Good	1	0.8263	0.8263
phosphatidylserine-exposure	HYPHENATION	Good	1.0	0.8263	0.8263
peritoneal dialysis prevalence	Normal_NP	Good	1	0.8263	0.8263
paroxysmal motor behaviours	Normal_NP	Good	1	0.8263	0.8263
osteogenic protein expression	Normal_NP	Good	1	0.8263	0.8263
osteoclastogenesis inhibition	Normal_NP	Good	1	0.8263	0.8263
ore concentration workshop	Normal_NP	Good	1	0.8263	0.8263
oral antipsychotics confidence	Normal_NP	Good	1	0.8263	0.8263
one-way sensitivity analyses	Normal_NP	Good	1	0.8263	0.8263
onabotulinumtoxina molecule	Normal_NP	Good	1	0.8263	0.8263
novartis pharmaceutical uk	Normal_NP	Good	1	0.8263	0.8263
neuropsychological batteries	Normal_NP	Good	1	0.8263	0.8263
neuronal supra-pinal populations	Normal_NP	Good	1	0.8263	0.8263
neo-natal clinical symptoms	Normal_NP	Good	1	0.8263	0.8263
medtronic corevalve evolut	Normal_NP	Good	1	0.8263	0.8263
maximal isometric contraction	Normal_NP	Good	1	0.8263	0.8263
intravenous fluid resuscitation	Normal_NP	Good	1	0.8263	0.8263
inhibitor-immunology-study	HYPHENATION	Good	1.0	0.8263	0.8263
inhibitor-immunology study	Normal_NP	Good	1	0.8263	0.8263
hyper-permeability syndrome	Normal_NP	Good	1	0.8263	0.8263
host response dengue viruses	Normal_NP	Good	1	0.8263	0.8263
government-sector collaboration	Normal_NP	Good	1	0.8263	0.8263
g-protein-coupled receptor	Normal_NP	Good	1	0.8263	0.8263
decision antiblastic treatment	Normal_NP	Good	1	0.8263	0.8263
clinical vertebral fractures	Normal_NP	Good	1	0.8263	0.8263
cancer site-specific sheets	Normal_NP	Good	1	0.8263	0.8263
c-reactive protein identification	Normal_NP	Good	1	0.8263	0.8263
butyryl cholinesterase activity	Normal_NP	Good	1	0.8263	0.8263
bovine pericardial leaflets	Normal_NP	Good	1	0.8263	0.8263
beta-hydroxyisobutyryl coa	Normal_NP	Good	1	0.8263	0.8263
azoxymethane-induced colon	Normal_NP	Good	1	0.8263	0.8263
peritoneal dialysis	Normal_NP	Good	1	0.8256	0.8256
trifluoperazine	SIMPLE	Good	1	0.8248	0.8248
rhipicephalinae	SIMPLE	Good	1	0.8248	0.8248
preterm labour	Normal_NP	Good	1	0.8248	0.8248
platelet count	Normal_NP	Good	1	0.8248	0.8248
pigmentary genes	Normal_NP	Good	1	0.8248	0.8248
oral parafunctions	Normal_NP	Good	1	0.8248	0.8248
oneiric stupor	Normal_NP	Good	1	0.8248	0.8248
nc-rbd patients	Normal_NP	Good	1	0.8248	0.8248
kvik framework	Normal_NP	Good	1	0.8248	0.8248
kappa b ligand	Normal_NP	Good	1	0.8248	0.8248
inotropic score	Normal_NP	Good	1	0.8248	0.8248
haemaphysalinae	SIMPLE	Good	1	0.8248	0.8248
cytokine storm	Normal_NP	Good	1	0.8248	0.8248
contrast module	Normal_NP	Good	1	0.8248	0.8248
chuukese women	Normal_NP	Good	1	0.8248	0.8248
baseline visit	Normal_NP	Good	1	0.8248	0.8248
airtum database	Normal_NP	Good	1	0.8248	0.8248
occipital lobe	Normal_NP	Good	1	0.8233	0.8233
abobotulinumtoxina	SIMPLE	Good	1	0.8225	0.8225
ventricular septal defect	Normal_NP	Good	1	0.8218	0.8218
vancomycin-resistant mrsa	Normal_NP	Good	1	0.8218	0.8218
transmission aggregometry	Normal_NP	Good	1	0.8218	0.8218
tokmak wildlife sanctuary	Normal_NP	Good	1	0.8218	0.8218
thrombocytopenia diagnosis	Normal_NP	Good	1	0.8218	0.8218
thermodynamic equilibrium	Normal_NP	Good	1	0.8218	0.8218
temporary vascular catheter	Normal_NP	Good	1	0.8218	0.8218
surgical wait time access	Normal_NP	Good	1	0.8218	0.8218
streptococcus constellatus	Normal_NP	Good	1	0.8218	0.8218
stem cell research onjornal	Normal_NP	Good	1	0.8218	0.8218
secondary periosteal erosion	Normal_NP	Good	1	0.8218	0.8218
reverse transcription pcr	Normal_NP	Good	1	0.8218	0.8218
revascularization therapies	Normal_NP	Good	1	0.8218	0.8218
repose onabotulinumtoxina	Normal_NP	Good	1	0.8218	0.8218
primary haemostasis treatment	Normal_NP	Good	1	0.8218	0.8218
preoperative radiotherapy	Normal_NP	Good	1	0.8218	0.8218
preeclampsia preeclampsia	Normal_NP	Good	1	0.8218	0.8218
post-treatment photographs	Normal_NP	Good	1	0.8218	0.8218
parathyroid cell proliferation	Normal_NP	Good	1	0.8218	0.8218
organ dysfunction syndrome	Normal_NP	Good	1	0.8218	0.8218
oncology pharmacy practice	Normal_NP	Good	1	0.8218	0.8218
onabotulinumtoxina injection	Normal_NP	Good	1	0.8218	0.8218
non-pharmacological management	Normal_NP	Good	1	0.8218	0.8218
neuropsychiatric manifestations	Normal_NP	Good	1	0.8218	0.8218
neurodevelopmental disorders	Normal_NP	Good	1	0.8218	0.8218
necrosis factor inhibitors	Normal_NP	Good	1	0.8218	0.8218
narcolepsy-cataplexy patients	Normal_NP	Good	1	0.8218	0.8218
midbrain cerebral peduncle	Normal_NP	Good	1	0.8218	0.8218
metastatic adenocarcinoma	Normal_NP	Good	1	0.8218	0.8218
mammary pre-malignant lesions	Normal_NP	Good	1	0.8218	0.8218
longer-term safety profile	Normal_NP	Good	1	0.8218	0.8218
lateral maxillary incisor	Normal_NP	Good	1	0.8218	0.8218
hepatitis b virus antigen	Normal_NP	Good	1	0.8218	0.8218
fibrillary acidic protein	Normal_NP	Good	1	0.8218	0.8218
familial hyperparathyroidism	Normal_NP	Good	1	0.8218	0.8218
ergotamine-containing medications	Normal_NP	Good	1	0.8218	0.8218
doctoral education doctoral	Normal_NP	Good	1	0.8218	0.8218
culture-negative endocarditis	Normal_NP	Good	1	0.8218	0.8218
coronary arteries--effect	Normal_NP	Good	1	0.8218	0.8218
colon epithelial proliferation	Normal_NP	Good	1	0.8218	0.8218
chromatide type--by deletions	Normal_NP	Good	1	0.8218	0.8218
calcium-phosphate metabolism	Normal_NP	Good	1	0.8218	0.8218
calcium homeostasis regulation	Normal_NP	Good	1	0.8218	0.8218
blastocyst-derived es cell	Normal_NP	Good	1	0.8218	0.8218
bilateral parotid inflammation	Normal_NP	Good	1	0.8218	0.8218
anti-inflammatory molecule	Normal_NP	Good	1	0.8218	0.8218
age-specific gastric cancer	Normal_NP	Good	1	0.8218	0.8218
orbiviruses	SIMPLE	Good	1	0.821	0.821
maldi-tof	HYPHENATION	Good	1.0	0.821	0.821
caucasians	SIMPLE	Good	1	0.821	0.821
bacteroides	SIMPLE	Good	1	0.821	0.821
b patients	Normal_NP	Good	1	0.821	0.821
urinary phosphate excretion	Normal_NP	Good	1	0.8195	0.8195
treatment post rituximab	Normal_NP	Good	1	0.8195	0.8195
trastuzumab-treated patients	Normal_NP	Good	1	0.8195	0.8195
three-state cohort model	Normal_NP	Good	1	0.8195	0.8195
symptomatic hypocalcemia	Normal_NP	Good	1	0.8195	0.8195
speech-language pathology	Normal_NP	Good	1	0.8195	0.8195
skeletal muscle contraction	Normal_NP	Good	1	0.8195	0.8195
serum calcium homeostasis	Normal_NP	Good	1	0.8195	0.8195
rio de janeiro polytechnic	Normal_NP	Good	1	0.8195	0.8195
review depot antipsychotics	Normal_NP	Good	1	0.8195	0.8195
research onjornal nacional	Normal_NP	Good	1	0.8195	0.8195
rehab experience holland	Normal_NP	Good	1	0.8195	0.8195
quality-control standards	Normal_NP	Good	1	0.8195	0.8195
psychotherapeutic services	Normal_NP	Good	1	0.8195	0.8195
protein mammalian target	Normal_NP	Good	1	0.8195	0.8195
precorrection method isp	Normal_NP	Good	1	0.8195	0.8195
postoperative haemorrhages	Normal_NP	Good	1	0.8195	0.8195
platelet function disorders	Normal_NP	Good	1	0.8195	0.8195
phlebology training week	Normal_NP	Good	1	0.8195	0.8195
perioperative practitioners	Normal_NP	Good	1	0.8195	0.8195
pediatric ulcerative colitis	Normal_NP	Good	1	0.8195	0.8195
pathophysiologic pathway	Normal_NP	Good	1	0.8195	0.8195
paravalvular aortic leaks	Normal_NP	Good	1	0.8195	0.8195
parathyroid hormone fragments	Normal_NP	Good	1	0.8195	0.8195
paediatric surgical wait	Normal_NP	Good	1	0.8195	0.8195
organophosphate compound	Normal_NP	Good	1	0.8195	0.8195
ore-preparation workshop	Normal_NP	Good	1	0.8195	0.8195
ophthalmoplastic surgery	Normal_NP	Good	1	0.8195	0.8195
onabotulinumtoxina treatment	Normal_NP	Good	1	0.8195	0.8195
oleksandr volodymyrovych	Normal_NP	Good	1	0.8195	0.8195
novel compound heterozygous	Normal_NP	Good	1	0.8195	0.8195
neurophysiological studies	Normal_NP	Good	1	0.8195	0.8195
neurocognitive subsystems	Normal_NP	Good	1	0.8195	0.8195
neisseria species vaccine	Normal_NP	Good	1	0.8195	0.8195
nccn oncology risk evaluation	Normal_NP	Good	1	0.8195	0.8195
munich haemophilia centre	Normal_NP	Good	1	0.8195	0.8195
mitral paravalvular leaks	Normal_NP	Good	1	0.8195	0.8195
mitochondria-specific dye	Normal_NP	Good	1	0.8195	0.8195
minirin parenteral infusion	Normal_NP	Good	1	0.8195	0.8195
microbiological diagnosis	Normal_NP	Good	1	0.8195	0.8195
majority caucasian population	Normal_NP	Good	1	0.8195	0.8195
limited-angle tomography	Normal_NP	Good	1	0.8195	0.8195
kustanaiskie mineral jsc	Normal_NP	Good	1	0.8195	0.8195
hypersensitivity parameters	Normal_NP	Good	1	0.8195	0.8195
hyperparathyroid syndrome	Normal_NP	Good	1	0.8195	0.8195
hermansky-pudlak syndrome	Normal_NP	Good	1	0.8195	0.8195
health--air quality--and	Normal_NP	Good	1	0.8195	0.8195
growth factor receptor-2	Normal_NP	Good	1	0.8195	0.8195
genentech oncology trend	Normal_NP	Good	1	0.8195	0.8195
focal cortical dysplasia	Normal_NP	Good	1	0.8195	0.8195
epistemological privileging	Normal_NP	Good	1	0.8195	0.8195
digital intraoral camera	Normal_NP	Good	1	0.8195	0.8195
differential backprojection	Normal_NP	Good	1	0.8195	0.8195
dermacentor daghestanicus	Normal_NP	Good	1	0.8195	0.8195
degenerative arthropathy	Normal_NP	Good	1	0.8195	0.8195
crystallographic parameters	Normal_NP	Good	1	0.8195	0.8195
cost-effectiveness model	Normal_NP	Good	1	0.8195	0.8195
cortical cytotoxic edema	Normal_NP	Good	1	0.8195	0.8195
clinical trial pityriasis	Normal_NP	Good	1	0.8195	0.8195
cf transmembrane conductance	Normal_NP	Good	1	0.8195	0.8195
cerebral hypoperfusionin	Normal_NP	Good	1	0.8195	0.8195
bovine pericardial tissue	Normal_NP	Good	1	0.8195	0.8195
automatic air quality stations	Normal_NP	Good	1	0.8195	0.8195
antiblastic chemotherapy	Normal_NP	Good	1	0.8195	0.8195
antibiotic dicloxacillin	Normal_NP	Good	1	0.8195	0.8195
anti-cancer chemotherapy	Normal_NP	Good	1	0.8195	0.8195
hyperparathyroidism primary hyperparathyroidism	Normal_NP	Good	1	0.8188	0.8188
youth alcohol	Normal_NP	Good	1	0.818	0.818
yangtze delta	Normal_NP	Good	1	0.818	0.818
valve repositioning	Normal_NP	Good	1	0.818	0.818
synoviorthesis	SIMPLE	Good	1	0.818	0.818
sweat chloride	Normal_NP	Good	1	0.818	0.818
picornaviridae	SIMPLE	Good	1	0.818	0.818
necrotic pulps	Normal_NP	Good	1	0.818	0.818
nccn colorectal	Normal_NP	Good	1	0.818	0.818
living frisbee	Normal_NP	Good	1	0.818	0.818
iga-lcl severity	Normal_NP	Good	1	0.818	0.818
hepatobiliary	SIMPLE	Good	1	0.818	0.818
endoprosthesis	SIMPLE	Good	1	0.818	0.818
doctoral education	Normal_NP	Good	1	0.818	0.818
ct dose index	Normal_NP	Good	1	0.818	0.818
arterial lactate	Normal_NP	Good	1	0.818	0.818
antibody-drug	HYPHENATION	Good	1.0	0.818	0.818
adenoidectomy	SIMPLE	Good	1	0.818	0.818
wait time access target	Normal_NP	Good	1	0.8173	0.8173
volodymyrovych palladin	Normal_NP	Good	1	0.8173	0.8173
vigidec medical network	Normal_NP	Good	1	0.8173	0.8173
ventricular hyperplasia	Normal_NP	Good	1	0.8173	0.8173
universalistic discourse	Normal_NP	Good	1	0.8173	0.8173
transapical aortic valve	Normal_NP	Good	1	0.8173	0.8173
symetis acurate ta valve	Normal_NP	Good	1	0.8173	0.8173
state-of-the art health	Normal_NP	Good	1	0.8173	0.8173
spontaneous joint bleedings	Normal_NP	Good	1	0.8173	0.8173
split face clinical trial	Normal_NP	Good	1	0.8173	0.8173
spheno-ethmoidal recess	Normal_NP	Good	1	0.8173	0.8173
sleep--the pre-dormitum	Normal_NP	Good	1	0.8173	0.8173
schizophreniform disorder	Normal_NP	Good	1	0.8173	0.8173
scapholunate joint instability	Normal_NP	Good	1	0.8173	0.8173
ristocetin cofactor activity	Normal_NP	Good	1	0.8173	0.8173
questionnaire-icu model	Normal_NP	Good	1	0.8173	0.8173
putative c-pth receptor	Normal_NP	Good	1	0.8173	0.8173
province-wide implementation	Normal_NP	Good	1	0.8173	0.8173
postoperative follow-up	Normal_NP	Good	1	0.8173	0.8173
platelet function studies	Normal_NP	Good	1	0.8173	0.8173
platelet function evaluation	Normal_NP	Good	1	0.8173	0.8173
physiotherapeutic treatment	Normal_NP	Good	1	0.8173	0.8173
pharmacy--jabsom experience	Normal_NP	Good	1	0.8173	0.8173
pathologic bone metabolism	Normal_NP	Good	1	0.8173	0.8173
parathyroid hyperplasia	Normal_NP	Good	1	0.8173	0.8173
oral health care services	Normal_NP	Good	1	0.8173	0.8173
oral antipsychotic drugs	Normal_NP	Good	1	0.8173	0.8173
obesity colorectal cancer	Normal_NP	Good	1	0.8173	0.8173
nurse-midwifery history	Normal_NP	Good	1	0.8173	0.8173
nucleosomal dna cleavage	Normal_NP	Good	1	0.8173	0.8173
nocturnal paroxysmal events	Normal_NP	Good	1	0.8173	0.8173
neuropsychological findings	Normal_NP	Good	1	0.8173	0.8173
necrosis factor therapies	Normal_NP	Good	1	0.8173	0.8173
nccn specialty pharmacy	Normal_NP	Good	1	0.8173	0.8173
nccn hepatobiliary cancers	Normal_NP	Good	1	0.8173	0.8173
myometrium mitochondria	Normal_NP	Good	1	0.8173	0.8173
multiresistant pathogens	Normal_NP	Good	1	0.8173	0.8173
multiple organ dysfunction	Normal_NP	Good	1	0.8173	0.8173
multifactorial aetiology	Normal_NP	Good	1	0.8173	0.8173
molecular weight multimers	Normal_NP	Good	1	0.8173	0.8173
microbiological aerosol	Normal_NP	Good	1	0.8173	0.8173
methylphenidate displays	Normal_NP	Good	1	0.8173	0.8173
metallothionein protein	Normal_NP	Good	1	0.8173	0.8173
long-acting antipsychotics	Normal_NP	Good	1	0.8173	0.8173
knowledge infrastructure	Normal_NP	Good	1	0.8173	0.8173
kinetic superficial emg	Normal_NP	Good	1	0.8173	0.8173
intramuscular administration	Normal_NP	Good	1	0.8173	0.8173
inter-subjective congruence	Normal_NP	Good	1	0.8173	0.8173
idiopathic form accounts	Normal_NP	Good	1	0.8173	0.8173
high-quality cancer care	Normal_NP	Good	1	0.8173	0.8173
hawaiian cultural identity	Normal_NP	Good	1	0.8173	0.8173
fungal aerosol concentration	Normal_NP	Good	1	0.8173	0.8173
focal transitional mastitis	Normal_NP	Good	1	0.8173	0.8173
fatal familial insomnia	Normal_NP	Good	1	0.8173	0.8173
excerpta medica database	Normal_NP	Good	1	0.8173	0.8173
english-language articles	Normal_NP	Good	1	0.8173	0.8173
education infrastructure	Normal_NP	Good	1	0.8173	0.8173
education doctoral education	Normal_NP	Good	1	0.8173	0.8173
disorder-specific genetics	Normal_NP	Good	1	0.8173	0.8173
dental matrix protein-1	Normal_NP	Good	1	0.8173	0.8173
cystic fibrosis newborn	Normal_NP	Good	1	0.8173	0.8173
cystathionine-b-synthase	HYPHENATION	Good	1.0	0.8173	0.8173
continuous infusion modality	Normal_NP	Good	1	0.8173	0.8173
competency training modalities	Normal_NP	Good	1	0.8173	0.8173
clinical microbiologists	Normal_NP	Good	1	0.8173	0.8173
ciencias afinesin buenos	Normal_NP	Good	1	0.8173	0.8173
cerebral astroglial cells	Normal_NP	Good	1	0.8173	0.8173
centrifugation sedimentation	Normal_NP	Good	1	0.8173	0.8173
cancer prevention radio	Normal_NP	Good	1	0.8173	0.8173
btxa intradermal injections	Normal_NP	Good	1	0.8173	0.8173
bronchial hyper-responsiveness	Normal_NP	Good	1	0.8173	0.8173
blastocyst stage embryos	Normal_NP	Good	1	0.8173	0.8173
bilateral occipital lobes	Normal_NP	Good	1	0.8173	0.8173
baseline clinical class	Normal_NP	Good	1	0.8173	0.8173
balloon-expandable valve	Normal_NP	Good	1	0.8173	0.8173
avp receptor antagonists	Normal_NP	Good	1	0.8173	0.8173
asthma pediatric asthma	Normal_NP	Good	1	0.8173	0.8173
anthropomorphic phantom	Normal_NP	Good	1	0.8173	0.8173
angiostatin infibrocystic	Normal_NP	Good	1	0.8173	0.8173
alcohol-free hand sanitizer	Normal_NP	Good	1	0.8173	0.8173
age-period-cohort model	Normal_NP	Good	1	0.8173	0.8173
adc brentuximab vedotin	Normal_NP	Good	1	0.8173	0.8173
acinetobacter baumannii	Normal_NP	Good	1	0.8173	0.8173
ffmct	ABBREVIATION	Good	1	0.8165	0.8165
world-leading institutions	Normal_NP	Good	1	0.8158	0.8158
watch-and-rescue treatment	Normal_NP	Good	1	0.8158	0.8158
v2 receptor antagonists	Normal_NP	Good	1	0.8158	0.8158
tyrosine kinase domains	Normal_NP	Good	1	0.8158	0.8158
transpulmonary plateau	Normal_NP	Good	1	0.8158	0.8158
transgenic mouse models	Normal_NP	Good	1	0.8158	0.8158
toronto school inspections	Normal_NP	Good	1	0.8158	0.8158
toexplore gene expression	Normal_NP	Good	1	0.8158	0.8158
three-tier data exploration	Normal_NP	Good	1	0.8158	0.8158
three-tier architecture	Normal_NP	Good	1	0.8158	0.8158
talonavicular arthrosis	Normal_NP	Good	1	0.8158	0.8158
surgical valve implantation	Normal_NP	Good	1	0.8158	0.8158
streptococcus anginosus	Normal_NP	Good	1	0.8158	0.8158
spatiotemporal resolution	Normal_NP	Good	1	0.8158	0.8158
socio-demographic variables	Normal_NP	Good	1	0.8158	0.8158
socio-demographic issues	Normal_NP	Good	1	0.8158	0.8158
skeletal muscle preparation	Normal_NP	Good	1	0.8158	0.8158
single-ventricle palliation	Normal_NP	Good	1	0.8158	0.8158
sga long-acting injections	Normal_NP	Good	1	0.8158	0.8158
self-expandable edwards	Normal_NP	Good	1	0.8158	0.8158
schizoaffective disorder	Normal_NP	Good	1	0.8158	0.8158
revista polit cnicaand	Normal_NP	Good	1	0.8158	0.8158
refractory menorrhagia	Normal_NP	Good	1	0.8158	0.8158
rapid bactericidal activity	Normal_NP	Good	1	0.8158	0.8158
pulmonary thromboembolism	Normal_NP	Good	1	0.8158	0.8158
prothrombinase complex	Normal_NP	Good	1	0.8158	0.8158
primary glomerulonephritis	Normal_NP	Good	1	0.8158	0.8158
post-injection syndrome	Normal_NP	Good	1	0.8158	0.8158
post-dormitum epilepsies	Normal_NP	Good	1	0.8158	0.8158
polychromatic sinogram	Normal_NP	Good	1	0.8158	0.8158
pharmacologic approach	Normal_NP	Good	1	0.8158	0.8158
peri-operative resources	Normal_NP	Good	1	0.8158	0.8158
paediatric asthma clinic	Normal_NP	Good	1	0.8158	0.8158
outreach cancer health	Normal_NP	Good	1	0.8158	0.8158
osteoporotic bone loss	Normal_NP	Good	1	0.8158	0.8158
oral commissure assessments	Normal_NP	Good	1	0.8158	0.8158
op-notes operative notes	Normal_NP	Good	1	0.8158	0.8158
occlusal caries detection	Normal_NP	Good	1	0.8158	0.8158
observational research	Normal_NP	Good	1	0.8158	0.8158
non-reproductive organs	Normal_NP	Good	1	0.8158	0.8158
neuroradiological findings	Normal_NP	Good	1	0.8158	0.8158
neurobiological disorder	Normal_NP	Good	1	0.8158	0.8158
nccn task force report	Normal_NP	Good	1	0.8158	0.8158
multistudy data exploration	Normal_NP	Good	1	0.8158	0.8158
minimization algorithm	Normal_NP	Good	1	0.8158	0.8158
middle-level households	Normal_NP	Good	1	0.8158	0.8158
methylenetetrahydrofolate	SIMPLE	Good	1	0.8158	0.8158
maxillofacial radiology	Normal_NP	Good	1	0.8158	0.8158
massive pyohaemothorax	Normal_NP	Good	1	0.8158	0.8158
low-profile nitinol stent	Normal_NP	Good	1	0.8158	0.8158
low-intensity x-ray ct	Normal_NP	Good	1	0.8158	0.8158
lipid-lowering therapies	Normal_NP	Good	1	0.8158	0.8158
kinesigenic dyskinesia	Normal_NP	Good	1	0.8158	0.8158
intra-individual study	Normal_NP	Good	1	0.8158	0.8158
intermediate-risk patients	Normal_NP	Good	1	0.8158	0.8158
inter-professional care	Normal_NP	Good	1	0.8158	0.8158
integrin-mediated niche	Normal_NP	Good	1	0.8158	0.8158
independence bluecross	Normal_NP	Good	1	0.8158	0.8158
hyaluronic acid injections	Normal_NP	Good	1	0.8158	0.8158
hawaiian health disparities	Normal_NP	Good	1	0.8158	0.8158
glomerular nephropathy	Normal_NP	Good	1	0.8158	0.8158
gap long-acting injections	Normal_NP	Good	1	0.8158	0.8158
fibrosis bronchiectasis	Normal_NP	Good	1	0.8158	0.8158
extrapyramidal symptoms	Normal_NP	Good	1	0.8158	0.8158
extra-frontal epilepsy	Normal_NP	Good	1	0.8158	0.8158
endotracheal granuloma	Normal_NP	Good	1	0.8158	0.8158
electrochemical sensor	Normal_NP	Good	1	0.8158	0.8158
disorganisation dimension	Normal_NP	Good	1	0.8158	0.8158
differential centrifugation	Normal_NP	Good	1	0.8158	0.8158
diagnostisch interview	Normal_NP	Good	1	0.8158	0.8158
covariate-specific odds	Normal_NP	Good	1	0.8158	0.8158
corevalve bioprosthesis	Normal_NP	Good	1	0.8158	0.8158
concentration workshop	Normal_NP	Good	1	0.8158	0.8158
collinsella aerofaciens	Normal_NP	Good	1	0.8158	0.8158
chrysotile asbestos ore	Normal_NP	Good	1	0.8158	0.8158
cf foundation guidelines	Normal_NP	Good	1	0.8158	0.8158
cardiopulmonary arrest	Normal_NP	Good	1	0.8158	0.8158
cardiometabolic outcomes	Normal_NP	Good	1	0.8158	0.8158
cardio-vascular diseases	Normal_NP	Good	1	0.8158	0.8158
camp-dependent protein	Normal_NP	Good	1	0.8158	0.8158
brain electrophysiology	Normal_NP	Good	1	0.8158	0.8158
beta-hydroxyisobutyryl	HYPHENATION	Good	1.0	0.8158	0.8158
antipsychotic oral medication	Normal_NP	Good	1	0.8158	0.8158
anti-tnf-based therapies	Normal_NP	Good	1	0.8158	0.8158
alopecia tool subclasses	Normal_NP	Good	1	0.8158	0.8158
airtum cancer registries	Normal_NP	Good	1	0.8158	0.8158
africa region colorectal	Normal_NP	Good	1	0.8158	0.8158
aerodynamic particle sizer	Normal_NP	Good	1	0.8158	0.8158
adult self-report scale	Normal_NP	Good	1	0.8158	0.8158
palpation	SIMPLE	Good	1	0.815	0.815
uk scientist	Normal_NP	Good	1	0.8143	0.8143
rehab experience	Normal_NP	Good	1	0.8143	0.8143
proton gradient	Normal_NP	Good	1	0.8143	0.8143
medical valve	Normal_NP	Good	1	0.8143	0.8143
low-fat milk	Normal_NP	Good	1	0.8143	0.8143
epistemonikos	SIMPLE	Good	1	0.8143	0.8143
dengue viruses	Normal_NP	Good	1	0.8143	0.8143
confocal laser	Normal_NP	Good	1	0.8143	0.8143
cohesive gel	Normal_NP	Good	1	0.8143	0.8143
tradeoff	SIMPLE	Good	1	0.8135	0.8135
jenavalve	SIMPLE	Good	1	0.8135	0.8135
hypertonic	SIMPLE	Good	1	0.8135	0.8135
dfm valve	Normal_NP	Good	1	0.8135	0.8135
osteoporosis therapy	Normal_NP	Good	1	0.8128	0.8128
wanfang data knowledge	Normal_NP	Good	1	0.812	0.812
uk marketing authorisation	Normal_NP	Good	1	0.812	0.812
u incobotulinumtoxina	Normal_NP	Good	1	0.812	0.812
trial pityriasis alba	Normal_NP	Good	1	0.812	0.812
trace aortic regurgitation	Normal_NP	Good	1	0.812	0.812
strain-gauge contraction	Normal_NP	Good	1	0.812	0.812
socioecological model	Normal_NP	Good	1	0.812	0.812
societal level reforms	Normal_NP	Good	1	0.812	0.812
sleep-to-wake transition	Normal_NP	Good	1	0.812	0.812
scientific lotus valve	Normal_NP	Good	1	0.812	0.812
rt001 botulinum toxin	Normal_NP	Good	1	0.812	0.812
radiological pathology	Normal_NP	Good	1	0.812	0.812
professor robert john	Normal_NP	Good	1	0.812	0.812
primary care workforce	Normal_NP	Good	1	0.812	0.812
preoperative investigation	Normal_NP	Good	1	0.812	0.812
preoperative antiseptic	Normal_NP	Good	1	0.812	0.812
post-operative outcomes	Normal_NP	Good	1	0.812	0.812
polysaccharide vaccines	Normal_NP	Good	1	0.812	0.812
polyprotein-precursor	HYPHENATION	Good	1.0	0.812	0.812
phosphorus homeostasis	Normal_NP	Good	1	0.812	0.812
perisylvian subsystem	Normal_NP	Good	1	0.812	0.812
pediatric critical illness	Normal_NP	Good	1	0.812	0.812
pediatric clinical illness	Normal_NP	Good	1	0.812	0.812
paul-ehrlich-institute	HYPHENATION	Good	1.0	0.812	0.812
parathyroid carcinoma	Normal_NP	Good	1	0.812	0.812
osteoclast differentiation	Normal_NP	Good	1	0.812	0.812
oneiric stupor episodes	Normal_NP	Good	1	0.812	0.812
oncology trend report	Normal_NP	Good	1	0.812	0.812
onabotulinumtoxina vial	Normal_NP	Good	1	0.812	0.812
observational character	Normal_NP	Good	1	0.812	0.812
novel botulinum toxin	Normal_NP	Good	1	0.812	0.812
non-systematic review	Normal_NP	Good	1	0.812	0.812
non-invasive approach	Normal_NP	Good	1	0.812	0.812
non-infectious diseases	Normal_NP	Good	1	0.812	0.812
neurological prognosis	Normal_NP	Good	1	0.812	0.812
nccn oncology insights	Normal_NP	Good	1	0.812	0.812
myocardial revascularization	Normal_NP	Good	1	0.812	0.812
myeloid leukemogenesis	Normal_NP	Good	1	0.812	0.812
murine oral osteotomies	Normal_NP	Good	1	0.812	0.812
multi-resistant today	Normal_NP	Good	1	0.812	0.812
mouse diaphragm assay	Normal_NP	Good	1	0.812	0.812
molecular pathogenesis	Normal_NP	Good	1	0.812	0.812
mena-nccn breast cancer	Normal_NP	Good	1	0.812	0.812
medical education--the	Normal_NP	Good	1	0.812	0.812
lysyl-oxydase inhibition	Normal_NP	Good	1	0.812	0.812
lymphocytic leukaemia	Normal_NP	Good	1	0.812	0.812
laryngotracheal separation	Normal_NP	Good	1	0.812	0.812
interinjection intervals	Normal_NP	Good	1	0.812	0.812
inotuzumab ozogamicin	Normal_NP	Good	1	0.812	0.812
immaterialist ontology	Normal_NP	Good	1	0.812	0.812
hyper-activity disorder	Normal_NP	Good	1	0.812	0.812
high t2 signal intensity	Normal_NP	Good	1	0.812	0.812
hermann von helmholtz	Normal_NP	Good	1	0.812	0.812
half-life time assessment	Normal_NP	Good	1	0.812	0.812
gemtuzumab ozogamicin	Normal_NP	Good	1	0.812	0.812
fulbright scholarship	Normal_NP	Good	1	0.812	0.812
free-carnitine deficiency	Normal_NP	Good	1	0.812	0.812
fastidious microorganisms	Normal_NP	Good	1	0.812	0.812
extensive menorrhagia	Normal_NP	Good	1	0.812	0.812
etio-pathogenic models	Normal_NP	Good	1	0.812	0.812
epistemonikos database	Normal_NP	Good	1	0.812	0.812
epileptiform discharges	Normal_NP	Good	1	0.812	0.812
empirico-transcendentalism	HYPHENATION	Good	1.0	0.812	0.812
emergency care--single	Normal_NP	Good	1	0.812	0.812
electrochemical gradient	Normal_NP	Good	1	0.812	0.812
desmopressin parenteral	Normal_NP	Good	1	0.812	0.812
daptomycin target site	Normal_NP	Good	1	0.812	0.812
cytotoxicity manifestations	Normal_NP	Good	1	0.812	0.812
corevalve evolut valve	Normal_NP	Good	1	0.812	0.812
congress angio access	Normal_NP	Good	1	0.812	0.812
chromatide type aberrations	Normal_NP	Good	1	0.812	0.812
children desmopressin	Normal_NP	Good	1	0.812	0.812
cement-free prosthesis	Normal_NP	Good	1	0.812	0.812
cardioverter-defibrillator	HYPHENATION	Good	1.0	0.812	0.812
calcium-dependent pkc	Normal_NP	Good	1	0.812	0.812
bronchopulmonary cancer	Normal_NP	Good	1	0.812	0.812
breast tissue exhibit	Normal_NP	Good	1	0.812	0.812
bilophila wadsworthia	Normal_NP	Good	1	0.812	0.812
behavioural interventions	Normal_NP	Good	1	0.812	0.812
baseline dissatisfaction	Normal_NP	Good	1	0.812	0.812
atherosclerotic heart	Normal_NP	Good	1	0.812	0.812
antipsychotics confidence	Normal_NP	Good	1	0.812	0.812
antipsychotic regimen	Normal_NP	Good	1	0.812	0.812
antimicrobial molecules	Normal_NP	Good	1	0.812	0.812
annuloplasty approaches	Normal_NP	Good	1	0.812	0.812
alpha-synucleinopathies	HYPHENATION	Good	1	0.812	0.812
valve transcatheter aortic valve implantation	Normal_NP	Good	1	0.8105	0.8105
myometrium cells	Normal_NP	Good	1	0.8098	0.8098
bont-a	HYPHENATION	Good	1.0	0.809	0.809
vascular endothelium	Normal_NP	Good	1	0.8083	0.8083
transmissible infections	Normal_NP	Good	1	0.8083	0.8083
toxic placental fragments	Normal_NP	Good	1	0.8083	0.8083
toothbrushing machine	Normal_NP	Good	1	0.8083	0.8083
tick-borne orbiviruses	Normal_NP	Good	1	0.8083	0.8083
thromboembolic complications	Normal_NP	Good	1	0.8083	0.8083
three-year follow-up	Normal_NP	Good	1	0.8083	0.8083
therapy-induced imid	Normal_NP	Good	1	0.8083	0.8083
syr-darya valley fever	Normal_NP	Good	1	0.8083	0.8083
synovial hyperplasia	Normal_NP	Good	1	0.8083	0.8083
spectral mammography	Normal_NP	Good	1	0.8083	0.8083
socio-economic status	Normal_NP	Good	1	0.8083	0.8083
scorecard philosophy	Normal_NP	Good	1	0.8083	0.8083
reprise clinical trial	Normal_NP	Good	1	0.8083	0.8083
rem behaviour disorder	Normal_NP	Good	1	0.8083	0.8083
relative cost-effectiveness	Normal_NP	Good	1	0.8083	0.8083
refractory hypoxemia	Normal_NP	Good	1	0.8083	0.8083
quantitative dce-mri	Normal_NP	Good	1	0.8083	0.8083
pulmonary interstitial	Normal_NP	Good	1	0.8083	0.8083
public health agenda	Normal_NP	Good	1	0.8083	0.8083
proteasome inhibitors	Normal_NP	Good	1	0.8083	0.8083
primary sensorimotor	Normal_NP	Good	1	0.8083	0.8083
preventive cardiology	Normal_NP	Good	1	0.8083	0.8083
post-market registry	Normal_NP	Good	1	0.8083	0.8083
porcine bioprosthesis	Normal_NP	Good	1	0.8083	0.8083
pleural mesothelioma	Normal_NP	Good	1	0.8083	0.8083
placental hypoperfusion	Normal_NP	Good	1	0.8083	0.8083
peripheral lymphocytes	Normal_NP	Good	1	0.8083	0.8083
percutaneous therapy	Normal_NP	Good	1	0.8083	0.8083
pegylated-interferon	HYPHENATION	Good	1.0	0.8083	0.8083
pathophysiologic sites	Normal_NP	Good	1	0.8083	0.8083
parkinsonian syndrome	Normal_NP	Good	1	0.8083	0.8083
parenteral administration	Normal_NP	Good	1	0.8083	0.8083
parasurgical therapy	Normal_NP	Good	1	0.8083	0.8083
parallel-group study	Normal_NP	Good	1	0.8083	0.8083
paediatric dentistry	Normal_NP	Good	1	0.8083	0.8083
ovarian cancer tissue	Normal_NP	Good	1	0.8083	0.8083
ornithodoros coniceps	Normal_NP	Good	1	0.8083	0.8083
oculoplastic surgery	Normal_NP	Good	1	0.8083	0.8083
oculoplastic surgeon	Normal_NP	Good	1	0.8083	0.8083
oculocutaneous albinism	Normal_NP	Good	1	0.8083	0.8083
occipital white matter	Normal_NP	Good	1	0.8083	0.8083
nosological distinction	Normal_NP	Good	1	0.8083	0.8083
normal ovarian tissue	Normal_NP	Good	1	0.8083	0.8083
nonyl acridine orange	Normal_NP	Good	1	0.8083	0.8083
non-randomised study	Normal_NP	Good	1	0.8083	0.8083
non-cancerous breast	Normal_NP	Good	1	0.8083	0.8083
next-generation tavi	Normal_NP	Good	1	0.8083	0.8083
neuromuscular diseases	Normal_NP	Good	1	0.8083	0.8083
neurocognitive models	Normal_NP	Good	1	0.8083	0.8083
network meta-analysis	Normal_NP	Good	1	0.8083	0.8083
near-universal cf nbs	Normal_NP	Good	1	0.8083	0.8083
narcolepsy-cataplexy	HYPHENATION	Good	1.0	0.8083	0.8083
multicenter research	Normal_NP	Good	1	0.8083	0.8083
moraxella catarrhalis	Normal_NP	Good	1	0.8083	0.8083
micrographic surgery	Normal_NP	Good	1	0.8083	0.8083
maternal endothelium	Normal_NP	Good	1	0.8083	0.8083
madrid health service	Normal_NP	Good	1	0.8083	0.8083
low-contrast phantom	Normal_NP	Good	1	0.8083	0.8083
klebsiella pneumoniae	Normal_NP	Good	1	0.8083	0.8083
jude medical portico	Normal_NP	Good	1	0.8083	0.8083
intravascular coagulation	Normal_NP	Good	1	0.8083	0.8083
intersectoral cooperation	Normal_NP	Good	1	0.8083	0.8083
inflammation inflammation	Normal_NP	Good	1	0.8083	0.8083
immunoregulatory role	Normal_NP	Good	1	0.8083	0.8083
immunomodulatory activities	Normal_NP	Good	1	0.8083	0.8083
hypocalcemic syndromes	Normal_NP	Good	1	0.8083	0.8083
hypertensive subjects	Normal_NP	Good	1	0.8083	0.8083
hyperhomocysteinemia	SIMPLE	Good	1	0.8083	0.8083
human papillomaviruses	Normal_NP	Good	1	0.8083	0.8083
high-sensitivity crp	Normal_NP	Good	1	0.8083	0.8083
hawaii cervical cancer	Normal_NP	Good	1	0.8083	0.8083
haemophilic children	Normal_NP	Good	1	0.8083	0.8083
glutathione reductase	Normal_NP	Good	1	0.8083	0.8083
genomic endophenotypes	Normal_NP	Good	1	0.8083	0.8083
gender-equal society	Normal_NP	Good	1	0.8083	0.8083
fr expandable sheath	Normal_NP	Good	1	0.8083	0.8083
exposure chlorpyrifos	Normal_NP	Good	1	0.8083	0.8083
epinephrine-cartridge	HYPHENATION	Good	1.0	0.8083	0.8083
epidemiologic picture	Normal_NP	Good	1	0.8083	0.8083
emergency contraception	Normal_NP	Good	1	0.8083	0.8083
edwards centera valve	Normal_NP	Good	1	0.8083	0.8083
dual-purpose therapies	Normal_NP	Good	1	0.8083	0.8083
dual source ct scanner	Normal_NP	Good	1	0.8083	0.8083
dissociable strategies	Normal_NP	Good	1	0.8083	0.8083
cytogenetic translocation	Normal_NP	Good	1	0.8083	0.8083
constipation symptoms	Normal_NP	Good	1	0.8083	0.8083
congenital hypotonia	Normal_NP	Good	1	0.8083	0.8083
coa deacylase deficiency	Normal_NP	Good	1	0.8083	0.8083
chin electromyographic	Normal_NP	Good	1	0.8083	0.8083
chimeric oncoproteins	Normal_NP	Good	1	0.8083	0.8083
biomechanical disorder	Normal_NP	Good	1	0.8083	0.8083
biological continuum	Normal_NP	Good	1	0.8083	0.8083
behavioural neurology	Normal_NP	Good	1	0.8083	0.8083
autonomic over-activation	Normal_NP	Good	1	0.8083	0.8083
autonomic hyperactivation	Normal_NP	Good	1	0.8083	0.8083
atrial septal defect	Normal_NP	Good	1	0.8083	0.8083
antiaging face treatment	Normal_NP	Good	1	0.8083	0.8083
anti-atherogenic activity	Normal_NP	Good	1	0.8083	0.8083
superoxide dismutase	Normal_NP	Good	1	0.8075	0.8075
topical gel	Normal_NP	Good	1	0.8053	0.8053
st jude medical	Normal_NP	Good	1	0.8053	0.8053
scientifique	SIMPLE	Good	1	0.8053	0.8053
rvwf-rfviii	HYPHENATION	Good	1.0	0.8053	0.8053
polit cnica	Normal_NP	Good	1	0.8053	0.8053
medani virus	Normal_NP	Good	1	0.8053	0.8053
ige syndromes	Normal_NP	Good	1	0.8053	0.8053
fr dfm valve	Normal_NP	Good	1	0.8053	0.8053
dmepos items	Normal_NP	Good	1	0.8053	0.8053
dermacentor	SIMPLE	Good	1	0.8053	0.8053
copolymerisation	SIMPLE	Good	1	0.8053	0.8053
centera thv	Normal_NP	Good	1	0.8053	0.8053
cell gliosis	Normal_NP	Good	1	0.8053	0.8053
burana virus	Normal_NP	Good	1	0.8053	0.8053
bt antibody	Normal_NP	Good	1	0.8053	0.8053
bendamustine	SIMPLE	Good	1	0.8053	0.8053
aortic leaks	Normal_NP	Good	1	0.8053	0.8053
anti-infective	HYPHENATION	Good	1.0	0.8053	0.8053
alemtuzumab	SIMPLE	Good	1	0.8053	0.8053
adc	SIMPLE	Good	1	0.8038	0.8038
human epidermal growth factor receptor	Normal_NP	Good	1	0.8023	0.8023
twice-annual school	Normal_NP	Good	1	0.8016	0.8016
tropheryma whipplei	Normal_NP	Good	1	0.8016	0.8016
treatment non-adherence	Normal_NP	Good	1	0.8016	0.8016
tonic-clonic seizures	Normal_NP	Good	1	0.8016	0.8016
tmd-related symptoms	Normal_NP	Good	1	0.8016	0.8016
tickborne orbiviruses	Normal_NP	Good	1	0.8016	0.8016
thiosulfonate derivatives	Normal_NP	Good	1	0.8016	0.8016
therapy osteoporosis	Normal_NP	Good	1	0.8016	0.8016
theranostic biomarkers	Normal_NP	Good	1	0.8016	0.8016
talonavicular joint	Normal_NP	Good	1	0.8016	0.8016
talocalcanean joint	Normal_NP	Good	1	0.8016	0.8016
synaptic cell adhesion	Normal_NP	Good	1	0.8016	0.8016
surgical revascularization	Normal_NP	Good	1	0.8016	0.8016
surgery--a challenge	Normal_NP	Good	1	0.8016	0.8016
suboptimal knowledge	Normal_NP	Good	1	0.8016	0.8016
subclinical inflammation	Normal_NP	Good	1	0.8016	0.8016
stereoregular polymers	Normal_NP	Good	1	0.8016	0.8016
spasmodic dysphonia	Normal_NP	Good	1	0.8016	0.8016
site-specific sheets	Normal_NP	Good	1	0.8016	0.8016
singlegland adenoma	Normal_NP	Good	1	0.8016	0.8016
serum free-carnitine	Normal_NP	Good	1	0.8016	0.8016
san francisco heart	Normal_NP	Good	1	0.8016	0.8016
s o paulo polytechnic	Normal_NP	Good	1	0.8016	0.8016
revista polit cnica	Normal_NP	Good	1	0.8016	0.8016
resuscitation fluid	Normal_NP	Good	1	0.8016	0.8016
rem sleep behaviour	Normal_NP	Good	1	0.8016	0.8016
reductase inhibitors	Normal_NP	Good	1	0.8016	0.8016
quantitative rt-pcr	Normal_NP	Good	1	0.8016	0.8016
psychomotor development	Normal_NP	Good	1	0.8016	0.8016
pretreatment workup	Normal_NP	Good	1	0.8016	0.8016
population subgroup	Normal_NP	Good	1	0.8016	0.8016
polygraphic expression	Normal_NP	Good	1	0.8016	0.8016
plasminogen cleavage	Normal_NP	Good	1	0.8016	0.8016
plasma ptx3 expression	Normal_NP	Good	1	0.8016	0.8016
pharmacologic management	Normal_NP	Good	1	0.8016	0.8016
personal best--back	Normal_NP	Good	1	0.8016	0.8016
pericranial infiltrations	Normal_NP	Good	1	0.8016	0.8016
pericardial leaflets	Normal_NP	Good	1	0.8016	0.8016
pd-centred catalyst	Normal_NP	Good	1	0.8016	0.8016
pathognomonic complications	Normal_NP	Good	1	0.8016	0.8016
paroxysmal dystonia	Normal_NP	Good	1	0.8016	0.8016
paliperidone palmitate	Normal_NP	Good	1	0.8016	0.8016
ostiomeatal complex	Normal_NP	Good	1	0.8016	0.8016
osteoblast-like cells	Normal_NP	Good	1	0.8016	0.8016
organozinc compounds	Normal_NP	Good	1	0.8016	0.8016
oral corticosteroids	Normal_NP	Good	1	0.8016	0.8016
optimizing interactions	Normal_NP	Good	1	0.8016	0.8016
oncology risk evaluation	Normal_NP	Good	1	0.8016	0.8016
nutritional biomarkers	Normal_NP	Good	1	0.8016	0.8016
nosocomial pathogens	Normal_NP	Good	1	0.8016	0.8016
non-value-added activities	Normal_NP	Good	1	0.8016	0.8016
non-stimulant treatments	Normal_NP	Good	1	0.8016	0.8016
non-invasive ventilation	Normal_NP	Good	1	0.8016	0.8016
non-clinical hospital	Normal_NP	Good	1	0.8016	0.8016
negative hpv detection	Normal_NP	Good	1	0.8016	0.8016
nccn-based guidelines	Normal_NP	Good	1	0.8016	0.8016
naso-esophageal tube	Normal_NP	Good	1	0.8016	0.8016
multiorganism panels	Normal_NP	Good	1	0.8016	0.8016
multicentric survey	Normal_NP	Good	1	0.8016	0.8016
multi-faceted organization	Normal_NP	Good	1	0.8016	0.8016
motoneuron paralysis	Normal_NP	Good	1	0.8016	0.8016
mitral valve plasty	Normal_NP	Good	1	0.8016	0.8016
malpractice--a patient	Normal_NP	Good	1	0.8016	0.8016
m-response amplitude	Normal_NP	Good	1	0.8016	0.8016
low-intensity x-ray	Normal_NP	Good	1	0.8016	0.8016
long-acting insulin	Normal_NP	Good	1	0.8016	0.8016
large cell lymphoma	Normal_NP	Good	1	0.8016	0.8016
knockin mouse model	Normal_NP	Good	1	0.8016	0.8016
kaplan-meier survival	Normal_NP	Good	1	0.8016	0.8016
joint endoprosthesis	Normal_NP	Good	1	0.8016	0.8016
intra-observer reliability	Normal_NP	Good	1	0.8016	0.8016
intra-examiner reliability	Normal_NP	Good	1	0.8016	0.8016
interview voor adhd	Normal_NP	Good	1	0.8016	0.8016
inner-city children	Normal_NP	Good	1	0.8016	0.8016
infectious endocarditis	Normal_NP	Good	1	0.8016	0.8016
inattention symptoms	Normal_NP	Good	1	0.8016	0.8016
hypopigmented patches	Normal_NP	Good	1	0.8016	0.8016
hyperhomocystinemia	SIMPLE	Good	1	0.8016	0.8016
hyperglycemic emergencies	Normal_NP	Good	1	0.8016	0.8016
host response dengue	Normal_NP	Good	1	0.8016	0.8016
hormonal contraceptives	Normal_NP	Good	1	0.8016	0.8016
hemodialysis prevalence	Normal_NP	Good	1	0.8016	0.8016
helmholtz interpretation	Normal_NP	Good	1	0.8016	0.8016
hbeag positive patients	Normal_NP	Good	1	0.8016	0.8016
hbeag negative patients	Normal_NP	Good	1	0.8016	0.8016
ground-glass attenuation	Normal_NP	Good	1	0.8016	0.8016
gestational inflammation	Normal_NP	Good	1	0.8016	0.8016
gemella morbillorum	Normal_NP	Good	1	0.8016	0.8016
gelatine zymography	Normal_NP	Good	1	0.8016	0.8016
fviii-binding capacity	Normal_NP	Good	1	0.8016	0.8016
fluence field optimization	Normal_NP	Good	1	0.8016	0.8016
excoriation desquamation	Normal_NP	Good	1	0.8016	0.8016
ethical-social issues	Normal_NP	Good	1	0.8016	0.8016
etco2 ratio decreases	Normal_NP	Good	1	0.8016	0.8016
erg base-case estimate	Normal_NP	Good	1	0.8016	0.8016
enterobacter cloacae	Normal_NP	Good	1	0.8016	0.8016
endocrine neoplasia	Normal_NP	Good	1	0.8016	0.8016
edwards centera thv	Normal_NP	Good	1	0.8016	0.8016
early-stage development	Normal_NP	Good	1	0.8016	0.8016
dermatological skin	Normal_NP	Good	1	0.8016	0.8016
degenerative disorders	Normal_NP	Good	1	0.8016	0.8016
daptomycin efficacy	Normal_NP	Good	1	0.8016	0.8016
current epidemiological	Normal_NP	Good	1	0.8016	0.8016
contractility modulation	Normal_NP	Good	1	0.8016	0.8016
congenital myopathy	Normal_NP	Good	1	0.8016	0.8016
congenital colobomas	Normal_NP	Good	1	0.8016	0.8016
cicatricial retraction	Normal_NP	Good	1	0.8016	0.8016
chlamydia pneumoniae	Normal_NP	Good	1	0.8016	0.8016
chemical mutagenesis	Normal_NP	Good	1	0.8016	0.8016
brentuximab vedotin	Normal_NP	Good	1	0.8016	0.8016
blastocyst-derived es	Normal_NP	Good	1	0.8016	0.8016
bedside inr monitors	Normal_NP	Good	1	0.8016	0.8016
autologous stem cell	Normal_NP	Good	1	0.8016	0.8016
asymptomatic disease	Normal_NP	Good	1	0.8016	0.8016
asymptomatic deficiency	Normal_NP	Good	1	0.8016	0.8016
area-under-the-curve	HYPHENATION	Good	1.0	0.8016	0.8016
antiaggregative activity	Normal_NP	Good	1	0.8016	0.8016
antiaggregation activity	Normal_NP	Good	1	0.8016	0.8016
africa region palliative	Normal_NP	Good	1	0.8016	0.8016
wild-type kras gene	Normal_NP	Good	1	0.8001	0.8001
virus-nucleic acid	Normal_NP	Good	1	0.8001	0.8001
ventricular growth	Normal_NP	Good	1	0.8001	0.8001
vancomycin exposure	Normal_NP	Good	1	0.8001	0.8001
tracheostomy stoma	Normal_NP	Good	1	0.8001	0.8001
tnf-alfa inhibitors	Normal_NP	Good	1	0.8001	0.8001
three-month intervals	Normal_NP	Good	1	0.8001	0.8001
syndromic diagnosis	Normal_NP	Good	1	0.8001	0.8001
symetis acurate ta	Normal_NP	Good	1	0.8001	0.8001
substitutive treatment	Normal_NP	Good	1	0.8001	0.8001
squamous epithelia	Normal_NP	Good	1	0.8001	0.8001
segmental consolidation	Normal_NP	Good	1	0.8001	0.8001
secondary arthrosis	Normal_NP	Good	1	0.8001	0.8001
rfviii product advate	Normal_NP	Good	1	0.8001	0.8001
residual fviii activity	Normal_NP	Good	1	0.8001	0.8001
researchable questions	Normal_NP	Good	1	0.8001	0.8001
radiosynoviorthesis	SIMPLE	Good	1	0.8001	0.8001
proteomic researches	Normal_NP	Good	1	0.8001	0.8001
proteinuria outcomes	Normal_NP	Good	1	0.8001	0.8001
proliferator activator	Normal_NP	Good	1	0.8001	0.8001
postsynaptic specializations	Normal_NP	Good	1	0.8001	0.8001
placental apoptosis	Normal_NP	Good	1	0.8001	0.8001
physician workforce	Normal_NP	Good	1	0.8001	0.8001
periodontal defects	Normal_NP	Good	1	0.8001	0.8001
perilesional brain	Normal_NP	Good	1	0.8001	0.8001
partitioned-survival	HYPHENATION	Good	1.0	0.8001	0.8001
osteoporosis treatments	Normal_NP	Good	1	0.8001	0.8001
osteogenic protein	Normal_NP	Good	1	0.8001	0.8001
ontological dependence	Normal_NP	Good	1	0.8001	0.8001
oncological diseases	Normal_NP	Good	1	0.8001	0.8001
omalizumab therapy	Normal_NP	Good	1	0.8001	0.8001
off-site rehabilitation	Normal_NP	Good	1	0.8001	0.8001
nucleotide homologies	Normal_NP	Good	1	0.8001	0.8001
non-pregnant women	Normal_NP	Good	1	0.8001	0.8001
non-inhibitor patients	Normal_NP	Good	1	0.8001	0.8001
nitrosative stress	Normal_NP	Good	1	0.8001	0.8001
nigra hyperechogenicity	Normal_NP	Good	1	0.8001	0.8001
neurologic syndrome	Normal_NP	Good	1	0.8001	0.8001
network adult adhd	Normal_NP	Good	1	0.8001	0.8001
nccn oncology risk	Normal_NP	Good	1	0.8001	0.8001
nccn hepatobiliary	Normal_NP	Good	1	0.8001	0.8001
munich haemophilia	Normal_NP	Good	1	0.8001	0.8001
multimer distribution	Normal_NP	Good	1	0.8001	0.8001
multicentric studies	Normal_NP	Good	1	0.8001	0.8001
mitral valve coaptation	Normal_NP	Good	1	0.8001	0.8001
mevalonate pathway	Normal_NP	Good	1	0.8001	0.8001
methionine synthase	Normal_NP	Good	1	0.8001	0.8001
methcillin susceptibility	Normal_NP	Good	1	0.8001	0.8001
medtronic corevalve	Normal_NP	Good	1	0.8001	0.8001
medicine bookshelf	Normal_NP	Good	1	0.8001	0.8001
measureable improvement	Normal_NP	Good	1	0.8001	0.8001
maytansinoid derivatives	Normal_NP	Good	1	0.8001	0.8001
mammary epithelium	Normal_NP	Good	1	0.8001	0.8001
majority caucasian	Normal_NP	Good	1	0.8001	0.8001
longer-term safety	Normal_NP	Good	1	0.8001	0.8001
long-acting formulations	Normal_NP	Good	1	0.8001	0.8001
liver microenvironment	Normal_NP	Good	1	0.8001	0.8001
last-born children	Normal_NP	Good	1	0.8001	0.8001
kustanaiskie mineral	Normal_NP	Good	1	0.8001	0.8001
klebsiella oxytoca	Normal_NP	Good	1	0.8001	0.8001
intradermal injections	Normal_NP	Good	1	0.8001	0.8001
inter-observer agreement	Normal_NP	Good	1	0.8001	0.8001
independent t-test	Normal_NP	Good	1	0.8001	0.8001
hydrostatic abnormalities	Normal_NP	Good	1	0.8001	0.8001
hydrophilic statins	Normal_NP	Good	1	0.8001	0.8001
homologous language	Normal_NP	Good	1	0.8001	0.8001
homolateral cortex	Normal_NP	Good	1	0.8001	0.8001
histological validation	Normal_NP	Good	1	0.8001	0.8001
haemostatic outcome	Normal_NP	Good	1	0.8001	0.8001
haemostatic disorder	Normal_NP	Good	1	0.8001	0.8001
glutamate receptor	Normal_NP	Good	1	0.8001	0.8001
genital hpv infections	Normal_NP	Good	1	0.8001	0.8001
genital epithelium	Normal_NP	Good	1	0.8001	0.8001
fundoscopic examination	Normal_NP	Good	1	0.8001	0.8001
first-in-man study	Normal_NP	Good	1	0.8001	0.8001
fand-graev formula	Normal_NP	Good	1	0.8001	0.8001
escola polit cnica	Normal_NP	Good	1	0.8001	0.8001
epidemiologic patient	Normal_NP	Good	1	0.8001	0.8001
epidemiologic link	Normal_NP	Good	1	0.8001	0.8001
enterococcus avium	Normal_NP	Good	1	0.8001	0.8001
enteral l-carnitine	Normal_NP	Good	1	0.8001	0.8001
endotracheal intubation	Normal_NP	Good	1	0.8001	0.8001
endodontic therapy	Normal_NP	Good	1	0.8001	0.8001
dysfunction intensity	Normal_NP	Good	1	0.8001	0.8001
duplicitous efforts	Normal_NP	Good	1	0.8001	0.8001
dissimilar antigens	Normal_NP	Good	1	0.8001	0.8001
dengue pathogenesis	Normal_NP	Good	1	0.8001	0.8001
delgado-escueta av	Normal_NP	Good	1	0.8001	0.8001
decision antiblastic	Normal_NP	Good	1	0.8001	0.8001
cytological atypia	Normal_NP	Good	1	0.8001	0.8001
critical phase bullous	Normal_NP	Good	1	0.8001	0.8001
creation ex nihilo	Normal_NP	Good	1	0.8001	0.8001
cosmetic bt injections	Normal_NP	Good	1	0.8001	0.8001
cortical dysplasia	Normal_NP	Good	1	0.8001	0.8001
continuous reevaluation	Normal_NP	Good	1	0.8001	0.8001
contentious evolution	Normal_NP	Good	1	0.8001	0.8001
colorectal surgery	Normal_NP	Good	1	0.8001	0.8001
cobalt chromium stent	Normal_NP	Good	1	0.8001	0.8001
chromosomal amplifications	Normal_NP	Good	1	0.8001	0.8001
cholinesterase activity	Normal_NP	Good	1	0.8001	0.8001
childhood epilepsy	Normal_NP	Good	1	0.8001	0.8001
cerebral hypotonia	Normal_NP	Good	1	0.8001	0.8001
cerebellar atrophy	Normal_NP	Good	1	0.8001	0.8001
carbocyanine-derived	HYPHENATION	Good	1.0	0.8001	0.8001
behavioral disturbances	Normal_NP	Good	1	0.8001	0.8001
baseline lcl severity	Normal_NP	Good	1	0.8001	0.8001
balloon sinuplasty	Normal_NP	Good	1	0.8001	0.8001
bacterial cell-wall	Normal_NP	Good	1	0.8001	0.8001
atheromatous plaques	Normal_NP	Good	1	0.8001	0.8001
antitumor antibiotic	Normal_NP	Good	1	0.8001	0.8001
anticoagulant clinics	Normal_NP	Good	1	0.8001	0.8001
angiogenesis regulation	Normal_NP	Good	1	0.8001	0.8001
allergologic evaluation	Normal_NP	Good	1	0.8001	0.8001
acute-onset disorders	Normal_NP	Good	1	0.8001	0.8001
2nd world congress	Normal_NP	Good	1	0.8001	0.8001
brain mri	Normal_NP	Good	1	0.7979	0.7979
nonfluent aphasia	Normal_NP	Good	1	0.7971	0.7971
sitagliptin	SIMPLE	Good	1	0.7964	0.7964
monocytogenes	SIMPLE	Good	1	0.7964	0.7964
pediatric septic shock	Normal_NP	Good	1	0.7949	0.7949
metastatic breast cancer	Normal_NP	Good	1	0.7949	0.7949
sero-status	HYPHENATION	Good	1.0	0.7941	0.7941
receptor-2	HYPHENATION	Good	1.0	0.7941	0.7941
pro-peptide	HYPHENATION	Good	1.0	0.7941	0.7941
pkd families	Normal_NP	Good	1	0.7941	0.7941
ozogamicin	SIMPLE	Good	1	0.7941	0.7941
note template	Normal_NP	Good	1	0.7941	0.7941
mr therapy	Normal_NP	Good	1	0.7941	0.7941
lotus valve	Normal_NP	Good	1	0.7941	0.7941
landomycin	SIMPLE	Good	1	0.7941	0.7941
klebsiella	SIMPLE	Good	1	0.7941	0.7941
hyalomminae	SIMPLE	Good	1	0.7941	0.7941
herpangina	SIMPLE	Good	1	0.7941	0.7941
hd patients	Normal_NP	Good	1	0.7941	0.7941
georgetown	SIMPLE	Good	1	0.7941	0.7941
epirubicin	SIMPLE	Good	1	0.7941	0.7941
epinephrine	SIMPLE	Good	1	0.7941	0.7941
enterovirus	SIMPLE	Good	1	0.7941	0.7941
emla cream	Normal_NP	Good	1	0.7941	0.7941
ebv infection	Normal_NP	Good	1	0.7941	0.7941
dyskinesia	SIMPLE	Good	1	0.7941	0.7941
cs exacerbations	Normal_NP	Good	1	0.7941	0.7941
cftr mutations	Normal_NP	Good	1	0.7941	0.7941
calmodulin	SIMPLE	Good	1	0.7941	0.7941
blueshield	SIMPLE	Good	1	0.7941	0.7941
pkd	ABBREVIATION	Good	1	0.7934	0.7934
ibd	ABBREVIATION	Good	1	0.7934	0.7934
hcx	SIMPLE	Good	1	0.7934	0.7934
year-plus subjects	Normal_NP	Good	1	0.7927	0.7927
volumetric analyses	Normal_NP	Good	1	0.7927	0.7927
vivo anti-microbial	Normal_NP	Good	1	0.7927	0.7927
univariate analyses	Normal_NP	Good	1	0.7927	0.7927
un-processed rvwf	Normal_NP	Good	1	0.7927	0.7927
two-stage exchange	Normal_NP	Good	1	0.7927	0.7927
trophoblast invasion	Normal_NP	Good	1	0.7927	0.7927
trastuzumab treatment	Normal_NP	Good	1	0.7927	0.7927
transitioning clients	Normal_NP	Good	1	0.7927	0.7927
transitional mastitis	Normal_NP	Good	1	0.7927	0.7927
transfemoral version	Normal_NP	Good	1	0.7927	0.7927
transcription pcr	Normal_NP	Good	1	0.7927	0.7927
toxin topical gel	Normal_NP	Good	1	0.7927	0.7927
thiosulfonic acids	Normal_NP	Good	1	0.7927	0.7927
thetaiotaomnicron	SIMPLE	Good	1	0.7927	0.7927
testicular detorsion	Normal_NP	Good	1	0.7927	0.7927
tarsus-aponeurosis	HYPHENATION	Good	1.0	0.7927	0.7927
synthetic agonist	Normal_NP	Good	1	0.7927	0.7927
supra-pinal populations	Normal_NP	Good	1	0.7927	0.7927
supine breast mri	Normal_NP	Good	1	0.7927	0.7927
subclinical bleedings	Normal_NP	Good	1	0.7927	0.7927
stem cell transplant	Normal_NP	Good	1	0.7927	0.7927
status dissociatus	Normal_NP	Good	1	0.7927	0.7927
skill gait rhythm	Normal_NP	Good	1	0.7927	0.7927
single-agent pldh	Normal_NP	Good	1	0.7927	0.7927
san francisco bay	Normal_NP	Good	1	0.7927	0.7927
research workshop	Normal_NP	Good	1	0.7927	0.7927
rapamycin pathway	Normal_NP	Good	1	0.7927	0.7927
radical polymerisation	Normal_NP	Good	1	0.7927	0.7927
radial-ulnar deviation	Normal_NP	Good	1	0.7927	0.7927
pulmnonary perfusion	Normal_NP	Good	1	0.7927	0.7927
pseudo-color filter	Normal_NP	Good	1	0.7927	0.7927
prototypical tenses	Normal_NP	Good	1	0.7927	0.7927
protein-free buffer	Normal_NP	Good	1	0.7927	0.7927
protein mammalian	Normal_NP	Good	1	0.7927	0.7927
prosthetic replacements	Normal_NP	Good	1	0.7927	0.7927
prosthesis deployment	Normal_NP	Good	1	0.7927	0.7927
professor nikolai	Normal_NP	Good	1	0.7927	0.7927
preemptive kidney	Normal_NP	Good	1	0.7927	0.7927
pre-malignant lesions	Normal_NP	Good	1	0.7927	0.7927
potential antigens	Normal_NP	Good	1	0.7927	0.7927
platelet receptors	Normal_NP	Good	1	0.7927	0.7927
physiologic studies	Normal_NP	Good	1	0.7927	0.7927
phenotypic switch	Normal_NP	Good	1	0.7927	0.7927
pharmaceutical uk	Normal_NP	Good	1	0.7927	0.7927
pericardial tissue	Normal_NP	Good	1	0.7927	0.7927
percentage energy	Normal_NP	Good	1	0.7927	0.7927
pediatric surgery	Normal_NP	Good	1	0.7927	0.7927
pediatric surgeon	Normal_NP	Good	1	0.7927	0.7927
pasture biocenosis	Normal_NP	Good	1	0.7927	0.7927
parvovirus infections	Normal_NP	Good	1	0.7927	0.7927
particulate species	Normal_NP	Good	1	0.7927	0.7927
paravalvular aortic	Normal_NP	Good	1	0.7927	0.7927
palladin institute	Normal_NP	Good	1	0.7927	0.7927
paediatric asthma	Normal_NP	Good	1	0.7927	0.7927
orbicularis muscle	Normal_NP	Good	1	0.7927	0.7927
optimizing survival	Normal_NP	Good	1	0.7927	0.7927
oncology pharmacy	Normal_NP	Good	1	0.7927	0.7927
on-demand therapy	Normal_NP	Good	1	0.7927	0.7927
observational bias	Normal_NP	Good	1	0.7927	0.7927
nonosmotic release	Normal_NP	Good	1	0.7927	0.7927
nociceptive afferents	Normal_NP	Good	1	0.7927	0.7927
near-universal cf	Normal_NP	Good	1	0.7927	0.7927
mid-term prognosis	Normal_NP	Good	1	0.7927	0.7927
microbial complexity	Normal_NP	Good	1	0.7927	0.7927
methodic approaches	Normal_NP	Good	1	0.7927	0.7927
mendelian inheritance	Normal_NP	Good	1	0.7927	0.7927
mammary dysplasia	Normal_NP	Good	1	0.7927	0.7927
lumi-aggregometry	HYPHENATION	Good	1.0	0.7927	0.7927
low-risk individuals	Normal_NP	Good	1	0.7927	0.7927
lipophilic statins	Normal_NP	Good	1	0.7927	0.7927
lactone intermediate	Normal_NP	Good	1	0.7927	0.7927
kyzylorda province	Normal_NP	Good	1	0.7927	0.7927
iterative correction	Normal_NP	Good	1	0.7927	0.7927
intravenous fluid	Normal_NP	Good	1	0.7927	0.7927
inpatient surgery	Normal_NP	Good	1	0.7927	0.7927
inpatient program	Normal_NP	Good	1	0.7927	0.7927
incremental reactivity	Normal_NP	Good	1	0.7927	0.7927
incidental aggravation	Normal_NP	Good	1	0.7927	0.7927
in-hospital management	Normal_NP	Good	1	0.7927	0.7927
immune-haematological	HYPHENATION	Good	1.0	0.7927	0.7927
hypervolemic patients	Normal_NP	Good	1	0.7927	0.7927
homeostasis regulation	Normal_NP	Good	1	0.7927	0.7927
hiv-negative patients	Normal_NP	Good	1	0.7927	0.7927
high-quality raise	Normal_NP	Good	1	0.7927	0.7927
high-quality cancer	Normal_NP	Good	1	0.7927	0.7927
hemostatic disorder	Normal_NP	Good	1	0.7927	0.7927
hemarthro-project	HYPHENATION	Good	1.0	0.7927	0.7927
haemostasis treatment	Normal_NP	Good	1	0.7927	0.7927
haemophilic treatment	Normal_NP	Good	1	0.7927	0.7927
gonococcus vaccines	Normal_NP	Good	1	0.7927	0.7927
genentech oncology	Normal_NP	Good	1	0.7927	0.7927
fungal overinfection	Normal_NP	Good	1	0.7927	0.7927
forearm haematoma	Normal_NP	Good	1	0.7927	0.7927
first-in-man feasibility	Normal_NP	Good	1	0.7927	0.7927
fibroadenoma masses	Normal_NP	Good	1	0.7927	0.7927
fetal fibronectin	Normal_NP	Good	1	0.7927	0.7927
femoral shaft fixation	Normal_NP	Good	1	0.7927	0.7927
femoral bone density	Normal_NP	Good	1	0.7927	0.7927
familial insomnia	Normal_NP	Good	1	0.7927	0.7927
extramammary findings	Normal_NP	Good	1	0.7927	0.7927
expert oculoplastic	Normal_NP	Good	1	0.7927	0.7927
expandable sheath	Normal_NP	Good	1	0.7927	0.7927
estrogenic hormones	Normal_NP	Good	1	0.7927	0.7927
epstein-barr virus	Normal_NP	Good	1	0.7927	0.7927
epistemic subjectivity	Normal_NP	Good	1	0.7927	0.7927
epileptogenic zone	Normal_NP	Good	1	0.7927	0.7927
eggerthella lenta	Normal_NP	Good	1	0.7927	0.7927
efficacious activation	Normal_NP	Good	1	0.7927	0.7927
dyskinesias onset	Normal_NP	Good	1	0.7927	0.7927
delusional disorder	Normal_NP	Good	1	0.7927	0.7927
deeply-held faith	Normal_NP	Good	1	0.7927	0.7927
daptomycin target	Normal_NP	Good	1	0.7927	0.7927
daptomycin infections	Normal_NP	Good	1	0.7927	0.7927
cytogenetic study	Normal_NP	Good	1	0.7927	0.7927
cultural-appropriateness	HYPHENATION	Good	1.0	0.7927	0.7927
core-valve evolut	Normal_NP	Good	1	0.7927	0.7927
contemporary visuality	Normal_NP	Good	1	0.7927	0.7927
confusional arousal	Normal_NP	Good	1	0.7927	0.7927
conductance regulator	Normal_NP	Good	1	0.7927	0.7927
commissure assessments	Normal_NP	Good	1	0.7927	0.7927
commercio newspaper	Normal_NP	Good	1	0.7927	0.7927
coexistent disease	Normal_NP	Good	1	0.7927	0.7927
ciencias afinesin	Normal_NP	Good	1	0.7927	0.7927
chromosomal study	Normal_NP	Good	1	0.7927	0.7927
chromatin condensation	Normal_NP	Good	1	0.7927	0.7927
chromatide ruptures	Normal_NP	Good	1	0.7927	0.7927
centromere rupture	Normal_NP	Good	1	0.7927	0.7927
centro brasileiro	Normal_NP	Good	1	0.7927	0.7927
calcium reabsorption	Normal_NP	Good	1	0.7927	0.7927
behavioral disorders	Normal_NP	Good	1	0.7927	0.7927
asymptomatic phpt	Normal_NP	Good	1	0.7927	0.7927
asymptomatic mother	Normal_NP	Good	1	0.7927	0.7927
aromatase inhibition	Normal_NP	Good	1	0.7927	0.7927
antipsychotic medication	Normal_NP	Good	1	0.7927	0.7927
antibiotic-resistance	HYPHENATION	Good	1.0	0.7927	0.7927
anti-ebv antibodies	Normal_NP	Good	1	0.7927	0.7927
anatomo-physiological	HYPHENATION	Good	1.0	0.7927	0.7927
amphibole asbestos	Normal_NP	Good	1	0.7927	0.7927
ame position statement	Normal_NP	Good	1	0.7927	0.7927
airtum data management	Normal_NP	Good	1	0.7927	0.7927
agrypnia excitata	Normal_NP	Good	1	0.7927	0.7927
aggressive biologic	Normal_NP	Good	1	0.7927	0.7927
adult self-report	Normal_NP	Good	1	0.7927	0.7927
acute-stay hospitals	Normal_NP	Good	1	0.7927	0.7927
actiheart monitor	Normal_NP	Good	1	0.7927	0.7927
accidental injury	Normal_NP	Good	1	0.7927	0.7927
second-generation antipsychotic lais	Normal_NP	Good	1	0.7919	0.7919
next-generation sequencing approach	Normal_NP	Good	1	0.7919	0.7919
self-management education	Normal_NP	Good	1	0.7912	0.7912
bidirectional association	Normal_NP	Good	1	0.7912	0.7912
vdalv	SIMPLE	Good	1	0.7905	0.7905
ddavp	SIMPLE	Good	1	0.7905	0.7905
c-pth	HYPHENATION	Good	1.0	0.7905	0.7905
chdp	ABBREVIATION	Good	1	0.7897	0.7897
cftr	SIMPLE	Good	1	0.7897	0.7897
transcatheter aortic valve implantation	Normal_NP	Good	1	0.7882	0.7882
anti-tumor necrosis factor therapies	Normal_NP	Good	1	0.7882	0.7882
voluntarist tendency	Normal_NP	Good	1	0.7875	0.7875
vitamin k deficiency	Normal_NP	Good	1	0.7875	0.7875
vertical overbite	Normal_NP	Good	1	0.7875	0.7875
uk resident patients	Normal_NP	Good	1	0.7875	0.7875
two-step implantation	Normal_NP	Good	1	0.7875	0.7875
transapical tavi	Normal_NP	Good	1	0.7875	0.7875
tracheal fistula	Normal_NP	Good	1	0.7875	0.7875
thrombin potential	Normal_NP	Good	1	0.7875	0.7875
thoracic surgery	Normal_NP	Good	1	0.7875	0.7875
thoracic oncology	Normal_NP	Good	1	0.7875	0.7875
t2 signal intensity	Normal_NP	Good	1	0.7875	0.7875
syr-darya valley	Normal_NP	Good	1	0.7875	0.7875
synovial fibrosis	Normal_NP	Good	1	0.7875	0.7875
superoxide anions	Normal_NP	Good	1	0.7875	0.7875
spatially-dependent	HYPHENATION	Good	1.0	0.7875	0.7875
sga-lai compound	Normal_NP	Good	1	0.7875	0.7875
self-report scale	Normal_NP	Good	1	0.7875	0.7875
refractory ascites	Normal_NP	Good	1	0.7875	0.7875
real-time rt-pcr	Normal_NP	Good	1	0.7875	0.7875
radiographic vitality	Normal_NP	Good	1	0.7875	0.7875
proteolytic fragments	Normal_NP	Good	1	0.7875	0.7875
protein receptor	Normal_NP	Good	1	0.7875	0.7875
professor robert	Normal_NP	Good	1	0.7875	0.7875
prioritizing dose	Normal_NP	Good	1	0.7875	0.7875
preterm delivery	Normal_NP	Good	1	0.7875	0.7875
predictive capacity	Normal_NP	Good	1	0.7875	0.7875
potential infection	Normal_NP	Good	1	0.7875	0.7875
postsurgical care	Normal_NP	Good	1	0.7875	0.7875
phosphate excretion	Normal_NP	Good	1	0.7875	0.7875
phlebology training	Normal_NP	Good	1	0.7875	0.7875
parvimonas micra	Normal_NP	Good	1	0.7875	0.7875
paroxysmal motor	Normal_NP	Good	1	0.7875	0.7875
parenteral infusion	Normal_NP	Good	1	0.7875	0.7875
osteoporotic bone	Normal_NP	Good	1	0.7875	0.7875
oral bisphosphonates	Normal_NP	Good	1	0.7875	0.7875
optimizing treatment	Normal_NP	Good	1	0.7875	0.7875
one-hour postponement	Normal_NP	Good	1	0.7875	0.7875
oncology insights	Normal_NP	Good	1	0.7875	0.7875
non-splenectomised	HYPHENATION	Good	1.0	0.7875	0.7875
no-adhd children	Normal_NP	Good	1	0.7875	0.7875
neurotrophic activity	Normal_NP	Good	1	0.7875	0.7875
neonatal network	Normal_NP	Good	1	0.7875	0.7875
negative predictive	Normal_NP	Good	1	0.7875	0.7875
negative calcium	Normal_NP	Good	1	0.7875	0.7875
myogenic potential	Normal_NP	Good	1	0.7875	0.7875
myocardial damage	Normal_NP	Good	1	0.7875	0.7875
multistate model	Normal_NP	Good	1	0.7875	0.7875
multidrug-resistant	HYPHENATION	Good	1.0	0.7875	0.7875
mr galactography	Normal_NP	Good	1	0.7875	0.7875
minamata convention	Normal_NP	Good	1	0.7875	0.7875
microarchitecture	SIMPLE	Good	1	0.7875	0.7875
mena-nccn breast	Normal_NP	Good	1	0.7875	0.7875
matrix protein-1	Normal_NP	Good	1	0.7875	0.7875
magazinesa de em	Normal_NP	Good	1	0.7875	0.7875
lupus-anticoagulant	HYPHENATION	Good	1.0	0.7875	0.7875
long term evolution	Normal_NP	Good	1	0.7875	0.7875
lisdexamphetamine	SIMPLE	Good	1	0.7875	0.7875
liposomal formulation	Normal_NP	Good	1	0.7875	0.7875
linguistic cohesiveness	Normal_NP	Good	1	0.7875	0.7875
legume-rhizobium	HYPHENATION	Good	1.0	0.7875	0.7875
invasive implantation	Normal_NP	Good	1	0.7875	0.7875
intracranial lesions	Normal_NP	Good	1	0.7875	0.7875
interosseus ligament	Normal_NP	Good	1	0.7875	0.7875
information--may	HYPHENATION	Good	1.0	0.7875	0.7875
imaginative narrative	Normal_NP	Good	1	0.7875	0.7875
hypophosphoremia	SIMPLE	Good	1	0.7875	0.7875
hydrogen peroxide	Normal_NP	Good	1	0.7875	0.7875
hugh agnew gamble	Normal_NP	Good	1	0.7875	0.7875
hospital-wide initiative	Normal_NP	Good	1	0.7875	0.7875
hmg-coa reductase	Normal_NP	Good	1	0.7875	0.7875
genomic rearrangements	Normal_NP	Good	1	0.7875	0.7875
gallbladder cancer	Normal_NP	Good	1	0.7875	0.7875
fusional languages	Normal_NP	Good	1	0.7875	0.7875
front-line staff	Normal_NP	Good	1	0.7875	0.7875
fourth-year students	Normal_NP	Good	1	0.7875	0.7875
first-step treatment	Normal_NP	Good	1	0.7875	0.7875
epigenetic modulation	Normal_NP	Good	1	0.7875	0.7875
endogenous fviii	Normal_NP	Good	1	0.7875	0.7875
empire bluecross	Normal_NP	Good	1	0.7875	0.7875
embolism syndrome	Normal_NP	Good	1	0.7875	0.7875
economic co-operation	Normal_NP	Good	1	0.7875	0.7875
dynamic contraction	Normal_NP	Good	1	0.7875	0.7875
dti tractography	Normal_NP	Good	1	0.7875	0.7875
drosophila testis	Normal_NP	Good	1	0.7875	0.7875
disorder symptoms	Normal_NP	Good	1	0.7875	0.7875
dhpg-treated cells	Normal_NP	Good	1	0.7875	0.7875
dental clinicians	Normal_NP	Good	1	0.7875	0.7875
deacylase deficiency	Normal_NP	Good	1	0.7875	0.7875
daptomycin tolerability	Normal_NP	Good	1	0.7875	0.7875
corevalve family	Normal_NP	Good	1	0.7875	0.7875
congenital ptosis	Normal_NP	Good	1	0.7875	0.7875
clinical oncology	Normal_NP	Good	1	0.7875	0.7875
cerebral peduncle	Normal_NP	Good	1	0.7875	0.7875
cartilage injury	Normal_NP	Good	1	0.7875	0.7875
cardiovirus genus	Normal_NP	Good	1	0.7875	0.7875
burv leiv-krg760	Normal_NP	Good	1	0.7875	0.7875
blastocyst-derived	HYPHENATION	Good	1.0	0.7875	0.7875
beam polychromaticity	Normal_NP	Good	1	0.7875	0.7875
baumannii infections	Normal_NP	Good	1	0.7875	0.7875
bactericidal activity	Normal_NP	Good	1	0.7875	0.7875
asymptomatic infant	Normal_NP	Good	1	0.7875	0.7875
arteries--effect	HYPHENATION	Good	1.0	0.7875	0.7875
angiogenic capacity	Normal_NP	Good	1	0.7875	0.7875
angelman syndrome	Normal_NP	Good	1	0.7875	0.7875
analgesic overuse	Normal_NP	Good	1	0.7875	0.7875
alcohol withdrawal	Normal_NP	Good	1	0.7875	0.7875
adaptative modelling	Normal_NP	Good	1	0.7875	0.7875
abu dhabi declaration	Normal_NP	Good	1	0.7875	0.7875
psoriatic arthritis	Normal_NP	Good	1	0.7846	0.7846
subsystem	SIMPLE	Good	1	0.7838	0.7838
reoviridae	SIMPLE	Good	1	0.7838	0.7838
porphyrins	SIMPLE	Good	1	0.7838	0.7838
parafunctions	SIMPLE	Good	1	0.7838	0.7838
nairovirus	SIMPLE	Good	1	0.7838	0.7838
modis aot	Normal_NP	Good	1	0.7838	0.7838
mitraclip	SIMPLE	Good	1	0.7838	0.7838
millilitres	SIMPLE	Good	1	0.7838	0.7838
mgc population	Normal_NP	Good	1	0.7838	0.7838
hypotonia	SIMPLE	Good	1	0.7838	0.7838
haemophilic	SIMPLE	Good	1	0.7838	0.7838
entropion	SIMPLE	Good	1	0.7838	0.7838
ectropion	SIMPLE	Good	1	0.7838	0.7838
chc model	Normal_NP	Good	1	0.7838	0.7838
cftr gene	Normal_NP	Good	1	0.7838	0.7838
cantabria	SIMPLE	Good	1	0.7838	0.7838
bloorview	SIMPLE	Good	1	0.7838	0.7838
actiheart	SIMPLE	Good	1	0.7838	0.7838
marketing authorisation	Normal_NP	Good	1	0.7831	0.7831
lymphohistiocytosis	SIMPLE	Good	1	0.7831	0.7831
chronic rhinosinusitis	Normal_NP	Good	1	0.7831	0.7831
cerebrovascular events	Normal_NP	Good	1	0.7831	0.7831
vascular injury	Normal_NP	Good	1	0.7823	0.7823
vascular biology	Normal_NP	Good	1	0.7823	0.7823
urinary calcium	Normal_NP	Good	1	0.7823	0.7823
urinary albumin	Normal_NP	Good	1	0.7823	0.7823
treatment ought	Normal_NP	Good	1	0.7823	0.7823
transition probability	Normal_NP	Good	1	0.7823	0.7823
transgenic mouse	Normal_NP	Good	1	0.7823	0.7823
tranexamic acid	Normal_NP	Good	1	0.7823	0.7823
titre inhibitor	Normal_NP	Good	1	0.7823	0.7823
thigh haematoma	Normal_NP	Good	1	0.7823	0.7823
taxonomic status	Normal_NP	Good	1	0.7823	0.7823
surgical admission	Normal_NP	Good	1	0.7823	0.7823
superficial emg	Normal_NP	Good	1	0.7823	0.7823
stressful child	Normal_NP	Good	1	0.7823	0.7823
skeletal trauma	Normal_NP	Good	1	0.7823	0.7823
sinus ostia patency	Normal_NP	Good	1	0.7823	0.7823
shank haematoma	Normal_NP	Good	1	0.7823	0.7823
schering-plough	HYPHENATION	Good	1.0	0.7823	0.7823
rt001 botulinum	Normal_NP	Good	1	0.7823	0.7823
risperidone lai	Normal_NP	Good	1	0.7823	0.7823
receptor family	Normal_NP	Good	1	0.7823	0.7823
real-world patients	Normal_NP	Good	1	0.7823	0.7823
prototypic virus	Normal_NP	Good	1	0.7823	0.7823
prosthetic valve	Normal_NP	Good	1	0.7823	0.7823
progressive psa	Normal_NP	Good	1	0.7823	0.7823
prevelent--that	HYPHENATION	Good	1.0	0.7823	0.7823
periosteal erosion	Normal_NP	Good	1	0.7823	0.7823
peg-ifn therapy	Normal_NP	Good	1	0.7823	0.7823
pediatric crohn	Normal_NP	Good	1	0.7823	0.7823
paulo polytechnic	Normal_NP	Good	1	0.7823	0.7823
patient organisations	Normal_NP	Good	1	0.7823	0.7823
parotid inflammation	Normal_NP	Good	1	0.7823	0.7823
pain modulatory	Normal_NP	Good	1	0.7823	0.7823
oral risperidone	Normal_NP	Good	1	0.7823	0.7823
optimise outcomes	Normal_NP	Good	1	0.7823	0.7823
onjornal nacional	Normal_NP	Good	1	0.7823	0.7823
oncology experts	Normal_NP	Good	1	0.7823	0.7823
olanzapine pamoate	Normal_NP	Good	1	0.7823	0.7823
nucleosomal dna	Normal_NP	Good	1	0.7823	0.7823
novel hibch mutations	Normal_NP	Good	1	0.7823	0.7823
novel botulinum	Normal_NP	Good	1	0.7823	0.7823
normal eeg tracings	Normal_NP	Good	1	0.7823	0.7823
nitinol stent housing	Normal_NP	Good	1	0.7823	0.7823
network-belfast	HYPHENATION	Good	1.0	0.7823	0.7823
neonatal assessment	Normal_NP	Good	1	0.7823	0.7823
multicentre trials	Normal_NP	Good	1	0.7823	0.7823
mr-spectroscopy	HYPHENATION	Good	1.0	0.7823	0.7823
mouse diaphragm	Normal_NP	Good	1	0.7823	0.7823
molecular tumor	Normal_NP	Good	1	0.7823	0.7823
mitral regurgitation	Normal_NP	Good	1	0.7823	0.7823
mexico lifestyle	Normal_NP	Good	1	0.7823	0.7823
membrane oxygenation	Normal_NP	Good	1	0.7823	0.7823
medical portico	Normal_NP	Good	1	0.7823	0.7823
macrophage mediators	Normal_NP	Good	1	0.7823	0.7823
lymphoma experts	Normal_NP	Good	1	0.7823	0.7823
lymphoid malignancies	Normal_NP	Good	1	0.7823	0.7823
liver metastasis	Normal_NP	Good	1	0.7823	0.7823
la vida program	Normal_NP	Good	1	0.7823	0.7823
intranet website	Normal_NP	Good	1	0.7823	0.7823
inter-hemispheric	HYPHENATION	Good	1.0	0.7823	0.7823
insulin glargine	Normal_NP	Good	1	0.7823	0.7823
hypoperfusionin	SIMPLE	Good	1	0.7823	0.7823
hydroxycoumarins	SIMPLE	Good	1	0.7823	0.7823
hydrophobic zones	Normal_NP	Good	1	0.7823	0.7823
hs-ctn concentration	Normal_NP	Good	1	0.7823	0.7823
hpv dna genotyping	Normal_NP	Good	1	0.7823	0.7823
holistic providers	Normal_NP	Good	1	0.7823	0.7823
glandular lavage	Normal_NP	Good	1	0.7823	0.7823
gap antipsychotics	Normal_NP	Good	1	0.7823	0.7823
fviii inhibitor	Normal_NP	Good	1	0.7823	0.7823
francisco heart	Normal_NP	Good	1	0.7823	0.7823
fourier upsampling	Normal_NP	Good	1	0.7823	0.7823
fluoropyrimidine	SIMPLE	Good	1	0.7823	0.7823
five-point scale	Normal_NP	Good	1	0.7823	0.7823
excerpta medica	Normal_NP	Good	1	0.7823	0.7823
england treasure	Normal_NP	Good	1	0.7823	0.7823
endogenous stores	Normal_NP	Good	1	0.7823	0.7823
endocrinologist	SIMPLE	Good	1	0.7823	0.7823
edwards centera	Normal_NP	Good	1	0.7823	0.7823
economic growth	Normal_NP	Good	1	0.7823	0.7823
e biotecnologia	Normal_NP	Good	1	0.7823	0.7823
diaphragm assay	Normal_NP	Good	1	0.7823	0.7823
delgado-escueta	HYPHENATION	Good	1.0	0.7823	0.7823
da manh newspaper	Normal_NP	Good	1	0.7823	0.7823
cytology detection	Normal_NP	Good	1	0.7823	0.7823
cutaneous immunity	Normal_NP	Good	1	0.7823	0.7823
cortical injury	Normal_NP	Good	1	0.7823	0.7823
correio da manh	Normal_NP	Good	1	0.7823	0.7823
comorbid diseases	Normal_NP	Good	1	0.7823	0.7823
clinical biology	Normal_NP	Good	1	0.7823	0.7823
cf transmembrane	Normal_NP	Good	1	0.7823	0.7823
cerebral abnormality	Normal_NP	Good	1	0.7823	0.7823
caucasian population	Normal_NP	Good	1	0.7823	0.7823
cation receptors	Normal_NP	Good	1	0.7823	0.7823
catenin pathway	Normal_NP	Good	1	0.7823	0.7823
candida albicans	Normal_NP	Good	1	0.7823	0.7823
bt antibody titers	Normal_NP	Good	1	0.7823	0.7823
bologna-illustrates	HYPHENATION	Good	1.0	0.7823	0.7823
blastocyst stage	Normal_NP	Good	1	0.7823	0.7823
biosecurity law	Normal_NP	Good	1	0.7823	0.7823
biguanide derivative	Normal_NP	Good	1	0.7823	0.7823
baseline outcomes	Normal_NP	Good	1	0.7823	0.7823
base-case model	Normal_NP	Good	1	0.7823	0.7823
base-case estimate	Normal_NP	Good	1	0.7823	0.7823
b virus antigen	Normal_NP	Good	1	0.7823	0.7823
autologous stem	Normal_NP	Good	1	0.7823	0.7823
atrial contraction	Normal_NP	Good	1	0.7823	0.7823
arterial calcification	Normal_NP	Good	1	0.7823	0.7823
aorta hypoplastic	Normal_NP	Good	1	0.7823	0.7823
anogenital cancer	Normal_NP	Good	1	0.7823	0.7823
alopecia areata	Normal_NP	Good	1	0.7823	0.7823
airtum registries	Normal_NP	Good	1	0.7823	0.7823
adc brentuximab	Normal_NP	Good	1	0.7823	0.7823
acurate ta valve	Normal_NP	Good	1	0.7823	0.7823
ningbo	SIMPLE	Good	1	0.7816	0.7816
fluo-4	HYPHENATION	Good	1.0	0.7816	0.7816
samoa	SIMPLE	Good	1	0.7801	0.7801
fluid resuscitation	Normal_NP	Good	1	0.7794	0.7794
zuclopenthixol	SIMPLE	Good	1	0.7779	0.7779
x-ray spectrum	Normal_NP	Good	1	0.7779	0.7779
vkas overdosage	Normal_NP	Good	1	0.7779	0.7779
venous malformation	Normal_NP	Good	1	0.7779	0.7779
type--by deletions	Normal_NP	Good	1	0.7779	0.7779
treatment week	Normal_NP	Good	1	0.7779	0.7779
toronto school	Normal_NP	Good	1	0.7779	0.7779
tokmak wildlife	Normal_NP	Good	1	0.7779	0.7779
tissue exhibit	Normal_NP	Good	1	0.7779	0.7779
ten-year existence	Normal_NP	Good	1	0.7779	0.7779
t-leukemia cells	Normal_NP	Good	1	0.7779	0.7779
superoxide radicals	Normal_NP	Good	1	0.7779	0.7779
stressful situation	Normal_NP	Good	1	0.7779	0.7779
stepwise escalation	Normal_NP	Good	1	0.7779	0.7779
staphylococcci	SIMPLE	Good	1	0.7779	0.7779
software module	Normal_NP	Good	1	0.7779	0.7779
saxonia-anhalt	HYPHENATION	Good	1.0	0.7779	0.7779
s o paulo elites	Normal_NP	Good	1	0.7779	0.7779
rio de janeiro	Normal_NP	Good	1	0.7779	0.7779
reticular opacities	Normal_NP	Good	1	0.7779	0.7779
residual fviii	Normal_NP	Good	1	0.7779	0.7779
rapid tranquilization	Normal_NP	Good	1	0.7779	0.7779
rajka criteria	Normal_NP	Good	1	0.7779	0.7779
pyohaemothorax	SIMPLE	Good	1	0.7779	0.7779
pulpal anatomy	Normal_NP	Good	1	0.7779	0.7779
pthrp receptor	Normal_NP	Good	1	0.7779	0.7779
pruritus severity	Normal_NP	Good	1	0.7779	0.7779
post rituximab	Normal_NP	Good	1	0.7779	0.7779
polit cnicaand	Normal_NP	Good	1	0.7779	0.7779
platelet adhesion	Normal_NP	Good	1	0.7779	0.7779
placental fragments	Normal_NP	Good	1	0.7779	0.7779
personal login	Normal_NP	Good	1	0.7779	0.7779
pediatric risk	Normal_NP	Good	1	0.7779	0.7779
osteoclast activity	Normal_NP	Good	1	0.7779	0.7779
oral osteotomies	Normal_NP	Good	1	0.7779	0.7779
oral olanzapine	Normal_NP	Good	1	0.7779	0.7779
ontario hospitals	Normal_NP	Good	1	0.7779	0.7779
olanzapine lai	Normal_NP	Good	1	0.7779	0.7779
off-target toxicity	Normal_NP	Good	1	0.7779	0.7779
ofatumumab arm	Normal_NP	Good	1	0.7779	0.7779
novel compound	Normal_NP	Good	1	0.7779	0.7779
non-lipid risk	Normal_NP	Good	1	0.7779	0.7779
non-consanguineous	HYPHENATION	Good	1.0	0.7779	0.7779
neoangiogenesis	SIMPLE	Good	1	0.7779	0.7779
nccn specialty	Normal_NP	Good	1	0.7779	0.7779
nccn interviews	Normal_NP	Good	1	0.7779	0.7779
nasal pathology	Normal_NP	Good	1	0.7779	0.7779
myoclonic jerks	Normal_NP	Good	1	0.7779	0.7779
myocardial toxicity	Normal_NP	Good	1	0.7779	0.7779
multispecialty	SIMPLE	Good	1	0.7779	0.7779
muciparous cells	Normal_NP	Good	1	0.7779	0.7779
mitral surgery	Normal_NP	Good	1	0.7779	0.7779
medica database	Normal_NP	Good	1	0.7779	0.7779
lymphoma panels	Normal_NP	Good	1	0.7779	0.7779
ligand-protein	HYPHENATION	Good	1.0	0.7779	0.7779
lateral canthus	Normal_NP	Good	1	0.7779	0.7779
lacunar apatite	Normal_NP	Good	1	0.7779	0.7779
ictal discharge	Normal_NP	Good	1	0.7779	0.7779
hunan children	Normal_NP	Good	1	0.7779	0.7779
high-risk drugs	Normal_NP	Good	1	0.7779	0.7779
hemodynamic stability	Normal_NP	Good	1	0.7779	0.7779
gunma children	Normal_NP	Good	1	0.7779	0.7779
georgia coalition	Normal_NP	Good	1	0.7779	0.7779
fviii concentrate	Normal_NP	Good	1	0.7779	0.7779
fungal particles	Normal_NP	Good	1	0.7779	0.7779
fungal aerosol	Normal_NP	Good	1	0.7779	0.7779
forsyth experiment	Normal_NP	Good	1	0.7779	0.7779
fontan surgery	Normal_NP	Good	1	0.7779	0.7779
f8 gene intron	Normal_NP	Good	1	0.7779	0.7779
eustachian tube	Normal_NP	Good	1	0.7779	0.7779
enterobacteria	SIMPLE	Good	1	0.7779	0.7779
endocrinopathy	SIMPLE	Good	1	0.7779	0.7779
edwards sapien	Normal_NP	Good	1	0.7779	0.7779
dysplastic acf	Normal_NP	Good	1	0.7779	0.7779
dual source ct	Normal_NP	Good	1	0.7779	0.7779
director-general	HYPHENATION	Good	1.0	0.7779	0.7779
diagnostic pcrs	Normal_NP	Good	1	0.7779	0.7779
ddavp efficacy	Normal_NP	Good	1	0.7779	0.7779
day l-carnitine	Normal_NP	Good	1	0.7779	0.7779
daily-life activities	Normal_NP	Good	1	0.7779	0.7779
cytology triage	Normal_NP	Good	1	0.7779	0.7779
critical enablers	Normal_NP	Good	1	0.7779	0.7779
congress angio	Normal_NP	Good	1	0.7779	0.7779
comorbidity lie	Normal_NP	Good	1	0.7779	0.7779
colon epithelial	Normal_NP	Good	1	0.7779	0.7779
cofa implementation	Normal_NP	Good	1	0.7779	0.7779
city level equity	Normal_NP	Good	1	0.7779	0.7779
chuukese population	Normal_NP	Good	1	0.7779	0.7779
choreoathetosis	SIMPLE	Good	1	0.7779	0.7779
chordal replacement	Normal_NP	Good	1	0.7779	0.7779
cf-causing mutation	Normal_NP	Good	1	0.7779	0.7779
cell cytoplasm	Normal_NP	Good	1	0.7779	0.7779
cdc73 gene mutations	Normal_NP	Good	1	0.7779	0.7779
cation exchange	Normal_NP	Good	1	0.7779	0.7779
cation accumulation	Normal_NP	Good	1	0.7779	0.7779
calcium-dependent	HYPHENATION	Good	1.0	0.7779	0.7779
calcium excretion	Normal_NP	Good	1	0.7779	0.7779
c-pth receptor	Normal_NP	Good	1	0.7779	0.7779
btxa intradermal	Normal_NP	Good	1	0.7779	0.7779
bethesda assay	Normal_NP	Good	1	0.7779	0.7779
bacterial lysis	Normal_NP	Good	1	0.7779	0.7779
astroglial cells	Normal_NP	Good	1	0.7779	0.7779
aral sea basin	Normal_NP	Good	1	0.7779	0.7779
antiviral drugs	Normal_NP	Good	1	0.7779	0.7779
annulus dimensions	Normal_NP	Good	1	0.7779	0.7779
adductor magnus	Normal_NP	Good	1	0.7779	0.7779
adaptive study	Normal_NP	Good	1	0.7779	0.7779
acridine orange	Normal_NP	Good	1	0.7779	0.7779
acidic protein	Normal_NP	Good	1	0.7779	0.7779
acidic fluoride	Normal_NP	Good	1	0.7779	0.7779
nocturnal frontal lobe epilepsy	Normal_NP	Good	1	0.7772	0.7772
dmh	SIMPLE	Good	1	0.7757	0.7757
cto	ABBREVIATION	Good	1	0.7757	0.7757
osteoporotic fracture	Normal_NP	Good	1	0.775	0.775
receptor antagonists	Normal_NP	Good	1	0.7743	0.7743
tv minimization	Normal_NP	Good	1	0.7728	0.7728
promotores	SIMPLE	Good	1	0.7728	0.7728
pldh arm	Normal_NP	Good	1	0.7728	0.7728
out-patients	HYPHENATION	Good	1	0.7728	0.7728
orbivirus	SIMPLE	Good	1	0.7728	0.7728
non-small	HYPHENATION	Good	1.0	0.7728	0.7728
non-binding	HYPHENATION	Good	1.0	0.7728	0.7728
myoplasm	SIMPLE	Good	1	0.7728	0.7728
myoclonus	SIMPLE	Good	1	0.7728	0.7728
medicina	SIMPLE	Good	1	0.7728	0.7728
mannitol	SIMPLE	Good	1	0.7728	0.7728
listeria	SIMPLE	Good	1	0.7728	0.7728
hydrazone	SIMPLE	Good	1	0.7728	0.7728
excitata	SIMPLE	Good	1	0.7728	0.7728
diastema	SIMPLE	Good	1	0.7728	0.7728
care-agreement	HYPHENATION	Good	1.0	0.7728	0.7728
butadiene	SIMPLE	Good	1	0.7728	0.7728
cardiac dysfunction	Normal_NP	Good	1	0.7721	0.7721
platelet	SIMPLE	Good	1	0.7714	0.7714
high-fat diet	Normal_NP	Good	1	0.7699	0.7699
statin	SIMPLE	Good	1	0.7692	0.7692
wild-type kras	Normal_NP	Good	1	0.7684	0.7684
visceral obesity	Normal_NP	Good	1	0.7684	0.7684
virus antigen	Normal_NP	Good	1	0.7684	0.7684
viral genotype	Normal_NP	Good	1	0.7684	0.7684
vessel growth	Normal_NP	Good	1	0.7684	0.7684
valve-in-valve	HYPHENATION	Good	1.0	0.7684	0.7684
uterus myocytes	Normal_NP	Good	1	0.7684	0.7684
under-connectivity	HYPHENATION	Good	1.0	0.7684	0.7684
ultravist-300	HYPHENATION	Good	1.0	0.7684	0.7684
two-year stay	Normal_NP	Good	1	0.7684	0.7684
training week	Normal_NP	Good	1	0.7684	0.7684
tracheal flap	Normal_NP	Good	1	0.7684	0.7684
tool subclasses	Normal_NP	Good	1	0.7684	0.7684
toexplore gene	Normal_NP	Good	1	0.7684	0.7684
tmd treatment	Normal_NP	Good	1	0.7684	0.7684
thrombography	SIMPLE	Good	1	0.7684	0.7684
thecorreio da	Normal_NP	Good	1	0.7684	0.7684
tensin analog	Normal_NP	Good	1	0.7684	0.7684
syr-darya river	Normal_NP	Good	1	0.7684	0.7684
surgical valve	Normal_NP	Good	1	0.7684	0.7684
sulphonylureas	SIMPLE	Good	1	0.7684	0.7684
skin melanoma	Normal_NP	Good	1	0.7684	0.7684
skin erythema	Normal_NP	Good	1	0.7684	0.7684
severest variants	Normal_NP	Good	1	0.7684	0.7684
rt-pcr subtyping	Normal_NP	Good	1	0.7684	0.7684
routine preoperative	Normal_NP	Good	1	0.7684	0.7684
rna-polymerase	HYPHENATION	Good	1.0	0.7684	0.7684
right occipital	Normal_NP	Good	1	0.7684	0.7684
reliability k	Normal_NP	Good	1	0.7684	0.7684
reasonable-quality	HYPHENATION	Good	1.0	0.7684	0.7684
prodifferentiating	SIMPLE	Good	1	0.7684	0.7684
pragmatic rct	Normal_NP	Good	1	0.7684	0.7684
potassium ion	Normal_NP	Good	1	0.7684	0.7684
phenprocoumon	SIMPLE	Good	1	0.7684	0.7684
pentoxifylline	SIMPLE	Good	1	0.7684	0.7684
pediatric ulcerative	Normal_NP	Good	1	0.7684	0.7684
patient-blind	HYPHENATION	Good	1.0	0.7684	0.7684
paroxysmal events	Normal_NP	Good	1	0.7684	0.7684
p-hpt patients	Normal_NP	Good	1	0.7684	0.7684
outreach cancer	Normal_NP	Good	1	0.7684	0.7684
oncology cancer	Normal_NP	Good	1	0.7684	0.7684
on-time starts	Normal_NP	Good	1	0.7684	0.7684
occlusal plane	Normal_NP	Good	1	0.7684	0.7684
occlusal caries	Normal_NP	Good	1	0.7684	0.7684
non-reproductive	HYPHENATION	Good	1.0	0.7684	0.7684
non-prescription	HYPHENATION	Good	1.0	0.7684	0.7684
non-introduction	HYPHENATION	Good	1.0	0.7684	0.7684
network adult	Normal_NP	Good	1	0.7684	0.7684
nccn lymphoma	Normal_NP	Good	1	0.7684	0.7684
muscle preparation	Normal_NP	Good	1	0.7684	0.7684
muscle atonia	Normal_NP	Good	1	0.7684	0.7684
mosquito-borne	HYPHENATION	Good	1.0	0.7684	0.7684
meta-paradigm	HYPHENATION	Good	1.0	0.7684	0.7684
medial canthus	Normal_NP	Good	1	0.7684	0.7684
magnesian ion	Normal_NP	Good	1	0.7684	0.7684
liver inflammation	Normal_NP	Good	1	0.7684	0.7684
liquid biopsies	Normal_NP	Good	1	0.7684	0.7684
lipid accumulation	Normal_NP	Good	1	0.7684	0.7684
life-5 dimensions	Normal_NP	Good	1	0.7684	0.7684
leukemogenesis	SIMPLE	Good	1	0.7684	0.7684
leigh syndrome	Normal_NP	Good	1	0.7684	0.7684
left ventricle	Normal_NP	Good	1	0.7684	0.7684
lactate clearance	Normal_NP	Good	1	0.7684	0.7684
kinase domains	Normal_NP	Good	1	0.7684	0.7684
jornal nacional	Normal_NP	Good	1	0.7684	0.7684
ixodidae ticks	Normal_NP	Good	1	0.7684	0.7684
infective site	Normal_NP	Good	1	0.7684	0.7684
iarc-iacr rules	Normal_NP	Good	1	0.7684	0.7684
hbsag decrease	Normal_NP	Good	1	0.7684	0.7684
harvard study	Normal_NP	Good	1	0.7684	0.7684
h-visa strains	Normal_NP	Good	1	0.7684	0.7684
gw nonsynonymous	Normal_NP	Good	1	0.7684	0.7684
free-carnitine	HYPHENATION	Good	1.0	0.7684	0.7684
fibrotic focus	Normal_NP	Good	1	0.7684	0.7684
factor-kappab	HYPHENATION	Good	1.0	0.7684	0.7684
et743-ova-301	HYPHENATION	Good	1.0	0.7684	0.7684
eeg synchrony	Normal_NP	Good	1	0.7684	0.7684
education--the	HYPHENATION	Good	1.0	0.7684	0.7684
eb virus replication	Normal_NP	Good	1	0.7684	0.7684
dismutase activity	Normal_NP	Good	1	0.7684	0.7684
dicloxacillin	SIMPLE	Good	1	0.7684	0.7684
database pubmed	Normal_NP	Good	1	0.7684	0.7684
cyclin d1 gene	Normal_NP	Good	1	0.7684	0.7684
cto implementation	Normal_NP	Good	1	0.7684	0.7684
coxsackievirus	SIMPLE	Good	1	0.7684	0.7684
corticogenesis	SIMPLE	Good	1	0.7684	0.7684
coronary sinus	Normal_NP	Good	1	0.7684	0.7684
complet genome	Normal_NP	Good	1	0.7684	0.7684
choreathetosis	SIMPLE	Good	1	0.7684	0.7684
chemical physics	Normal_NP	Good	1	0.7684	0.7684
care workforce	Normal_NP	Good	1	0.7684	0.7684
care neuroscience	Normal_NP	Good	1	0.7684	0.7684
calicheamicin	SIMPLE	Good	1	0.7684	0.7684
calcium gradient	Normal_NP	Good	1	0.7684	0.7684
burana village	Normal_NP	Good	1	0.7684	0.7684
bronchiectasis	SIMPLE	Good	1	0.7684	0.7684
bovine enamel	Normal_NP	Good	1	0.7684	0.7684
bonta complex	Normal_NP	Good	1	0.7684	0.7684
bloorview kids	Normal_NP	Good	1	0.7684	0.7684
blepharoptosis	SIMPLE	Good	1	0.7684	0.7684
blepharoplastic	SIMPLE	Good	1	0.7684	0.7684
biotecnologia	SIMPLE	Good	1	0.7684	0.7684
benzodiazepines	SIMPLE	Good	1	0.7684	0.7684
autonomic activities	Normal_NP	Good	1	0.7684	0.7684
asthma asthma	Normal_NP	Good	1	0.7684	0.7684
arousal modulation	Normal_NP	Good	1	0.7684	0.7684
antiaging face	Normal_NP	Good	1	0.7684	0.7684
answer--the date	Normal_NP	Good	1	0.7684	0.7684
alopecia tool	Normal_NP	Good	1	0.7684	0.7684
adult subjects	Normal_NP	Good	1	0.7684	0.7684
adhd research	Normal_NP	Good	1	0.7684	0.7684
bevacizumab	SIMPLE	Good	1	0.7677	0.7677
mitochondrial membrane	Normal_NP	Good	1	0.7663	0.7663
hypoparathyroidism	SIMPLE	Good	1	0.7655	0.7655
hypoparathyroid	SIMPLE	Good	1	0.7655	0.7655
hyperparathyroidism-jaw tumor	Normal_NP	Good	1	0.7648	0.7648
nc	SIMPLE	Good	1	0.7641	0.7641
primary molar	Normal_NP	Good	1	0.7634	0.7634
enterococcus	SIMPLE	Good	1	0.7626	0.7626
complexing proteins	Normal_NP	Good	1	0.7619	0.7619
epiq	ABBREVIATION	Good	1	0.7612	0.7612
ca10	SIMPLE	Good	1	0.7612	0.7612
burv	ABBREVIATION	Good	1	0.7612	0.7612
aral	SIMPLE	Good	1	0.7612	0.7612
exenatide	SIMPLE	Good	1	0.7597	0.7597
encapsulation	SIMPLE	Good	1	0.7597	0.7597
arthrosis	SIMPLE	Good	1	0.7597	0.7597
year-plus age	Normal_NP	Good	1	0.759	0.759
x-ray fluence	Normal_NP	Good	1	0.759	0.759
video-recordings	HYPHENATION	Good	1	0.759	0.759
vida program	Normal_NP	Good	1	0.759	0.759
veneto population	Normal_NP	Good	1	0.759	0.759
venalpina vi	Normal_NP	Good	1	0.759	0.759
valve plasty	Normal_NP	Good	1	0.759	0.759
toxoplasmosis	SIMPLE	Good	1	0.759	0.759
total h2 so4	Normal_NP	Good	1	0.759	0.759
tomosynthesis	SIMPLE	Good	1	0.759	0.759
thrombin activity	Normal_NP	Good	1	0.759	0.759
synaptic cell	Normal_NP	Good	1	0.759	0.759
symetis acurate	Normal_NP	Good	1	0.759	0.759
study focussing	Normal_NP	Good	1	0.759	0.759
sporadic pkd	Normal_NP	Good	1	0.759	0.759
social cohesion	Normal_NP	Good	1	0.759	0.759
snr criteria	Normal_NP	Good	1	0.759	0.759
sinus rhythm	Normal_NP	Good	1	0.759	0.759
sensorimotor	SIMPLE	Good	1	0.759	0.759
semi-quantitative	HYPHENATION	Good	1.0	0.759	0.759
second-generation	HYPHENATION	Good	1.0	0.759	0.759
seasonal flu	Normal_NP	Good	1	0.759	0.759
saskatchewan	SIMPLE	Good	1	0.759	0.759
samoa department	Normal_NP	Good	1	0.759	0.759
report-generation	HYPHENATION	Good	1.0	0.759	0.759
re-distribution	HYPHENATION	Good	1.0	0.759	0.759
rbd diagnosis	Normal_NP	Good	1	0.759	0.759
rbd behaviors	Normal_NP	Good	1	0.759	0.759
r aeruginosa	Normal_NP	Good	1	0.759	0.759
quality--and	HYPHENATION	Good	1.0	0.759	0.759
pulp necrosis	Normal_NP	Good	1	0.759	0.759
pseudotumour	SIMPLE	Good	1	0.759	0.759
probe amplification	Normal_NP	Good	1	0.759	0.759
pre-progression	HYPHENATION	Good	1.0	0.759	0.759
pre-delivery	HYPHENATION	Good	1.0	0.759	0.759
phototherapy	SIMPLE	Good	1	0.759	0.759
peroxynitrites	SIMPLE	Good	1	0.759	0.759
over-connectivity	HYPHENATION	Good	1.0	0.759	0.759
onychomadesis	SIMPLE	Good	1	0.759	0.759
oncology care	Normal_NP	Good	1	0.759	0.759
normal flora	Normal_NP	Good	1	0.759	0.759
nonprewhitening	SIMPLE	Good	1	0.759	0.759
non-value-added	HYPHENATION	Good	1.0	0.759	0.759
non-randomised	HYPHENATION	Good	1.0	0.759	0.759
non-mass lesions	Normal_NP	Good	1	0.759	0.759
non-anonymisation	HYPHENATION	Good	1.0	0.759	0.759
negative hpv	Normal_NP	Good	1	0.759	0.759
nasal mucosa	Normal_NP	Good	1	0.759	0.759
na1-xkxcdpb3	HYPHENATION	Good	1.0	0.759	0.759
mycobacteria	SIMPLE	Good	1	0.759	0.759
mutant cebpa	Normal_NP	Good	1	0.759	0.759
murine fviii	Normal_NP	Good	1	0.759	0.759
mri guidelines	Normal_NP	Good	1	0.759	0.759
mih-criteria	HYPHENATION	Good	1.0	0.759	0.759
mesial drift	Normal_NP	Good	1	0.759	0.759
melanogenesis	SIMPLE	Good	1	0.759	0.759
manh newspaper	Normal_NP	Good	1	0.759	0.759
liver injury	Normal_NP	Good	1	0.759	0.759
liposomal pbs	Normal_NP	Good	1	0.759	0.759
lateral palpation	Normal_NP	Good	1	0.759	0.759
laryngoscopy	SIMPLE	Good	1	0.759	0.759
ladd syndrome	Normal_NP	Good	1	0.759	0.759
knockin mouse	Normal_NP	Good	1	0.759	0.759
kidney tubules	Normal_NP	Good	1	0.759	0.759
kentucky usa	Normal_NP	Good	1	0.759	0.759
johannesburg	SIMPLE	Good	1	0.759	0.759
iupac representatives	Normal_NP	Good	1	0.759	0.759
intra-examiner	HYPHENATION	Good	1.0	0.759	0.759
infra-occlusion	HYPHENATION	Good	1.0	0.759	0.759
ige manifests	Normal_NP	Good	1	0.759	0.759
icu participation	Normal_NP	Good	1	0.759	0.759
hypocalcemia	SIMPLE	Good	1	0.759	0.759
hyperechogenicity	SIMPLE	Good	1	0.759	0.759
hydroxyl radicals	Normal_NP	Good	1	0.759	0.759
hup programme	Normal_NP	Good	1	0.759	0.759
hp sero-staus	Normal_NP	Good	1	0.759	0.759
her2 expression	Normal_NP	Good	1	0.759	0.759
hemophagocytic	SIMPLE	Good	1	0.759	0.759
hemodiafiltration	SIMPLE	Good	1	0.759	0.759
hcv coinfection	Normal_NP	Good	1	0.759	0.759
gfap expression	Normal_NP	Good	1	0.759	0.759
fungal hyphae	Normal_NP	Good	1	0.759	0.759
focal infection	Normal_NP	Good	1	0.759	0.759
fibroadenoma	SIMPLE	Good	1	0.759	0.759
fgf receptors	Normal_NP	Good	1	0.759	0.759
fatal familial	Normal_NP	Good	1	0.759	0.759
eyelid tumor	Normal_NP	Good	1	0.759	0.759
ed physicians	Normal_NP	Good	1	0.759	0.759
diuretic doses	Normal_NP	Good	1	0.759	0.759
dialysis modality	Normal_NP	Good	1	0.759	0.759
diagnostisch	SIMPLE	Good	1	0.759	0.759
dhabi declaration	Normal_NP	Good	1	0.759	0.759
daghestanicus	SIMPLE	Good	1	0.759	0.759
corpus uteri	Normal_NP	Good	1	0.759	0.759
cofactor activity	Normal_NP	Good	1	0.759	0.759
cofa citizens	Normal_NP	Good	1	0.759	0.759
clinical rbd	Normal_NP	Good	1	0.759	0.759
chloride ion	Normal_NP	Good	1	0.759	0.759
chemoprevention	SIMPLE	Good	1	0.759	0.759
cell transplant	Normal_NP	Good	1	0.759	0.759
carbapenemases	SIMPLE	Good	1	0.759	0.759
bereshchenko	SIMPLE	Good	1	0.759	0.759
baseline lcl	Normal_NP	Good	1	0.759	0.759
avp receptor	Normal_NP	Good	1	0.759	0.759
auditory latencies	Normal_NP	Good	1	0.759	0.759
asd children	Normal_NP	Good	1	0.759	0.759
arteriopathy	SIMPLE	Good	1	0.759	0.759
aptt prolongation	Normal_NP	Good	1	0.759	0.759
antibody titers	Normal_NP	Good	1	0.759	0.759
anti-microbial	HYPHENATION	Good	1.0	0.759	0.759
annuloplasty	SIMPLE	Good	1	0.759	0.759
amniocentesis	SIMPLE	Good	1	0.759	0.759
aggregometry	SIMPLE	Good	1	0.759	0.759
adult plasma	Normal_NP	Good	1	0.759	0.759
adp-cartridge	HYPHENATION	Good	1.0	0.759	0.759
itp	ABBREVIATION	Good	1	0.7576	0.7576
city health development plan	Normal_NP	Good	1	0.7568	0.7568
ischemic heart	Normal_NP	Good	1	0.7561	0.7561
siadh	ABBREVIATION	Good	1	0.7554	0.7554
pv ar	Normal_NP	Good	1	0.7554	0.7554
prrt2	ABBREVIATION	Good	1	0.7554	0.7554
pipaq	SIMPLE	Good	1	0.7554	0.7554
p-hpt	ABBREVIATION	Good	1	0.7554	0.7554
minimization	SIMPLE	Good	1	0.7554	0.7554
irlen	SIMPLE	Good	1	0.7554	0.7554
dmepos	SIMPLE	Good	1	0.7554	0.7554
cstat	SIMPLE	Good	1	0.7554	0.7554
avado	SIMPLE	Good	1	0.7554	0.7554
vca-igm	HYPHENATION	Good	1.0	0.7539	0.7539
vca-igg	HYPHENATION	Good	1.0	0.7539	0.7539
vasoactive	SIMPLE	Good	1	0.7539	0.7539
uhh cop	Normal_NP	Good	1	0.7539	0.7539
tourette	SIMPLE	Good	1	0.7539	0.7539
st jude	Normal_NP	Good	1	0.7539	0.7539
rubella	SIMPLE	Good	1	0.7539	0.7539
pac-qol	ABBREVIATION	Good	1	0.7539	0.7539
oralmedic	SIMPLE	Good	1	0.7539	0.7539
oq scores	Normal_NP	Good	1	0.7539	0.7539
la vida	Normal_NP	Good	1	0.7539	0.7539
inr poc	Normal_NP	Good	1	0.7539	0.7539
hemiface	SIMPLE	Good	1	0.7539	0.7539
fragilis	SIMPLE	Good	1	0.7539	0.7539
fanzago	SIMPLE	Good	1	0.7539	0.7539
ebv-dna	HYPHENATION	Good	1.0	0.7539	0.7539
chuukese	SIMPLE	Good	1	0.7539	0.7539
avastin	SIMPLE	Good	1	0.7539	0.7539
onabotulinumtoxin	SIMPLE	Good	1	0.7518	0.7518
maxillary incisor	Normal_NP	Good	1	0.7518	0.7518
kazakhstan republic	Normal_NP	Good	1	0.7518	0.7518
daptomycin	SIMPLE	Good	1	0.7511	0.7511
work--models	HYPHENATION	Good	1.0	0.7503	0.7503
wnt protein	Normal_NP	Good	1	0.7503	0.7503
wadsworthia	SIMPLE	Good	1	0.7503	0.7503
vwd patients	Normal_NP	Good	1	0.7503	0.7503
visuo-spatial	HYPHENATION	Good	1.0	0.7503	0.7503
verb conjugation	Normal_NP	Good	1	0.7503	0.7503
vegf release	Normal_NP	Good	1	0.7503	0.7503
valve coaptation	Normal_NP	Good	1	0.7503	0.7503
v2 receptor	Normal_NP	Good	1	0.7503	0.7503
underutilisation	SIMPLE	Good	1	0.7503	0.7503
uk cf trust	Normal_NP	Good	1	0.7503	0.7503
total femur	Normal_NP	Good	1	0.7503	0.7503
thereof--are	HYPHENATION	Good	1.0	0.7503	0.7503
std prevention	Normal_NP	Good	1	0.7503	0.7503
sialography	SIMPLE	Good	1	0.7503	0.7503
serum elisas	Normal_NP	Good	1	0.7503	0.7503
seizure-free	HYPHENATION	Good	1.0	0.7503	0.7503
rrt patients	Normal_NP	Good	1	0.7503	0.7503
rogawski ma	Normal_NP	Good	1	0.7503	0.7503
robert john	Normal_NP	Good	1	0.7503	0.7503
redox index	Normal_NP	Good	1	0.7503	0.7503
reconstitution	SIMPLE	Good	1	0.7503	0.7503
realpolitik	SIMPLE	Good	1	0.7503	0.7503
re-socialisation	HYPHENATION	Good	1.0	0.7503	0.7503
radioisotopic	SIMPLE	Good	1	0.7503	0.7503
pth metabolism	Normal_NP	Good	1	0.7503	0.7503
pseudocoloring	SIMPLE	Good	1	0.7503	0.7503
prrt2 mutations	Normal_NP	Good	1	0.7503	0.7503
protonophore	SIMPLE	Good	1	0.7503	0.7503
posttraumatic	SIMPLE	Good	1	0.7503	0.7503
polychromaticity	SIMPLE	Good	1	0.7503	0.7503
pneumocystis	SIMPLE	Good	1	0.7503	0.7503
pneumococci	SIMPLE	Good	1	0.7503	0.7503
pkd patients	Normal_NP	Good	1	0.7503	0.7503
pka account	Normal_NP	Good	1	0.7503	0.7503
pasi outcomes	Normal_NP	Good	1	0.7503	0.7503
parathyroids	SIMPLE	Good	1	0.7503	0.7503
paracetamol	SIMPLE	Good	1	0.7503	0.7503
ova-301 trial	Normal_NP	Good	1	0.7503	0.7503
outreach initiative	Normal_NP	Good	1	0.7503	0.7503
ornithodoros	SIMPLE	Good	1	0.7503	0.7503
o3 concentration	Normal_NP	Good	1	0.7503	0.7503
nz research	Normal_NP	Good	1	0.7503	0.7503
novel hibch	Normal_NP	Good	1	0.7503	0.7503
nodal status	Normal_NP	Good	1	0.7503	0.7503
niche adhesion	Normal_NP	Good	1	0.7503	0.7503
nfle seizures	Normal_NP	Good	1	0.7503	0.7503
neuroanatomical	SIMPLE	Good	1	0.7503	0.7503
nasal lavage	Normal_NP	Good	1	0.7503	0.7503
myeloid cells	Normal_NP	Good	1	0.7503	0.7503
mthfr mutations	Normal_NP	Good	1	0.7503	0.7503
mrsa strains	Normal_NP	Good	1	0.7503	0.7503
morbillorum	SIMPLE	Good	1	0.7503	0.7503
mineral jsc	Normal_NP	Good	1	0.7503	0.7503
micronesians	SIMPLE	Good	1	0.7503	0.7503
likert scale	Normal_NP	Good	1	0.7503	0.7503
leukocytosis	SIMPLE	Good	1	0.7503	0.7503
leiv-krg760	HYPHENATION	Good	1.0	0.7503	0.7503
lai therapy	Normal_NP	Good	1	0.7503	0.7503
kustanaiskie	SIMPLE	Good	1	0.7503	0.7503
kupffer cells	Normal_NP	Good	1	0.7503	0.7503
joint bleedings	Normal_NP	Good	1	0.7503	0.7503
intersectoral	SIMPLE	Good	1	0.7503	0.7503
intensivist	SIMPLE	Good	1	0.7503	0.7503
infraocclusion	SIMPLE	Good	1	0.7503	0.7503
infibrocystic	SIMPLE	Good	1	0.7503	0.7503
immunoregulation	SIMPLE	Good	1	0.7503	0.7503
ia-05 trial	Normal_NP	Good	1	0.7503	0.7503
hypnic jerks	Normal_NP	Good	1	0.7503	0.7503
hotspot mutation	Normal_NP	Good	1	0.7503	0.7503
high-sensitivity	HYPHENATION	Good	1.0	0.7503	0.7503
hia practice	Normal_NP	Good	1	0.7503	0.7503
hermann von	Normal_NP	Good	1	0.7503	0.7503
hemophiliaa	SIMPLE	Good	1	0.7503	0.7503
helsingborg	SIMPLE	Good	1	0.7503	0.7503
hbe antigen	Normal_NP	Good	1	0.7503	0.7503
haemolyticus	SIMPLE	Good	1	0.7503	0.7503
haematocrit	SIMPLE	Good	1	0.7503	0.7503
haemarthroses	SIMPLE	Good	1	0.7503	0.7503
glycopeptides	SIMPLE	Good	1	0.7503	0.7503
genital hpv	Normal_NP	Good	1	0.7503	0.7503
gene intron	Normal_NP	Good	1	0.7503	0.7503
gas-particle	HYPHENATION	Good	1.0	0.7503	0.7503
gait rhythm	Normal_NP	Good	1	0.7503	0.7503
fviii dosage	Normal_NP	Good	1	0.7503	0.7503
flupentixol	SIMPLE	Good	1	0.7503	0.7503
fihp families	Normal_NP	Good	1	0.7503	0.7503
fgfr ligand	Normal_NP	Good	1	0.7503	0.7503
fetal wellbeing	Normal_NP	Good	1	0.7503	0.7503
femoral bone	Normal_NP	Good	1	0.7503	0.7503
exogenous cation	Normal_NP	Good	1	0.7503	0.7503
evolut valve	Normal_NP	Good	1	0.7503	0.7503
eneas study	Normal_NP	Good	1	0.7503	0.7503
eggerthella	SIMPLE	Good	1	0.7503	0.7503
eeep median	Normal_NP	Good	1	0.7503	0.7503
dna cleavage	Normal_NP	Good	1	0.7503	0.7503
dic multiple	Normal_NP	Good	1	0.7503	0.7503
dentine lesions	Normal_NP	Good	1	0.7503	0.7503
daptmomycin	SIMPLE	Good	1	0.7503	0.7503
dalbavancin	SIMPLE	Good	1	0.7503	0.7503
css exacerbations	Normal_NP	Good	1	0.7503	0.7503
cotransporter	SIMPLE	Good	1	0.7503	0.7503
cosmetic bt	Normal_NP	Good	1	0.7503	0.7503
constellatus	SIMPLE	Good	1	0.7503	0.7503
collinsella	SIMPLE	Good	1	0.7503	0.7503
cofa treaties	Normal_NP	Good	1	0.7503	0.7503
chronic itp	Normal_NP	Good	1	0.7503	0.7503
chromium stent	Normal_NP	Good	1	0.7503	0.7503
ceftobiprole	SIMPLE	Good	1	0.7503	0.7503
care-service	HYPHENATION	Good	1.0	0.7503	0.7503
care--single	HYPHENATION	Good	1.0	0.7503	0.7503
bedside inr	Normal_NP	Good	1	0.7503	0.7503
baluchistan	SIMPLE	Good	1	0.7503	0.7503
b-precursor	HYPHENATION	Good	1.0	0.7503	0.7503
albumin-free	HYPHENATION	Good	1.0	0.7503	0.7503
airtum cancer	Normal_NP	Good	1	0.7503	0.7503
agnew gamble	Normal_NP	Good	1	0.7503	0.7503
wmv	ABBREVIATION	Good	1	0.7496	0.7496
nbs	SIMPLE	Good	1	0.7496	0.7496
eox	ABBREVIATION	Good	1	0.7496	0.7496
noninferiority	SIMPLE	Good	1	0.7489	0.7489
ptosis	SIMPLE	Good	1	0.7482	0.7482
symptomatic aortic stenosis	Normal_NP	Good	1	0.7467	0.7467
oncology practice	Normal_NP	Good	1	0.7453	0.7453
vwf-deficient	HYPHENATION	Good	1.0	0.7446	0.7446
virus replication	Normal_NP	Good	1	0.7446	0.7446
vincristine	SIMPLE	Good	1	0.7446	0.7446
vancomycin	SIMPLE	Good	1	0.7446	0.7446
undersampling	SIMPLE	Good	1	0.7446	0.7446
tropheryma	SIMPLE	Good	1	0.7446	0.7446
transfemoral	SIMPLE	Good	1	0.7446	0.7446
total-variation	HYPHENATION	Good	1.0	0.7446	0.7446
time--four	HYPHENATION	Good	1.0	0.7446	0.7446
thecorreio	SIMPLE	Good	1	0.7446	0.7446
tamdy virus	Normal_NP	Good	1	0.7446	0.7446
tajikistan	SIMPLE	Good	1	0.7446	0.7446
stereo-eeg	HYPHENATION	Good	1.0	0.7446	0.7446
stent housing	Normal_NP	Good	1	0.7446	0.7446
sinuplasty	SIMPLE	Good	1	0.7446	0.7446
segmentary	SIMPLE	Good	1	0.7446	0.7446
rio conference	Normal_NP	Good	1	0.7446	0.7446
repositionable	SIMPLE	Good	1	0.7446	0.7446
repeat-dose	HYPHENATION	Good	1.0	0.7446	0.7446
pulmonology	SIMPLE	Good	1	0.7446	0.7446
pth secretion	Normal_NP	Good	1	0.7446	0.7446
prrt2 gene	Normal_NP	Good	1	0.7446	0.7446
prr2 mutations	Normal_NP	Good	1	0.7446	0.7446
pre-diabetes	HYPHENATION	Good	1.0	0.7446	0.7446
pontresina	SIMPLE	Good	1	0.7446	0.7446
phantom ct	Normal_NP	Good	1	0.7446	0.7446
pepsinogens	SIMPLE	Good	1	0.7446	0.7446
paulo elites	Normal_NP	Good	1	0.7446	0.7446
particle sizer	Normal_NP	Good	1	0.7446	0.7446
overinfection	SIMPLE	Good	1	0.7446	0.7446
over-activation	HYPHENATION	Good	1.0	0.7446	0.7446
onex-geneve	HYPHENATION	Good	1.0	0.7446	0.7446
npwe model	Normal_NP	Good	1	0.7446	0.7446
normal eeg	Normal_NP	Good	1	0.7446	0.7446
non-modifiable	HYPHENATION	Good	1.0	0.7446	0.7446
non-eb-hlh	HYPHENATION	Good	1.0	0.7446	0.7446
non-comparative	HYPHENATION	Good	1.0	0.7446	0.7446
nitinol stent	Normal_NP	Good	1	0.7446	0.7446
naso-gastric	HYPHENATION	Good	1.0	0.7446	0.7446
myometrium	SIMPLE	Good	1	0.7446	0.7446
mp definition	Normal_NP	Good	1	0.7446	0.7446
misdiagnoses	SIMPLE	Good	1	0.7446	0.7446
microabrasion	SIMPLE	Good	1	0.7446	0.7446
mastopathy	SIMPLE	Good	1	0.7446	0.7446
maldi-imaging	HYPHENATION	Good	1.0	0.7446	0.7446
lunate bones	Normal_NP	Good	1	0.7446	0.7446
limb amputation	Normal_NP	Good	1	0.7446	0.7446
legionella	SIMPLE	Good	1	0.7446	0.7446
laterotrusion	SIMPLE	Good	1	0.7446	0.7446
kyrgyzstan	SIMPLE	Good	1	0.7446	0.7446
kondratiev	SIMPLE	Good	1	0.7446	0.7446
key comparators	Normal_NP	Good	1	0.7446	0.7446
kappa scores	Normal_NP	Good	1	0.7446	0.7446
interstitial	SIMPLE	Good	1	0.7446	0.7446
ino brasil	Normal_NP	Good	1	0.7446	0.7446
hypohidrotic	SIMPLE	Good	1	0.7446	0.7446
hugh agnew	Normal_NP	Good	1	0.7446	0.7446
hpv detection	Normal_NP	Good	1	0.7446	0.7446
hospitalisation	SIMPLE	Good	1	0.7446	0.7446
hcv-infection	HYPHENATION	Good	1.0	0.7446	0.7446
hcss scores	Normal_NP	Good	1	0.7446	0.7446
gentamycin	SIMPLE	Good	1	0.7446	0.7446
genotype b	Normal_NP	Good	1	0.7446	0.7446
generalists	SIMPLE	Good	1	0.7446	0.7446
gender-equal	HYPHENATION	Good	1.0	0.7446	0.7446
genbank id	Normal_NP	Good	1	0.7446	0.7446
game changer	Normal_NP	Good	1	0.7446	0.7446
fmri studies	Normal_NP	Good	1	0.7446	0.7446
fludarabine	SIMPLE	Good	1	0.7446	0.7446
floodplains	SIMPLE	Good	1	0.7446	0.7446
fibrin glue	Normal_NP	Good	1	0.7446	0.7446
fgf10 gene	Normal_NP	Good	1	0.7446	0.7446
f concentrations	Normal_NP	Good	1	0.7446	0.7446
enterobacter	SIMPLE	Good	1	0.7446	0.7446
ec account	Normal_NP	Good	1	0.7446	0.7446
dynamic ct	Normal_NP	Good	1	0.7446	0.7446
dissociatus	SIMPLE	Good	1	0.7446	0.7446
disinhibition	SIMPLE	Good	1	0.7446	0.7446
disconnection	SIMPLE	Good	1	0.7446	0.7446
dhr--ready	HYPHENATION	Good	1.0	0.7446	0.7446
correio da	Normal_NP	Good	1	0.7446	0.7446
complica tions	Normal_NP	Good	1	0.7446	0.7446
colposcopy	SIMPLE	Good	1	0.7446	0.7446
cofa peoples	Normal_NP	Good	1	0.7446	0.7446
chest hrct	Normal_NP	Good	1	0.7446	0.7446
cdc73 gene	Normal_NP	Good	1	0.7446	0.7446
catarrhalis	SIMPLE	Good	1	0.7446	0.7446
cardiovirus	SIMPLE	Good	1	0.7446	0.7446
c-13 studies	Normal_NP	Good	1	0.7446	0.7446
best--back	HYPHENATION	Good	1.0	0.7446	0.7446
atomoxetine	SIMPLE	Good	1	0.7446	0.7446
apgar score	Normal_NP	Good	1	0.7446	0.7446
antiaggregation	SIMPLE	Good	1	0.7446	0.7446
alcoholists	SIMPLE	Good	1	0.7446	0.7446
aerofaciens	SIMPLE	Good	1	0.7446	0.7446
adult obesity	Normal_NP	Good	1	0.7446	0.7446
adult adhd	Normal_NP	Good	1	0.7446	0.7446
adalimumab	SIMPLE	Good	1	0.7446	0.7446
acurate ta	Normal_NP	Good	1	0.7446	0.7446
proof-of-concept study	Normal_NP	Good	1	0.7432	0.7432
multidisciplinary communication strategies	Normal_NP	Good	1	0.7424	0.7424
cisplatin	SIMPLE	Good	1	0.7417	0.7417
stereotactic radiotherapy	Normal_NP	Good	1	0.741	0.741
inr	ABBREVIATION	Good	1	0.7403	0.7403
low-intensity	HYPHENATION	Good	1.0	0.7396	0.7396
aeruginosa	SIMPLE	Good	1	0.7396	0.7396
symetis	SIMPLE	Good	1	0.7389	0.7389
rfviia	SIMPLE	Good	1	0.7389	0.7389
nc-rbd	ABBREVIATION	Good	1	0.7389	0.7389
nacional	SIMPLE	Good	1	0.7389	0.7389
mg tid	Normal_NP	Good	1	0.7389	0.7389
hg cin	Normal_NP	Good	1	0.7389	0.7389
h-visa	HYPHENATION	Good	1.0	0.7389	0.7389
fr dfm	Normal_NP	Good	1	0.7389	0.7389
danville	SIMPLE	Good	1	0.7389	0.7389
cofa nations	Normal_NP	Good	1	0.7389	0.7389
cloacae	SIMPLE	Good	1	0.7389	0.7389
canthus	SIMPLE	Good	1	0.7389	0.7389
inter-hospital transport	Normal_NP	Good	1	0.7367	0.7367
voc	SIMPLE	Good	1	0.736	0.736
years-plus	HYPHENATION	Good	1.0	0.7339	0.7339
wnt activation	Normal_NP	Good	1	0.7339	0.7339
vwf-fviii	HYPHENATION	Good	1.0	0.7339	0.7339
voor adhd	Normal_NP	Good	1	0.7339	0.7339
volunteerism	SIMPLE	Good	1	0.7339	0.7339
video-psg	HYPHENATION	Good	1.0	0.7339	0.7339
venalpina	SIMPLE	Good	1	0.7339	0.7339
uk marketing	Normal_NP	Good	1	0.7339	0.7339
tygecyline	SIMPLE	Good	1	0.7339	0.7339
tv screen	Normal_NP	Good	1	0.7339	0.7339
trichiasis	SIMPLE	Good	1	0.7339	0.7339
total nh3	Normal_NP	Good	1	0.7339	0.7339
total hip	Normal_NP	Good	1	0.7339	0.7339
tmj luxation	Normal_NP	Good	1	0.7339	0.7339
thuringia	SIMPLE	Good	1	0.7339	0.7339
swine flu	Normal_NP	Good	1	0.7339	0.7339
supply agency	Normal_NP	Good	1	0.7339	0.7339
subregions	SIMPLE	Good	1	0.7339	0.7339
sub-sample	HYPHENATION	Good	1.0	0.7339	0.7339
sti management	Normal_NP	Good	1	0.7339	0.7339
static ct	Normal_NP	Good	1	0.7339	0.7339
split-face	HYPHENATION	Good	1.0	0.7339	0.7339
specialisation	SIMPLE	Good	1	0.7339	0.7339
sero-staus	HYPHENATION	Good	1.0	0.7339	0.7339
sapien xt	Normal_NP	Good	1	0.7339	0.7339
re-capturability	HYPHENATION	Good	1.0	0.7339	0.7339
ptyr-binding	HYPHENATION	Good	1.0	0.7339	0.7339
pseudocode	SIMPLE	Good	1	0.7339	0.7339
prosthesis	SIMPLE	Good	1	0.7339	0.7339
prediabetes	SIMPLE	Good	1	0.7339	0.7339
polyreactive	SIMPLE	Good	1	0.7339	0.7339
polymerisation	SIMPLE	Good	1	0.7339	0.7339
picu stay	Normal_NP	Good	1	0.7339	0.7339
pharmamar	SIMPLE	Good	1	0.7339	0.7339
periorbital	SIMPLE	Good	1	0.7339	0.7339
overdosage	SIMPLE	Good	1	0.7339	0.7339
ostia patency	Normal_NP	Good	1	0.7339	0.7339
operationalization	SIMPLE	Good	1	0.7339	0.7339
only rvwf	Normal_NP	Good	1	0.7339	0.7339
oleksandr	SIMPLE	Good	1	0.7339	0.7339
non-metallic	HYPHENATION	Good	1.0	0.7339	0.7339
nccn task	Normal_NP	Good	1	0.7339	0.7339
moraxella	SIMPLE	Good	1	0.7339	0.7339
metachronous	SIMPLE	Good	1	0.7339	0.7339
mendelian	SIMPLE	Good	1	0.7339	0.7339
maxillary	SIMPLE	Good	1	0.7339	0.7339
lung cander	Normal_NP	Good	1	0.7339	0.7339
low-frequency	HYPHENATION	Good	1.0	0.7339	0.7339
louisiana	SIMPLE	Good	1	0.7339	0.7339
long-stay	HYPHENATION	Good	1.0	0.7339	0.7339
linezolid	SIMPLE	Good	1	0.7339	0.7339
lcl severity	Normal_NP	Good	1	0.7339	0.7339
lanthanides	SIMPLE	Good	1	0.7339	0.7339
lai treatment	Normal_NP	Good	1	0.7339	0.7339
j nk ping	Normal_NP	Good	1	0.7339	0.7339
intercurrent	SIMPLE	Good	1	0.7339	0.7339
icu occupancy	Normal_NP	Good	1	0.7339	0.7339
hypoxemia	SIMPLE	Good	1	0.7339	0.7339
hiv-status	HYPHENATION	Good	1.0	0.7339	0.7339
hibch mutations	Normal_NP	Good	1	0.7339	0.7339
heterozygous	SIMPLE	Good	1	0.7339	0.7339
helmholtz	SIMPLE	Good	1	0.7339	0.7339
healthnow	SIMPLE	Good	1	0.7339	0.7339
hbsag titer	Normal_NP	Good	1	0.7339	0.7339
hawaii--a	HYPHENATION	Good	1.0	0.7339	0.7339
haemolysis	SIMPLE	Good	1	0.7339	0.7339
grassroots	SIMPLE	Good	1	0.7339	0.7339
genentech	SIMPLE	Good	1	0.7339	0.7339
fviii-activity	HYPHENATION	Good	1.0	0.7339	0.7339
fviii activity	Normal_NP	Good	1	0.7339	0.7339
foot exam	Normal_NP	Good	1	0.7339	0.7339
fibrocystic	SIMPLE	Good	1	0.7339	0.7339
factor-kb	HYPHENATION	Good	1.0	0.7339	0.7339
f regimens	Normal_NP	Good	1	0.7339	0.7339
ex nihilo	Normal_NP	Good	1	0.7339	0.7339
epien medical	Normal_NP	Good	1	0.7339	0.7339
dna viruses	Normal_NP	Good	1	0.7339	0.7339
dna today	Normal_NP	Good	1	0.7339	0.7339
dna study	Normal_NP	Good	1	0.7339	0.7339
divine agency	Normal_NP	Good	1	0.7339	0.7339
demandingness	SIMPLE	Good	1	0.7339	0.7339
cofa migrants	Normal_NP	Good	1	0.7339	0.7339
co-factor	HYPHENATION	Good	1.0	0.7339	0.7339
chlamydia	SIMPLE	Good	1	0.7339	0.7339
childbearing	SIMPLE	Good	1	0.7339	0.7339
cebpa mutations	Normal_NP	Good	1	0.7339	0.7339
carbocaine	SIMPLE	Good	1	0.7339	0.7339
bt injections	Normal_NP	Good	1	0.7339	0.7339
brackmann	SIMPLE	Good	1	0.7339	0.7339
bookshelf	SIMPLE	Good	1	0.7339	0.7339
bluecross	SIMPLE	Good	1	0.7339	0.7339
biocenosis	SIMPLE	Good	1	0.7339	0.7339
bal fluid	Normal_NP	Good	1	0.7339	0.7339
baku virus	Normal_NP	Good	1	0.7339	0.7339
avp blockers	Normal_NP	Good	1	0.7339	0.7339
asbestosis	SIMPLE	Good	1	0.7339	0.7339
adult prp	Normal_NP	Good	1	0.7339	0.7339
adult itp	Normal_NP	Good	1	0.7339	0.7339
acss scores	Normal_NP	Good	1	0.7339	0.7339
abu dhabi	Normal_NP	Good	1	0.7339	0.7339
2nd world	Normal_NP	Good	1	0.7339	0.7339
high-sensitivity c-reactive protein	Normal_NP	Good	1	0.7332	0.7332
gram-positive bacteria	Normal_NP	Good	1	0.7317	0.7317
vco2	SIMPLE	Good	1	0.731	0.731
tno3	SIMPLE	Good	1	0.731	0.731
tmev	SIMPLE	Good	1	0.731	0.731
rvwf	SIMPLE	Good	1	0.731	0.731
men1	SIMPLE	Good	1	0.731	0.731
gfap	ABBREVIATION	Good	1	0.731	0.731
emla	SIMPLE	Good	1	0.731	0.731
dhpg	SIMPLE	Good	1	0.731	0.731
cstf	ABBREVIATION	Good	1	0.731	0.731
ventricular outflow tract obstruction	Normal_NP	Good	1	0.7303	0.7303
health equity	Normal_NP	Good	1	0.7296	0.7296
epidemiologic study	Normal_NP	Good	1	0.7289	0.7289
metagenome	SIMPLE	Good	1	0.7282	0.7282
docetaxel	SIMPLE	Good	1	0.7282	0.7282
transoesophageal echocardiography	Normal_NP	Good	1	0.7261	0.7261
transcatheter aortic valve replacement	Normal_NP	Good	1	0.7261	0.7261
hemophagocytic lymphohistiocytosis	Normal_NP	Good	1	0.7261	0.7261
hpv infection	Normal_NP	Good	1	0.7254	0.7254
hia	ABBREVIATION	Good	1	0.7247	0.7247
ecx	SIMPLE	Good	1	0.7247	0.7247
ebv	ABBREVIATION	Good	1	0.7247	0.7247
crms	SIMPLE	Good	1	0.7247	0.7247
chp	SIMPLE	Good	1	0.7247	0.7247
chf	ABBREVIATION	Good	1	0.7247	0.7247
acf	ABBREVIATION	Good	1	0.7247	0.7247
brain metastases	Normal_NP	Good	1	0.7239	0.7239
hepatitis b infection	Normal_NP	Good	1	0.7232	0.7232
hematologic malignancies	Normal_NP	Good	1	0.7232	0.7232
laparotomy	SIMPLE	Good	1	0.7225	0.7225
serum sodium	Normal_NP	Good	1	0.7218	0.7218
pediatric critical care medicine	Normal_NP	Good	1	0.7211	0.7211
intrahepatic cholangiocarcinoma	Normal_NP	Good	1	0.7211	0.7211
glucagon-like peptide-1 agonist	Normal_NP	Good	1	0.7211	0.7211
year-plus	HYPHENATION	Good	1.0	0.7204	0.7204
x-ray ct	Normal_NP	Good	1	0.7204	0.7204
whipplei	SIMPLE	Good	1	0.7204	0.7204
visualisation	SIMPLE	Good	1	0.7204	0.7204
vilyuisk	SIMPLE	Good	1	0.7204	0.7204
varadero	SIMPLE	Good	1	0.7204	0.7204
valproate	SIMPLE	Good	1	0.7204	0.7204
uk residents	Normal_NP	Good	1	0.7204	0.7204
tranquilization	SIMPLE	Good	1	0.7204	0.7204
total oc	Normal_NP	Good	1	0.7204	0.7204
total h2	Normal_NP	Good	1	0.7204	0.7204
tmj pain	Normal_NP	Good	1	0.7204	0.7204
sinogram	SIMPLE	Good	1	0.7204	0.7204
showcards	SIMPLE	Good	1	0.7204	0.7204
sf match	Normal_NP	Good	1	0.7204	0.7204
rogawski	SIMPLE	Good	1	0.7204	0.7204
risk hpv	Normal_NP	Good	1	0.7204	0.7204
ptp peep	Normal_NP	Good	1	0.7204	0.7204
premotor	SIMPLE	Good	1	0.7204	0.7204
post-ash	HYPHENATION	Good	1.0	0.7204	0.7204
phenoxides	SIMPLE	Good	1	0.7204	0.7204
particulate	SIMPLE	Good	1	0.7204	0.7204
olsen rw	Normal_NP	Good	1	0.7204	0.7204
objectification	SIMPLE	Good	1	0.7204	0.7204
o brasil	Normal_NP	Good	1	0.7204	0.7204
novel ct	Normal_NP	Good	1	0.7204	0.7204
non-ev71	HYPHENATION	Good	1.0	0.7204	0.7204
non-ca16	HYPHENATION	Good	1.0	0.7204	0.7204
neurogenic	SIMPLE	Good	1	0.7204	0.7204
n-reflex	HYPHENATION	Good	1.0	0.7204	0.7204
mistreatments	SIMPLE	Good	1	0.7204	0.7204
mid-1980s	HYPHENATION	Good	1	0.7204	0.7204
memoriam	SIMPLE	Good	1	0.7204	0.7204
macrolides	SIMPLE	Good	1	0.7204	0.7204
low-mortality	HYPHENATION	Good	1.0	0.7204	0.7204
lentigines	SIMPLE	Good	1	0.7204	0.7204
lais offer	Normal_NP	Good	1	0.7204	0.7204
kras gene	Normal_NP	Good	1	0.7204	0.7204
kirgizia	SIMPLE	Good	1	0.7204	0.7204
kentucky	SIMPLE	Good	1	0.7204	0.7204
kemerovo	SIMPLE	Good	1	0.7204	0.7204
kda fragment	Normal_NP	Good	1	0.7204	0.7204
k-m curve	Normal_NP	Good	1	0.7204	0.7204
k deficiency	Normal_NP	Good	1	0.7204	0.7204
iopromide	SIMPLE	Good	1	0.7204	0.7204
ibandronate	SIMPLE	Good	1	0.7204	0.7204
iatrogenic	SIMPLE	Good	1	0.7204	0.7204
hangzhou	SIMPLE	Good	1	0.7204	0.7204
half-life	HYPHENATION	Good	1.0	0.7204	0.7204
grade-ia	HYPHENATION	Good	1.0	0.7204	0.7204
glitazones	SIMPLE	Good	1	0.7204	0.7204
excerpta	SIMPLE	Good	1	0.7204	0.7204
epigenome	SIMPLE	Good	1	0.7204	0.7204
eeg tracings	Normal_NP	Good	1	0.7204	0.7204
diaspora	SIMPLE	Good	1	0.7204	0.7204
cpr carts	Normal_NP	Good	1	0.7204	0.7204
conselho	SIMPLE	Good	1	0.7204	0.7204
colobomas	SIMPLE	Good	1	0.7204	0.7204
coinfection	SIMPLE	Good	1	0.7204	0.7204
cell-wall	HYPHENATION	Good	1.0	0.7204	0.7204
biopolitics	SIMPLE	Good	1	0.7204	0.7204
bethesda	SIMPLE	Good	1	0.7204	0.7204
b ligand	Normal_NP	Good	1	0.7204	0.7204
argasidae	SIMPLE	Good	1	0.7204	0.7204
ar severity	Normal_NP	Good	1	0.7204	0.7204
anginosus	SIMPLE	Good	1	0.7204	0.7204
angelman	SIMPLE	Good	1	0.7204	0.7204
anamnesis	SIMPLE	Good	1	0.7204	0.7204
ahrq psi	Normal_NP	Good	1	0.7204	0.7204
6th hour	Normal_NP	Good	1	0.7204	0.7204
cabg	ABBREVIATION	Good	1	0.719	0.719
tamdy	SIMPLE	Good	1	0.7169	0.7169
rehab	SIMPLE	Good	1	0.7169	0.7169
pucai	ABBREVIATION	Good	1	0.7169	0.7169
psarc	SIMPLE	Good	1	0.7169	0.7169
pcdai	SIMPLE	Good	1	0.7169	0.7169
parotitis	SIMPLE	Good	1	0.7169	0.7169
nshpt	ABBREVIATION	Good	1	0.7169	0.7169
non-native	HYPHENATION	Good	1.0	0.7169	0.7169
mglur	SIMPLE	Good	1	0.7169	0.7169
graev	SIMPLE	Good	1	0.7169	0.7169
etco2	SIMPLE	Good	1	0.7169	0.7169
eq-5d	ABBREVIATION	Good	1	0.7169	0.7169
bullae	SIMPLE	Good	1	0.7169	0.7169
advate	SIMPLE	Good	1	0.7169	0.7169
multicentre prospective study	Normal_NP	Good	1	0.7148	0.7148
dd	SIMPLE	Good	1	0.7134	0.7134
dismutase	SIMPLE	Good	1	0.7127	0.7127
mbd	SIMPLE	Good	1	0.7113	0.7113
haemophilic arthropathy	Normal_NP	Good	1	0.7106	0.7106
reticulum	SIMPLE	Good	1	0.7099	0.7099
nt-probnp	HYPHENATION	Good	1.0	0.7099	0.7099
video-polysomnography	HYPHENATION	Good	1.0	0.7085	0.7085
paravalvular regurgitation	Normal_NP	Good	1	0.7085	0.7085
osteoblast differentiation	Normal_NP	Good	1	0.7085	0.7085
haemophilus influenzae	Normal_NP	Good	1	0.7085	0.7085
frontal lobe epilepsy	Normal_NP	Good	1	0.7085	0.7085
extracellular calcium	Normal_NP	Good	1	0.7085	0.7085
cystic fibrosis foundation	Normal_NP	Good	1	0.7085	0.7085
fibroblast growth factor-23	Normal_NP	Good	1	0.7071	0.7071
subclinical atherosclerosis	Normal_NP	Good	1	0.7064	0.7064
secondary hyperparathyroidism	Normal_NP	Good	1	0.7064	0.7064
quality-adjusted-life-year	HYPHENATION	Good	1.0	0.7064	0.7064
matrix metalloproteinase-9	Normal_NP	Good	1	0.7064	0.7064
wanfang	SIMPLE	Good	1	0.7057	0.7057
vp1-vp4	HYPHENATION	Good	1.0	0.7057	0.7057
vedotin	SIMPLE	Good	1	0.7057	0.7057
upsampling	SIMPLE	Good	1	0.7057	0.7057
triptans	SIMPLE	Good	1	0.7057	0.7057
treaters	SIMPLE	Good	1	0.7057	0.7057
tangibles	SIMPLE	Good	1	0.7057	0.7057
ta valve	Normal_NP	Good	1	0.7057	0.7057
subdermal	SIMPLE	Good	1	0.7057	0.7057
sga-lais	HYPHENATION	Good	1.0	0.7057	0.7057
saxonia	SIMPLE	Good	1	0.7057	0.7057
saq-icu	HYPHENATION	Good	1.0	0.7057	0.7057
re-agudization	HYPHENATION	Good	1.0	0.7057	0.7057
ras lesions	Normal_NP	Good	1	0.7057	0.7057
psoriatic	SIMPLE	Good	1	0.7057	0.7057
prodrome	SIMPLE	Good	1	0.7057	0.7057
poc inr	Normal_NP	Good	1	0.7057	0.7057
peg-ifn	ABBREVIATION	Good	1	0.7057	0.7057
peduncle	SIMPLE	Good	1	0.7057	0.7057
pac-sym	ABBREVIATION	Good	1	0.7057	0.7057
oxytoca	SIMPLE	Good	1	0.7057	0.7057
overbite	SIMPLE	Good	1	0.7057	0.7057
os patients	Normal_NP	Good	1	0.7057	0.7057
novartis	SIMPLE	Good	1	0.7057	0.7057
nitinol	SIMPLE	Good	1	0.7057	0.7057
mythifying	SIMPLE	Good	1	0.7057	0.7057
mevalonate	SIMPLE	Good	1	0.7057	0.7057
may-june	HYPHENATION	Good	1.0	0.7057	0.7057
mastitis	SIMPLE	Good	1	0.7057	0.7057
lvot-ao	HYPHENATION	Good	1.0	0.7057	0.7057
lung ct	Normal_NP	Good	1	0.7057	0.7057
keratoses	SIMPLE	Good	1	0.7057	0.7057
ivs2-3c	HYPHENATION	Good	1.0	0.7057	0.7057
inactivation	SIMPLE	Good	1	0.7057	0.7057
ili river	Normal_NP	Good	1	0.7057	0.7057
iga-lcl	HYPHENATION	Good	1.0	0.7057	0.7057
ib evidence	Normal_NP	Good	1	0.7057	0.7057
hmg-coa	HYPHENATION	Good	1.0	0.7057	0.7057
hanifin	SIMPLE	Good	1	0.7057	0.7057
germline	SIMPLE	Good	1	0.7057	0.7057
gemella	SIMPLE	Good	1	0.7057	0.7057
g mutation	Normal_NP	Good	1	0.7057	0.7057
fiocruz	SIMPLE	Good	1	0.7057	0.7057
f8 gene	Normal_NP	Good	1	0.7057	0.7057
erp latencies	Normal_NP	Good	1	0.7057	0.7057
engadin	SIMPLE	Good	1	0.7057	0.7057
ecublens	SIMPLE	Good	1	0.7057	0.7057
ebv-hlh	HYPHENATION	Good	1.0	0.7057	0.7057
dysoxia	SIMPLE	Good	1	0.7057	0.7057
dna vai	Normal_NP	Good	1	0.7057	0.7057
diuresis	SIMPLE	Good	1	0.7057	0.7057
desquamation	SIMPLE	Good	1	0.7057	0.7057
dce-mri	HYPHENATION	Good	1.0	0.7057	0.7057
d1 gene	Normal_NP	Good	1	0.7057	0.7057
ct dose	Normal_NP	Good	1	0.7057	0.7057
correio	SIMPLE	Good	1	0.7057	0.7057
coniceps	SIMPLE	Good	1	0.7057	0.7057
ciencias	SIMPLE	Good	1	0.7057	0.7057
changer	SIMPLE	Good	1	0.7057	0.7057
centera	SIMPLE	Good	1	0.7057	0.7057
ce-mark	HYPHENATION	Good	1.0	0.7057	0.7057
ce mark	Normal_NP	Good	1	0.7057	0.7057
catphan	SIMPLE	Good	1	0.7057	0.7057
bsc arm	Normal_NP	Good	1	0.7057	0.7057
armenia	SIMPLE	Good	1	0.7057	0.7057
ar grade	Normal_NP	Good	1	0.7057	0.7057
albicans	SIMPLE	Good	1	0.7057	0.7057
adam-12	HYPHENATION	Good	1.0	0.7057	0.7057
ab fragments	Normal_NP	Good	1	0.7057	0.7057
oral contraception	Normal_NP	Good	1	0.705	0.705
bacterial genome	Normal_NP	Good	1	0.705	0.705
cultural competency	Normal_NP	Good	1	0.7043	0.7043
menorrhagia	SIMPLE	Good	1	0.7029	0.7029
jupiter trial	Normal_NP	Good	1	0.7029	0.7029
chronic synovitis	Normal_NP	Good	1	0.7022	0.7022
tension-type headache	Normal_NP	Good	1	0.7008	0.7008
mycoplasma pneumoniae	Normal_NP	Good	1	0.7008	0.7008
enterococcus faecium	Normal_NP	Good	1	0.7008	0.7008
enterococcus faecalis	Normal_NP	Good	1	0.7008	0.7008
arginine vasopressin	Normal_NP	Good	1	0.7008	0.7008
aortic valve implantation	Normal_NP	Good	1	0.7008	0.7008
peritoneal dialysis patients	Normal_NP	Good	1	0.7001	0.7001
cost-effectiveness studies	Normal_NP	Good	1	0.7001	0.7001
cardiorespiratory arrest	Normal_NP	Good	1	0.7001	0.7001
oral cavity	Normal_NP	Good	1	0.6987	0.6987
ionophore	SIMPLE	Good	1	0.6987	0.6987
ionophor	SIMPLE	Good	1	0.6987	0.6987
ed visit	Normal_NP	Good	1	0.6987	0.6987
authorisation	SIMPLE	Good	1	0.6987	0.6987
acculturation	SIMPLE	Good	1	0.6987	0.6987
bone metastasis	Normal_NP	Good	1	0.6973	0.6973
second-generation antipsychotic	Normal_NP	Good	1	0.6966	0.6966
chronic hepatitis b	Normal_NP	Good	1	0.6959	0.6959
tissue oxidative stress	Normal_NP	Good	1	0.6946	0.6946
childhood atopic dermatitis	Normal_NP	Good	1	0.6946	0.6946
desmopressin	SIMPLE	Good	1	0.6939	0.6939
eb	ABBREVIATION	Good	1	0.6932	0.6932
vwjs	SIMPLE	Good	1	0.6925	0.6925
std	SIMPLE	Good	1	0.6925	0.6925
rvh	SIMPLE	Good	1	0.6925	0.6925
psi	ABBREVIATION	Good	1	0.6925	0.6925
poc	ABBREVIATION	Good	1	0.6925	0.6925
mgy	SIMPLE	Good	1	0.6925	0.6925
l-s	HYPHENATION	Good	1	0.6925	0.6925
hup	ABBREVIATION	Good	1	0.6925	0.6925
hps	SIMPLE	Good	1	0.6925	0.6925
chc	SIMPLE	Good	1	0.6925	0.6925
ca4	SIMPLE	Good	1	0.6925	0.6925
aes	ABBREVIATION	Good	1	0.6925	0.6925
subcortical white matter	Normal_NP	Good	1	0.6918	0.6918
socio-economic development	Normal_NP	Good	1	0.6918	0.6918
second-look ultrasound	Normal_NP	Good	1	0.6918	0.6918
non-melanoma skin cancer	Normal_NP	Good	1	0.6918	0.6918
first-episode psychosis	Normal_NP	Good	1	0.6918	0.6918
end-stage liver disease	Normal_NP	Good	1	0.6918	0.6918
electroencephalography	SIMPLE	Good	1	0.6918	0.6918
cytotoxic chemotherapy	Normal_NP	Good	1	0.6918	0.6918
constitutional symptoms	Normal_NP	Good	1	0.6918	0.6918
transcatheter heart	Normal_NP	Good	1	0.6911	0.6911
postoperative bleedings	Normal_NP	Good	1	0.6911	0.6911
osteoblast proliferation	Normal_NP	Good	1	0.6911	0.6911
osteoblast apoptosis	Normal_NP	Good	1	0.6911	0.6911
dysfunction syndrome	Normal_NP	Good	1	0.6911	0.6911
disease osteoporosis	Normal_NP	Good	1	0.6911	0.6911
aortic valve disease	Normal_NP	Good	1	0.6911	0.6911
wellness	SIMPLE	Good	1	0.6904	0.6904
vhev	SIMPLE	Good	1	0.6904	0.6904
tso4	SIMPLE	Good	1	0.6904	0.6904
tnh3	ABBREVIATION	Good	1	0.6904	0.6904
tamv	ABBREVIATION	Good	1	0.6904	0.6904
spgi	SIMPLE	Good	1	0.6904	0.6904
seeg	ABBREVIATION	Good	1	0.6904	0.6904
npwe	ABBREVIATION	Good	1	0.6904	0.6904
ncct	SIMPLE	Good	1	0.6904	0.6904
mssa	ABBREVIATION	Good	1	0.6904	0.6904
ladd	ABBREVIATION	Good	1	0.6904	0.6904
kemv	ABBREVIATION	Good	1	0.6904	0.6904
hrql	ABBREVIATION	Good	1	0.6904	0.6904
hno2	SIMPLE	Good	1	0.6904	0.6904
hhcy	ABBREVIATION	Good	1	0.6904	0.6904
hcss	SIMPLE	Good	1	0.6904	0.6904
fmea	SIMPLE	Good	1	0.6904	0.6904
fand	SIMPLE	Good	1	0.6904	0.6904
ebdm	ABBREVIATION	Good	1	0.6904	0.6904
cebes	SIMPLE	Good	1	0.6904	0.6904
bakv	SIMPLE	Good	1	0.6904	0.6904
ahrq	SIMPLE	Good	1	0.6904	0.6904
acss	SIMPLE	Good	1	0.6904	0.6904
ev71	SIMPLE	Good	1	0.689	0.689
whilst	SIMPLE	Good	1	0.6877	0.6877
vulval	SIMPLE	Good	1	0.6877	0.6877
vienna	SIMPLE	Good	1	0.6877	0.6877
up-date	HYPHENATION	Good	1.0	0.6877	0.6877
unicef	SIMPLE	Good	1	0.6877	0.6877
ukraine	SIMPLE	Good	1	0.6877	0.6877
tokmak	SIMPLE	Good	1	0.6877	0.6877
synovial	SIMPLE	Good	1	0.6877	0.6877
specifity	SIMPLE	Good	1	0.6877	0.6877
snap25	SIMPLE	Good	1	0.6877	0.6877
sflt-1	HYPHENATION	Good	1.0	0.6877	0.6877
seawater	SIMPLE	Good	1	0.6877	0.6877
reprise	SIMPLE	Good	1	0.6877	0.6877
prenylation	SIMPLE	Good	1	0.6877	0.6877
plasty	SIMPLE	Good	1	0.6877	0.6877
patency	SIMPLE	Good	1	0.6877	0.6877
parietal	SIMPLE	Good	1	0.6877	0.6877
papp-a	HYPHENATION	Good	1.0	0.6877	0.6877
pamoate	SIMPLE	Good	1	0.6877	0.6877
palmitate	SIMPLE	Good	1	0.6877	0.6877
op-notes	HYPHENATION	Good	1.0	0.6877	0.6877
olenev	SIMPLE	Good	1	0.6877	0.6877
noebels	SIMPLE	Good	1	0.6877	0.6877
nihilo	SIMPLE	Good	1	0.6877	0.6877
myogenic	SIMPLE	Good	1	0.6877	0.6877
mouse es	Normal_NP	Good	1	0.6877	0.6877
mitosis	SIMPLE	Good	1	0.6877	0.6877
microg	SIMPLE	Good	1	0.6877	0.6877
malaga	SIMPLE	Good	1	0.6877	0.6877
likert	SIMPLE	Good	1	0.6877	0.6877
lead-6	HYPHENATION	Good	1.0	0.6877	0.6877
lead-5	HYPHENATION	Good	1.0	0.6877	0.6877
lactone	SIMPLE	Good	1	0.6877	0.6877
lacrimal	SIMPLE	Good	1	0.6877	0.6877
kla-cpe	HYPHENATION	Good	1.0	0.6877	0.6877
kcdpb3	SIMPLE	Good	1	0.6877	0.6877
jabsom	SIMPLE	Good	1	0.6877	0.6877
isrctn	SIMPLE	Good	1	0.6877	0.6877
isotype	SIMPLE	Good	1	0.6877	0.6877
hybenx	SIMPLE	Good	1	0.6877	0.6877
humana	SIMPLE	Good	1	0.6877	0.6877
hs-crp	HYPHENATION	Good	1.0	0.6877	0.6877
hpt-jt	HYPHENATION	Good	1.0	0.6877	0.6877
hominis	SIMPLE	Good	1	0.6877	0.6877
h-test	HYPHENATION	Good	1.0	0.6877	0.6877
gi cells	Normal_NP	Good	1	0.6877	0.6877
g-banding	HYPHENATION	Good	1.0	0.6877	0.6877
frisbee	ABBREVIATION	Good	1	0.6877	0.6877
fistulous	SIMPLE	Good	1	0.6877	0.6877
fact-b	ABBREVIATION	Good	1	0.6877	0.6877
f-test	HYPHENATION	Good	1.0	0.6877	0.6877
f dose	Normal_NP	Good	1	0.6877	0.6877
es cells	Normal_NP	Good	1	0.6877	0.6877
equinus	SIMPLE	Good	1	0.6877	0.6877
emollients	SIMPLE	Good	1	0.6877	0.6877
em debate	Normal_NP	Good	1	0.6877	0.6877
ea-igg	HYPHENATION	Good	1.0	0.6877	0.6877
dw-mri	HYPHENATION	Good	1.0	0.6877	0.6877
dr cll	Normal_NP	Good	1	0.6877	0.6877
detorsion	SIMPLE	Good	1	0.6877	0.6877
cofindings	SIMPLE	Good	1	0.6877	0.6877
cingulate	SIMPLE	Good	1	0.6877	0.6877
chop-r	HYPHENATION	Good	1.0	0.6877	0.6877
cander	SIMPLE	Good	1	0.6877	0.6877
caelyx	SIMPLE	Good	1	0.6877	0.6877
ca ions	Normal_NP	Good	1	0.6877	0.6877
burana	SIMPLE	Good	1	0.6877	0.6877
bullous	SIMPLE	Good	1	0.6877	0.6877
ba-hcm	HYPHENATION	Good	1.0	0.6877	0.6877
atypia	SIMPLE	Good	1	0.6877	0.6877
atonia	SIMPLE	Good	1	0.6877	0.6877
areata	SIMPLE	Good	1	0.6877	0.6877
apatite	SIMPLE	Good	1	0.6877	0.6877
antiaging	SIMPLE	Good	1	0.6877	0.6877
af cure	Normal_NP	Good	1	0.6877	0.6877
pharmacokinetic studies	Normal_NP	Good	1	0.687	0.687
open-source framework	Normal_NP	Good	1	0.687	0.687
glutathione peroxidase	Normal_NP	Good	1	0.687	0.687
antimicrobial therapy	Normal_NP	Good	1	0.687	0.687
platelet-rich plasma	Normal_NP	Good	1	0.6863	0.6863
turkmenistan	SIMPLE	Good	1	0.6856	0.6856
periprocedural complication	Normal_NP	Good	1	0.6842	0.6842
optimize patient care	Normal_NP	Good	1	0.6842	0.6842
neoplastic transformation	Normal_NP	Good	1	0.6842	0.6842
nccn member institutions	Normal_NP	Good	1	0.6842	0.6842
intervention project	Normal_NP	Good	1	0.6842	0.6842
community-led coalition	Normal_NP	Good	1	0.6842	0.6842
medtronic	SIMPLE	Good	1	0.6835	0.6835
phospholipids	SIMPLE	Good	1	0.6828	0.6828
postmenopausal women	Normal_NP	Good	1	0.6822	0.6822
transapical access	Normal_NP	Good	1	0.6815	0.6815
sleep-wake transition	Normal_NP	Good	1	0.6815	0.6815
high-risk individuals	Normal_NP	Good	1	0.6815	0.6815
hematologic disorders	Normal_NP	Good	1	0.6815	0.6815
calcium homeostasis	Normal_NP	Good	1	0.6815	0.6815
antirheumatic drugs	Normal_NP	Good	1	0.6815	0.6815
anti-tumor necrosis	Normal_NP	Good	1	0.6815	0.6815
tmj	SIMPLE	Good	1	0.6808	0.6808
subcutaneous injection	Normal_NP	Good	1	0.6801	0.6801
phylogenetic analyses	Normal_NP	Good	1	0.6801	0.6801
metalloproteinase-9	HYPHENATION	Good	1.0	0.6801	0.6801
hyperprolactinaemia	SIMPLE	Good	1	0.6801	0.6801
genetic architecture	Normal_NP	Good	1	0.6801	0.6801
epithelial proliferation	Normal_NP	Good	1	0.6801	0.6801
aortic valve replacement	Normal_NP	Good	1	0.6801	0.6801
antimicrobial classes	Normal_NP	Good	1	0.6801	0.6801
dystonia	SIMPLE	Good	1	0.6787	0.6787
p300	SIMPLE	Good	1	0.6774	0.6774
spectrofluorometry	SIMPLE	Good	1	0.6767	0.6767
predictive biomarkers	Normal_NP	Good	1	0.6767	0.6767
phenotypic expression	Normal_NP	Good	1	0.6767	0.6767
oxidative destruction	Normal_NP	Good	1	0.6767	0.6767
noninvasive ventilation	Normal_NP	Good	1	0.6767	0.6767
microbial pathogens	Normal_NP	Good	1	0.6767	0.6767
methicillin-resistant	HYPHENATION	Good	1.0	0.6767	0.6767
mediterranean diet	Normal_NP	Good	1	0.6767	0.6767
medical oncologists	Normal_NP	Good	1	0.6767	0.6767
low-energy fractures	Normal_NP	Good	1	0.6767	0.6767
lipid hydroperoxides	Normal_NP	Good	1	0.6767	0.6767
isometric contraction	Normal_NP	Good	1	0.6767	0.6767
haemorrhagic shock	Normal_NP	Good	1	0.6767	0.6767
genome-wide association	Normal_NP	Good	1	0.6767	0.6767
cardiac transplantation	Normal_NP	Good	1	0.6767	0.6767
antimicrobial drug	Normal_NP	Good	1	0.6767	0.6767
osteocalcin	SIMPLE	Good	1	0.676	0.676
adiponectin	SIMPLE	Good	1	0.676	0.676
nepal	SIMPLE	Good	1	0.6753	0.6753
paravalvular leak	Normal_NP	Good	1	0.6739	0.6739
trimester exposure	Normal_NP	Good	1	0.6719	0.6719
radiographic findings	Normal_NP	Good	1	0.6719	0.6719
psychosocial skills	Normal_NP	Good	1	0.6719	0.6719
parathyroidectomy	SIMPLE	Good	1	0.6719	0.6719
metastatic breast	Normal_NP	Good	1	0.6719	0.6719
haemostaseologists	SIMPLE	Good	1	0.6719	0.6719
enterobacteriaceae	SIMPLE	Good	1	0.6719	0.6719
depot antipsychotics	Normal_NP	Good	1	0.6719	0.6719
antiblastic treatment	Normal_NP	Good	1	0.6719	0.6719
capecitabine	SIMPLE	Good	1	0.6705	0.6705
year-old children	Normal_NP	Good	1	0.6699	0.6699
vertebral fractures	Normal_NP	Good	1	0.6699	0.6699
underserved population	Normal_NP	Good	1	0.6699	0.6699
psychotic symptoms	Normal_NP	Good	1	0.6699	0.6699
peptide-1 agonist	Normal_NP	Good	1	0.6699	0.6699
nosocomial infection	Normal_NP	Good	1	0.6699	0.6699
interaction affinity	Normal_NP	Good	1	0.6699	0.6699
wellbeing	SIMPLE	Good	1	0.6685	0.6685
vtco2	SIMPLE	Good	1	0.6685	0.6685
uteri	SIMPLE	Good	1	0.6685	0.6685
uk nhs	Normal_NP	Good	1	0.6685	0.6685
uk cf	Normal_NP	Good	1	0.6685	0.6685
triage	SIMPLE	Good	1	0.6685	0.6685
svcam	SIMPLE	Good	1	0.6685	0.6685
stoma	SIMPLE	Good	1	0.6685	0.6685
sindh	SIMPLE	Good	1	0.6685	0.6685
s-eng	HYPHENATION	Good	1.0	0.6685	0.6685
rajka	SIMPLE	Good	1	0.6685	0.6685
pplat	SIMPLE	Good	1	0.6685	0.6685
penile	SIMPLE	Good	1	0.6685	0.6685
ovatus	SIMPLE	Good	1	0.6685	0.6685
oneiric	SIMPLE	Good	1	0.6685	0.6685
ohana	SIMPLE	Good	1	0.6685	0.6685
ntdba	SIMPLE	Good	1	0.6685	0.6685
nssnp	SIMPLE	Good	1	0.6685	0.6685
nowac	SIMPLE	Good	1	0.6685	0.6685
micra	SIMPLE	Good	1	0.6685	0.6685
login	SIMPLE	Good	1	0.6685	0.6685
lenta	SIMPLE	Good	1	0.6685	0.6685
iupac	SIMPLE	Good	1	0.6685	0.6685
hunan	SIMPLE	Good	1	0.6685	0.6685
hrpt2	SIMPLE	Good	1	0.6685	0.6685
hptjt	ABBREVIATION	Good	1	0.6685	0.6685
hbsag	SIMPLE	Good	1	0.6685	0.6685
gunma	SIMPLE	Good	1	0.6685	0.6685
furin	SIMPLE	Good	1	0.6685	0.6685
funct	SIMPLE	Good	1	0.6685	0.6685
fgfr3	SIMPLE	Good	1	0.6685	0.6685
fgfr2	ABBREVIATION	Good	1	0.6685	0.6685
epien	SIMPLE	Good	1	0.6685	0.6685
decimation	SIMPLE	Good	1	0.6685	0.6685
cm-kb	HYPHENATION	Good	1.0	0.6685	0.6685
chuuk	SIMPLE	Good	1	0.6685	0.6685
cf nbs	Normal_NP	Good	1	0.6685	0.6685
cebpa	SIMPLE	Good	1	0.6685	0.6685
cdc73	SIMPLE	Good	1	0.6685	0.6685
buenos	SIMPLE	Good	1	0.6685	0.6685
btxco	SIMPLE	Good	1	0.6685	0.6685
bmp-2	ABBREVIATION	Good	1	0.6685	0.6685
avoli	SIMPLE	Good	1	0.6685	0.6685
ashcn	ABBREVIATION	Good	1	0.6685	0.6685
aphpt	SIMPLE	Good	1	0.6685	0.6685
alkenes	SIMPLE	Good	1	0.6685	0.6685
albinism	SIMPLE	Good	1	0.6685	0.6685
afferents	SIMPLE	Good	1	0.6685	0.6685
aetna	SIMPLE	Good	1	0.6685	0.6685
2-afc	ABBREVIATION	Good	1	0.6685	0.6685
psychoactive substance	Normal_NP	Good	1	0.6678	0.6678
myocytes	SIMPLE	Good	1	0.6665	0.6665
multimers	SIMPLE	Good	1	0.6665	0.6665
meninges	SIMPLE	Good	1	0.6665	0.6665
surgical anatomy	Normal_NP	Good	1	0.6651	0.6651
hepatic dysfunction	Normal_NP	Good	1	0.6651	0.6651
growth factor-23	Normal_NP	Good	1	0.6651	0.6651
base-case analyses	Normal_NP	Good	1	0.6651	0.6651
sclerostin	SIMPLE	Good	1	0.6644	0.6644
interprofessional collaboration	Normal_NP	Good	1	0.6637	0.6637
mutagenesis	SIMPLE	Good	1	0.6631	0.6631
heterozygous mutations	Normal_NP	Good	1	0.6617	0.6617
vascular catheter	Normal_NP	Good	1	0.661	0.661
skeletal biology	Normal_NP	Good	1	0.661	0.661
progression-free	HYPHENATION	Good	1.0	0.661	0.661
nasogastric tube	Normal_NP	Good	1	0.661	0.661
mid-term outcome	Normal_NP	Good	1	0.661	0.661
medline database	Normal_NP	Good	1	0.661	0.661
medical oncology	Normal_NP	Good	1	0.661	0.661
hdl cholesterol	Normal_NP	Good	1	0.661	0.661
gastric fistula	Normal_NP	Good	1	0.661	0.661
electromyographic	SIMPLE	Good	1	0.661	0.661
cytotoxic edema	Normal_NP	Good	1	0.661	0.661
cutaneous flora	Normal_NP	Good	1	0.661	0.661
cadaveric study	Normal_NP	Good	1	0.661	0.661
breast pathology	Normal_NP	Good	1	0.661	0.661
antioxidant balance	Normal_NP	Good	1	0.661	0.661
hs	ABBREVIATION	Good	1	0.6604	0.6604
uhh	SIMPLE	Good	1	0.6597	0.6597
tid	SIMPLE	Good	1	0.6597	0.6597
tfm	ABBREVIATION	Good	1	0.6597	0.6597
svr	ABBREVIATION	Good	1	0.6597	0.6597
spd	SIMPLE	Good	1	0.6597	0.6597
sbp	ABBREVIATION	Good	1	0.6597	0.6597
pvl	ABBREVIATION	Good	1	0.6597	0.6597
pho	ABBREVIATION	Good	1	0.6597	0.6597
nmd	ABBREVIATION	Good	1	0.6597	0.6597
mts	SIMPLE	Good	1	0.6597	0.6597
mcos	SIMPLE	Good	1	0.6597	0.6597
lts	SIMPLE	Good	1	0.6597	0.6597
lcas	ABBREVIATION	Good	1	0.6597	0.6597
ippe	ABBREVIATION	Good	1	0.6597	0.6597
hed	ABBREVIATION	Good	1	0.6597	0.6597
fhh	ABBREVIATION	Good	1	0.6597	0.6597
fbp	ABBREVIATION	Good	1	0.6597	0.6597
evs	SIMPLE	Good	1	0.6597	0.6597
etp	ABBREVIATION	Good	1	0.6597	0.6597
ecf	ABBREVIATION	Good	1	0.6597	0.6597
dhr	SIMPLE	Good	1	0.6597	0.6597
dfm	ABBREVIATION	Good	1	0.6597	0.6597
cpf	SIMPLE	Good	1	0.6597	0.6597
caf	SIMPLE	Good	1	0.6597	0.6597
bpf	ABBREVIATION	Good	1	0.6597	0.6597
asl	ABBREVIATION	Good	1	0.6597	0.6597
ari	ABBREVIATION	Good	1	0.6597	0.6597
aot	SIMPLE	Good	1	0.6597	0.6597
rem sleep behavior disorder	Normal_NP	Good	1	0.6583	0.6583
temporomandibular disorder	Normal_NP	Good	1	0.6577	0.6577
endoscopic sinus surgery	Normal_NP	Good	1	0.6577	0.6577
endocarditis	SIMPLE	Good	1	0.657	0.657
transcatheter heart valve	Normal_NP	Good	1	0.6563	0.6563
pentraxin	SIMPLE	Good	1	0.6556	0.6556
microhardness	SIMPLE	Good	1	0.6556	0.6556
personal genome	Normal_NP	Good	1	0.655	0.655
patient-specific	HYPHENATION	Good	1.0	0.655	0.655
organ dysfunction	Normal_NP	Good	1	0.655	0.655
neoplastic cells	Normal_NP	Good	1	0.655	0.655
multiple organ	Normal_NP	Good	1	0.655	0.655
mr angiography	Normal_NP	Good	1	0.655	0.655
microbiologist	SIMPLE	Good	1	0.655	0.655
methamphetamines	SIMPLE	Good	1	0.655	0.655
laryngeal nerve	Normal_NP	Good	1	0.655	0.655
disease-specific	HYPHENATION	Good	1.0	0.655	0.655
cirrhotic patient	Normal_NP	Good	1	0.655	0.655
baseline severity	Normal_NP	Good	1	0.655	0.655
hcy	ABBREVIATION	Good	1	0.6543	0.6543
semi-solid	HYPHENATION	Good	1.0	0.653	0.653
ct scanner	Normal_NP	Good	1	0.653	0.653
sleep-wake cycle	Normal_NP	Good	1	0.6516	0.6516
pcr london valves	Normal_NP	Good	1	0.6516	0.6516
delirium tremens	Normal_NP	Good	1	0.6516	0.6516
igf-i	HYPHENATION	Good	1.0	0.6509	0.6509
video-analysis	HYPHENATION	Good	1.0	0.6503	0.6503
urine protein	Normal_NP	Good	1	0.6503	0.6503
suboptimal quality	Normal_NP	Good	1	0.6503	0.6503
parotid gland	Normal_NP	Good	1	0.6503	0.6503
optimize patient	Normal_NP	Good	1	0.6503	0.6503
mediterranean	SIMPLE	Good	1	0.6503	0.6503
medical equipment	Normal_NP	Good	1	0.6503	0.6503
health agenda	Normal_NP	Good	1	0.6503	0.6503
galactography	SIMPLE	Good	1	0.6503	0.6503
end-stage liver	Normal_NP	Good	1	0.6503	0.6503
clinical judgment	Normal_NP	Good	1	0.6503	0.6503
zhuo	SIMPLE	Good	1	0.6496	0.6496
yondelis	SIMPLE	Good	1	0.6496	0.6496
vwd1	SIMPLE	Good	1	0.6496	0.6496
vmev	SIMPLE	Good	1	0.6496	0.6496
vaud	SIMPLE	Good	1	0.6496	0.6496
varc	ABBREVIATION	Good	1	0.6496	0.6496
ukads	SIMPLE	Good	1	0.6496	0.6496
tpot	ABBREVIATION	Good	1	0.6496	0.6496
tions	SIMPLE	Good	1	0.6496	0.6496
tfpi	SIMPLE	Good	1	0.6496	0.6496
tfcd	SIMPLE	Good	1	0.6496	0.6496
stbm	SIMPLE	Good	1	0.6496	0.6496
prr2	SIMPLE	Good	1	0.6496	0.6496
pp13	SIMPLE	Good	1	0.6496	0.6496
pmid	SIMPLE	Good	1	0.6496	0.6496
plgf	SIMPLE	Good	1	0.6496	0.6496
nzno	SIMPLE	Good	1	0.6496	0.6496
nanjing	SIMPLE	Good	1	0.6496	0.6496
n400	SIMPLE	Good	1	0.6496	0.6496
n200	SIMPLE	Good	1	0.6496	0.6496
mrf2	SIMPLE	Good	1	0.6496	0.6496
mlpa	ABBREVIATION	Good	1	0.6496	0.6496
men4	SIMPLE	Good	1	0.6496	0.6496
l-pbs	HYPHENATION	Good	1	0.6496	0.6496
irbd	SIMPLE	Good	1	0.6496	0.6496
inca	SIMPLE	Good	1	0.6496	0.6496
ilsi	SIMPLE	Good	1	0.6496	0.6496
hrct	SIMPLE	Good	1	0.6496	0.6496
hmfd	SIMPLE	Good	1	0.6496	0.6496
fihp	ABBREVIATION	Good	1	0.6496	0.6496
esbl	SIMPLE	Good	1	0.6496	0.6496
eneas	SIMPLE	Good	1	0.6496	0.6496
ehcn	ABBREVIATION	Good	1	0.6496	0.6496
ederer	SIMPLE	Good	1	0.6496	0.6496
drd5	SIMPLE	Good	1	0.6496	0.6496
drd4	SIMPLE	Good	1	0.6496	0.6496
diva	ABBREVIATION	Good	1	0.6496	0.6496
dat1	SIMPLE	Good	1	0.6496	0.6496
ctni	SIMPLE	Good	1	0.6496	0.6496
ctdi	SIMPLE	Good	1	0.6496	0.6496
cish	SIMPLE	Good	1	0.6496	0.6496
cin3	SIMPLE	Good	1	0.6496	0.6496
cin1	SIMPLE	Good	1	0.6496	0.6496
cihi	SIMPLE	Good	1	0.6496	0.6496
cde1	SIMPLE	Good	1	0.6496	0.6496
cd30	SIMPLE	Good	1	0.6496	0.6496
cccp	SIMPLE	Good	1	0.6496	0.6496
capd	ABBREVIATION	Good	1	0.6496	0.6496
ca14	SIMPLE	Good	1	0.6496	0.6496
ca12	SIMPLE	Good	1	0.6496	0.6496
c-13	HYPHENATION	Good	1.0	0.6496	0.6496
aprn	SIMPLE	Good	1	0.6496	0.6496
acurate	SIMPLE	Good	1	0.6496	0.6496
2so4	SIMPLE	Good	1	0.6496	0.6496
snr	ABBREVIATION	Good	1	0.6489	0.6489
oq	ABBREVIATION	Good	1	0.6476	0.6476
jv	SIMPLE	Good	1	0.6476	0.6476
hypoplasia	SIMPLE	Good	1	0.6469	0.6469
ca16	ABBREVIATION	Good	1	0.6463	0.6463
aa	ABBREVIATION	Good	1	0.6456	0.6456
decubitus ulcer	Normal_NP	Good	1	0.6443	0.6443
antitumor activity	Normal_NP	Good	1	0.6443	0.6443
wnt	SIMPLE	Good	1	0.6429	0.6429
tcp	ABBREVIATION	Good	1	0.6429	0.6429
b infection	Normal_NP	Good	1	0.6416	0.6416
mantle cell lymphoma	Normal_NP	Good	1	0.6409	0.6409
profilometry	SIMPLE	Good	1	0.6403	0.6403
polycythemia	SIMPLE	Good	1	0.6403	0.6403
lung inflammation	Normal_NP	Good	1	0.6403	0.6403
hydroperoxides	SIMPLE	Good	1	0.6403	0.6403
distal radius	Normal_NP	Good	1	0.6403	0.6403
conceptualisation	SIMPLE	Good	1	0.6403	0.6403
anthropometrics	SIMPLE	Good	1	0.6403	0.6403
multimorbidity	SIMPLE	Good	1	0.6383	0.6383
preeclampsia	SIMPLE	Good	1	0.6376	0.6376
empowerment	SIMPLE	Good	1	0.6369	0.6369
multivariable logistic regression	Normal_NP	Good	1	0.6363	0.6363
morvan syndrome	Normal_NP	Good	1	0.6356	0.6356
hormone secretion	Normal_NP	Good	1	0.6356	0.6356
vitro study	Normal_NP	Good	1	0.635	0.635
vitro evaluation	Normal_NP	Good	1	0.635	0.635
tissue oxidative	Normal_NP	Good	1	0.635	0.635
sub-network	HYPHENATION	Good	1.0	0.635	0.635
skin exfoliation	Normal_NP	Good	1	0.635	0.635
primary dna	Normal_NP	Good	1	0.635	0.635
oncoproteins	SIMPLE	Good	1	0.635	0.635
non-responders	HYPHENATION	Good	1	0.635	0.635
multiresistant	SIMPLE	Good	1	0.635	0.635
multiresistance	SIMPLE	Good	1	0.635	0.635
motion cycle	Normal_NP	Good	1	0.635	0.635
maxillofacial	SIMPLE	Good	1	0.635	0.635
head injury	Normal_NP	Good	1	0.635	0.635
genomic dna	Normal_NP	Good	1	0.635	0.635
electrochemical	SIMPLE	Good	1	0.635	0.635
conjunctiva	SIMPLE	Good	1	0.635	0.635
ca concentration	Normal_NP	Good	1	0.635	0.635
acinetobacter	SIMPLE	Good	1	0.635	0.635
5-fu	ABBREVIATION	Good	1	0.6343	0.6343
who-ehcn	ABBREVIATION	Good	1	0.633	0.633
pakistan	SIMPLE	Good	1	0.633	0.633
toronto	SIMPLE	Good	1	0.6317	0.6317
alveoli	SIMPLE	Good	1	0.6317	0.6317
ptx3	ABBREVIATION	Good	1	0.629	0.629
zymography	SIMPLE	Good	1	0.6277	0.6277
phosphatase	SIMPLE	Good	1	0.6277	0.6277
pathogenetic	SIMPLE	Good	1	0.6277	0.6277
narcolepsy	SIMPLE	Good	1	0.6277	0.6277
immunoblotting	SIMPLE	Good	1	0.6277	0.6277
gadolinium	SIMPLE	Good	1	0.6277	0.6277
excitatory	SIMPLE	Good	1	0.6277	0.6277
epidermidis	SIMPLE	Good	1	0.6277	0.6277
pao2	SIMPLE	Good	1	0.627	0.627
hno3	SIMPLE	Good	1	0.627	0.627
fio2	SIMPLE	Good	1	0.627	0.627
staphylococci	SIMPLE	Good	1	0.6238	0.6238
san francisco	Normal_NP	Good	1	0.6238	0.6238
lobe epilepsy	Normal_NP	Good	1	0.6238	0.6238
lung injury	Normal_NP	Good	1	0.6231	0.6231
wfh	SIMPLE	Good	1	0.6224	0.6224
vrt	ABBREVIATION	Good	1	0.6224	0.6224
vp5	SIMPLE	Good	1	0.6224	0.6224
vp2	SIMPLE	Good	1	0.6224	0.6224
vco	SIMPLE	Good	1	0.6224	0.6224
vai	SIMPLE	Good	1	0.6224	0.6224
upa	SIMPLE	Good	1	0.6224	0.6224
tna	SIMPLE	Good	1	0.6224	0.6224
spg	SIMPLE	Good	1	0.6224	0.6224
sh2	SIMPLE	Good	1	0.6224	0.6224
scs	ABBREVIATION	Good	1	0.6224	0.6224
qmc	SIMPLE	Good	1	0.6224	0.6224
ptt	ABBREVIATION	Good	1	0.6224	0.6224
ptp	SIMPLE	Good	1	0.6224	0.6224
pm2	SIMPLE	Good	1	0.6224	0.6224
nh4	SIMPLE	Good	1	0.6224	0.6224
n03	SIMPLE	Good	1	0.6224	0.6224
mics	SIMPLE	Good	1	0.6224	0.6224
mgc	SIMPLE	Good	1	0.6224	0.6224
lbj	ABBREVIATION	Good	1	0.6224	0.6224
kvp	SIMPLE	Good	1	0.6224	0.6224
jsc	SIMPLE	Good	1	0.6224	0.6224
jrp	ABBREVIATION	Good	1	0.6224	0.6224
jdh	ABBREVIATION	Good	1	0.6224	0.6224
igr	SIMPLE	Good	1	0.6224	0.6224
igh	SIMPLE	Good	1	0.6224	0.6224
iga	ABBREVIATION	Good	1	0.6224	0.6224
ifr	SIMPLE	Good	1	0.6224	0.6224
ied	ABBREVIATION	Good	1	0.6224	0.6224
idv	ABBREVIATION	Good	1	0.6224	0.6224
hdf	ABBREVIATION	Good	1	0.6224	0.6224
hcg	SIMPLE	Good	1	0.6224	0.6224
hcf	ABBREVIATION	Good	1	0.6224	0.6224
gwa	SIMPLE	Good	1	0.6224	0.6224
gth	SIMPLE	Good	1	0.6224	0.6224
gsk	SIMPLE	Good	1	0.6224	0.6224
fio	SIMPLE	Good	1	0.6224	0.6224
fgf	SIMPLE	Good	1	0.6224	0.6224
fga	ABBREVIATION	Good	1	0.6224	0.6224
ffn	SIMPLE	Good	1	0.6224	0.6224
facs	SIMPLE	Good	1	0.6224	0.6224
et2	SIMPLE	Good	1	0.6224	0.6224
e25	SIMPLE	Good	1	0.6224	0.6224
drg	SIMPLE	Good	1	0.6224	0.6224
dhg	SIMPLE	Good	1	0.6224	0.6224
dce	ABBREVIATION	Good	1	0.6224	0.6224
ctn	SIMPLE	Good	1	0.6224	0.6224
cpk	SIMPLE	Good	1	0.6224	0.6224
cpa	ABBREVIATION	Good	1	0.6224	0.6224
ccw	SIMPLE	Good	1	0.6224	0.6224
cb5	SIMPLE	Good	1	0.6224	0.6224
cb2	SIMPLE	Good	1	0.6224	0.6224
ca9	SIMPLE	Good	1	0.6224	0.6224
ca8	SIMPLE	Good	1	0.6224	0.6224
ca5	SIMPLE	Good	1	0.6224	0.6224
ca2	SIMPLE	Good	1	0.6224	0.6224
asrs	SIMPLE	Good	1	0.6224	0.6224
apd	ABBREVIATION	Good	1	0.6224	0.6224
aom	ABBREVIATION	Good	1	0.6224	0.6224
ame	SIMPLE	Good	1	0.6224	0.6224
8th	SIMPLE	Good	1	0.6224	0.6224
4th	SIMPLE	Good	1	0.6224	0.6224
2df	SIMPLE	Good	1	0.6224	0.6224
